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The success of human IVF is essentially determined by the quality of the embryo (itself a 
function of the quality of the oocyte and sperm), the endometrium and of the interaction 
between them. While there are established means of establishing the quality of each 
individually, some of these are limited and, in particular, the embryo-endometrial 
dialogue is difficult to capture and observe. As a result, it is under-studied and, with this 
in mind, the aims of this thesis were threefold: 
 
First, to investigate the corona cell transcriptome of euploid oocytes, RNA sequencing of 
corona cells from individual cumulus oocyte complexes  that developed into euploid 
blastocysts was employed. Alongside bioinformatic and statistical analysis to compare IVF 
outcomes, a mean number of sequence reads of 21.2 million were produced. 
Differentially expressed gene analysis revealed 343 statistically significant transcripts and 
enriched pathway analysis showed WNT signaling, MAPK signaling, focal adhesion and 
TCA cycle to be related to IVF outcome. Specifically, key genes within the WNT/beta-
catenin signaling pathway, including AXIN, were associated with oocyte competence. 
Furthermore, key genes and signaling pathways were identified in corona cell profiles in 
association with IVF outcome following the transfer of euploid blastocysts previously 
vitrified in a frozen embryo transfer. 
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A second study investigated an association between advanced maternal age (AMA) and 
endometriosis on the embryo-endometrial molecular dialogue before implantation. Co-
culture experiments were performed with endometrial epithelial cells (EEC) and 
cryopreserved day 5 blastocysts from AMA or endometriosis patients. Extracellular 
vesicles isolated from the co-culture supernatant were analyzed for miRNA expression 
and revealed significant alterations correlating to AMA or endometriosis. Functional 
annotation analysis of miRNA-target genes revealed enriched pathways for both infertility 
etiologies, including disrupted cell cycle regulation and proliferation. These extracellular 
vesicle-bound secreted miRNAs are key transcriptional regulators in embryo-endometrial 
dialogue. 
 
The third study was concerned with the placental epigenome, which plays a critical role 
in regulating mammalian growth and development. Alterations to placental methylation, 
often observed at imprinted genes, can lead to adverse pregnancy complications such as 
intrauterine growth restriction and preterm birth. Similar associations have been 
observed in offspring derived from advanced paternal age fathers. As parental age at time 
of conception continues to rise, the impact of advanced paternal age on these 
reproductive outcomes is a growing concern, but limited information is available on the 
molecular mechanisms affected in utero. This longitudinal murine research study 
investigated the impact of paternal aging on genomic imprinting. Paternal age 
significantly impacted embryonic placental weight, fetal weight and length, significant 
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hypermethylation was observed upon natural paternal aging and several transcript level 
alterations attributable to advanced paternal age were identified.  
 
This thesis also presents a series of co-authored studies on related subjects such as 
embryonic epigenetic dysregulation, unexplained male factor and the sperm epigenome, 
the dynamic transcriptome of IVF blastocysts in association with infertility, redox balance 
and aging-related changes in the mouse ovary/oocyte, obesity and the human sperm 
proteome. 
 
Collectively, these data could inform the development novel biomarkers for non-invasive 
assessment of oocyte competence and implantation success. They also demonstrate a 
paternal age effect with dysregulation at numerous imprinted loci, providing a 
mechanism for future adverse placental and offspring health conditions. 
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10.0 General Introduction 
 
Infertility is a disease defined by the World Health Organization as “failure to achieve a 
clinical pregnancy after 12 months or more of regular unprotected sexual intercourse” 
(Zegers-Hochschild et al. 2009). According to the European Society for Reproduction and 
Embryology (ESHRE) and National Institute of Health and (NIH) its prevalence is ~ 1 in 6 
of couples trying to conceive. https://medlineplus.gov/infertility.html   
 
According to the most recent data provided by the Centers for Disease Control and 
Prevention, within the United States 35% of couples are diagnosed with infertility due to 
a combination of male and female influences, with 8% of couples experiencing infertility  
as male factor infertility as the principle cause 
(https://www.cdc.gov/reproductivehealth/infertility/index.htm).  There are many factors 
contributing to the infertility phenotype including advanced maternal age, male factor, 
uterine factors, endometriosis, tubal factor, ovulatory disorders, luteal phase defects, 
repeated pregnancy loss, idiopathic (i.e. unknown), health and lifestyle, as well as specific 
oocyte related factors including mitochondrial health, metabolomic processes, spindle 
assembly functionality and meiotic success (Prates, Nunes, and Pereira 2014; Keefe, 
Kumar, and Kalmbach 2015). Infertility treatment regimes are similarly numerous e.g. 
intrauterine (IUI) or intracervical insemination (ICI) for patients with sufficient motile 
sperm available, normal hormone profiles and a functional uterus. Other interventions 
include optimal timing of intercourse, clomiphene citrate treatment to stimulate follicle 
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growth, human chorionic gonadotrophin administration to trigger ovulation or low dose 
gonadotropin administration to encourage ovarian follicular growth. Assisted 
Reproductive Technology (ART) is a generally applied term applied to indicate when 
oocytes, sperm and embryos are handled outside of the body including, significantly, in 
vitro Fertilization (IVF).    
 
10.1. In-vitro fertilization (IVF) 
 
Louise Brown and Alastair MacDonald in 1978 - 1979 are credited as the world’s first IVF 
babies (Steptoe and Edwards 1978) and the approach has significantly improved over the 
years to one that is routine. Within the United States, it is currently estimated that 1 in 6 
couples will have difficulty conceiving a child through conventional means, and will 
require the use of ART in order to be successful (Thoma et al. 2013). According to the 
Society for Assisted Reproductive Technology, In 2017, 248,086 total IVF treatment cycles 
had been performed in the United States. According to the Final National Summary 
Report for 2017, the overall IVF birth rate for first embryo transfers in 2017 is estimated 
to be 31.6 % for women aged 35-37, 21.5 % for women aged 38-40 and 11.2% for women 
aged 41-42 (sartcorsonline.com).  
 
There are essentially three factors that ensure IVF success, namely the quality of the 
oocyte/embryo, uterus and sperm of the infertility patients. IVF begins with hyper-
stimulation of the ovaries, and the subsequent capture of ~10-20 oocytes. To do this, the 
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pituitary gland is downregulated by administration of a dose of a gonadotrophin releasing 
hormone (GnRH) analogue (agonist or antagonist) to suppress endogenous hormone 
expression ahead of cycle commencement. Administration of follicle stimulating 
hormone (FSH) and/or human menopausal gonadotrophin (hMG) results in the 
recruitment and development of multiple antral follicles. Once follicles start to grow, they 
produce estrogen, which causes the endometrial proliferation. Once the follicle reaches 
a diameter of around 17mm, an artificial luteinising hormone (LH) surge is usually 
generated by either a dose of human Chorionic Gonadotropin (hCG) or a combination of 
a high dose agonist/low dose hCG to achieve the same effect. If an embryo transfer is to 
occur in the same cycle (fresh transfer), then progesterone is administered after oocyte 
retrieval to prepare the endometrium and maintain it. On the male side, semen is 
collected by the male partner or donor either by masturbation or more invasive means, 
including testicular sperm aspiration (TESA), percutaneous epididymal sperm aspiration 
(PESA), testicular sperm extraction (TESE), microepididymal sperm aspiration (MESA) or 
microdissection TESE (microTESE) (Coward and Mills 2017).  Next, the sperm is purified 
and concentrated prior to its quality/quantity is analysed.  Specifically, the viscosity, 
volume, color, pH, concentration, motility, vitality, the presence of leukocytes and the 
morphology of the sperm are recorded (Cooper et al. 2010)  Next, to ensure fertilization, 
insemination is performed in the laboratory and sperm are either mixed with the 
collected oocytes (IVF), or injected (intracytoplasmic sperm injection (ICSI)) directly. 
Following fertilisation assessment, the following day (presence of 2 pronuclei), the 
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embryos that have been generated are kept in culture with the hope that a proportion 
will reach blastocyst stage.  
 
Blastocyst transfer usually happens on day 5 post fertilization, and the remaining embryos 
can be vitrified to be transferred in either a later natural or artificial cycle. In a natural 
cycle, embryo transfer is timed either at 7 days following hCG trigger or 6 days following 
LH surge. In an artificial cycle, pituitary gland down-regulation and administration of 
exogenous oestrogen is applied to prepare the endometrium for implantation. When the 





10.2.  Endometrial factors affecting fertility  
 
Implantation is an incredibly complex process determined by both embryonic and 
endometrial factors. Gene expression studies demonstrate noticeable changes during the 
cycle and, at the most receptive phase, growth factors, cytokines, glycoproteins and 
immunosuppressive agents are secreted into the uterine cavity (Melford, Taylor, and 
Konje 2014). The most receptive phase is usually termed the “window of Implantation” 
(WOI) at around 5-7 days post ovulation (Lessey 2000). To ensure appropriate timing for 
embryo transfer timing the WOI, which may differ between patients may be (Ruiz-Alonso 
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et al. 2013; Mahajan 2015). Commercial assays to measure endometrial receptivity and 
the WOI include “ERA” from Igenomix and “ER Peak” from Cooper Surgical. These have 
been developed by analysing a series of genes that are differentially expressed at 
different stages of the cycle. An algorithm is applied to accurately predict a personal WOI 
for women with repeated implantation failure (RIF) (Ruiz-Alonso, Blesa, and Simon 2012). 
Gomez et al (2015) (Gomez et al. 2015) reported that 25% of patients with RIF have an 
altered WOI. A recent randomised controlled trial (RCT) established evidence of proof of 
principle for the potential of using an ERA assay, demonstrating a significant increase in 
cumulative pregnancy rate (intention to treat criteria) when the ERA was used (Simon et 
al. 2020).  
 
This thesis is concerned in part with the genetic quality of the embryo and partly its 
interaction with the endometrium.  
10.3. Factors affecting the quality of the Sperm 
Recently, there have been several meta-analysis studies that show male factors are 
present in 20-70% of all infertility cases. Furthermore, the overall quality of sperm among 
men appears to be in decline (Agarwal et al. 2015; Sengupta et al. 2018; Levine et al. 
2017).  Male fertility is influenced by a variety of factors including environmental, 
occupational and lifestyle choices as well as genetics, which may contribute to 
deteriorating sperm quality.  An example of an external factor that can affect male fertility 
is smoking tobacco.  Cigarette smoke for example contains over 7000 chemicals including 
known carcinogens and volatile organic compounds.  Smoking has been shown to affect 
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male fertility and is associated with leucocytospermia, a major endogenous source of 
reactive oxygen species (ROS).  At elevated levels, these ROS can overwhelm endogenous 
antioxidant defences leading to increased oxidative stress within the spermatozoa, 
compromising male fertility (Harlev et al. 2015).  Specifically smoking has been negatively 
associated with sperm count, concentration motility as well as morphology (Adashi et al. 
1994; Sharma, Harlev, et al. 2016).  Additionally, the use of smoking tobacco products is 
also associated with increases in DNA damage, aneuploidies and mutations in sperm 
(Beal, Yauk, and Marchetti 2017).  Similarly, frequent alcohol use also has negative 
consequences for semen volume and sperm morphology and motility (Li et al. 2011; 
Donnelly et al. 1999).   
 
Males that have excessive fat accumulation resulting in a body mass index >30 have been 
shown to have decreased sperm quality and increased risk of infertility and elevated levels 
of ROS.  A review of 30 studies including a total of 115,158 males found that paternal 
obesity was associated with significantly reduced reproductive potential.  Obese men 
were found to have a higher percentage of sperm with DNA fragmentations, abnormal 
morphology and low mitochondrial membrane potential (Campbell et al. 2015; Lobascio 
et al. 2015).  Additionally, obese men are also more likely to be oligozoospermic or 
azoospermic compared to men of a healthy weight range (Sermondade et al. 2013). 
 
High levels of psychological stress can have serious side effects on the reproductive 
hormones and sperm quality in males.  The HPA axis and gonadotrophin-inhibitory 
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hormone (GnIH) exert an inhibitory effect on the HPG axis and testicular Leydig cells. The 
resulting inhibition of the HPG axis reduces testosterone levels, which leads to changes in 
sertoli cells and the blood–testis barrier. The consequences, cause spermatogenesis to be 
suppressed, and further impairs testosterone secretion (Nargund 2015). 
 
Another known contributor to male infertility is advanced paternal age.  Advanced 
paternal age is not particularly well defined, with most studies estimating it to start 
between 35-50 years of age (Wu, Lipshultz, and Kovac 2016).  A meta-analysis of 90 
studies investigating the effects of advanced paternal age, involving 93 839 participants 
reported a paternal age associated decline in semen volume, sperm total, and progressive 
motility, normal sperm morphology as well as an increase in DNA fragmentation (Johnson 
et al. 2015).  As men advance in age, testicular function and metabolism deteriorates once 
the testis undergoes morphological changes associated with aging, such as a decrease in 
the number of germ cells, leydig and sertoli cells, as well as structural changes, which 
include the narrowing of seminiferous tubules (Gunes et al. 2016). Concentrations of free 
and total testosterone also steadily decline with advanced paternal age, leading to 
primary hypogonadism. Regulation of the HPG axis is also shown to change as men get 
older. Furthermore, accumulation of ROS in male germ cells throughout the course of 
aging leads to oxidative stress, apoptosis and damage to sperm DNA (Gunes et al. 2016). 
 
Finally, genetic factors have been found to contribute up to 15-30% of male infertility.  
Spermatazoa occurs in a sequential manner, and genes are in control of programming the 
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mitotic, meiotic, and postmeiotic differentiation phases (Shamsi, Kumar, and Dada 2011).  
Genetic factors affecting the viability of sperm include chromosomal abnormalities which 
can include both numerical errors and chromosomal anomalies, and account for 5-10% of 
oligozoospermia (which may be balanced or unbalanced), to 15%–25% cases with 
unobstructed azoospermia.  An example of a numerical chromosome error found in male 
infertility is 47, XXY Klinefelter syndrome which is the most common cause of 
azoospermia (11% of cases), and is due to seminiferous tubule dysgenesis.  Interestingly 
studies on the sperm chromosome of Kilenefelter men have shown that the extra 
chromosome is excluded during spermatogenesis, and that these men are able to have 
normal offspring, however there is also an increased risk of aneuploidy (Martin 2008; 
Selice et al. 2010; Rives et al. 2000).   
 
Structural aberrations that can affect male fertility include Robertsonian and reciprocal 
translocations.  Robertsonian translocations result in the fusion long arm of 2 acrocentric 
(Group D chromosomes: 13, 14, 15 and Group G chromosomes: 21, 22, and Y) 
chromosomes.  The fused short arms are typically lost, so the carrier has a chromosomal 
constitution with 45 chromosomes. When the chromosomes pair during meiosis, they do 
so as a trivalent, and the resulting gametes can be chromosomally normal or aneuploid 
with an extra or missing long arm of chromosome (Kumar et al. 2007).  Reciprical 
translocations occur due to an interchange in genetic material between nonhomologous 
chromosomes, and affects ~1% of infertile men (Meza-Espinoza, Anguiano, and Rivera 
2008).  During meiosis, chromosomes pair as quadravalents resulting in a higher 
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frequency of unbalanced chromosomes as compared with carriers of Roberstsonian 
translocations.  Many of these imbalances lead to fetal mortality, with approximately 12% 
of translocation imbalances at prenatal diagnosis being paternally derived (Boue and 
Gallano 1984).  Another structural aberration that may lead to male infertility are 
inversions.  Inversions are balanced structural rearrangements that occurs when 2 
chromosome breaks occur on the same chromosome and join after a 180° rotation, and 
are found within 0.1% of infertile men (Meza-Espinoza, Anguiano, and Rivera 2008).  
Inversions can be paracentric, with both breakpoints are on one chromosome arm and 
exclude the centromere or pericentric, when chromosome breaks include the centromere 
and the short and long arm of the chromosome. 
 
The Y chromosome is the smallest of the human chromosomes, and is polymorphic in 
length, and divided into 7 deletion intervals.  Microdeletions on the long arm of the Y 
chromosome (Yq) is one of the most significant defects associated with male infertility.  
Yq microdeletions are found within 13% azoospermic men, 1%-7% severely 
oligozoospermic men (sperm count less than 0.5 million/mL). These deletions are 
clustered in interval 5 and 6 of the Y chromosome (Colaco and Modi 2018). 
 
Epigenetic modifications control a number of systems found within the body, and 
epigenetic dysregulation/modifications can have significant effects on male fertility.  Two 
modifications that occur in chromatin are DNA methylation and post-translational histone 
modifications.  DNA methylation involves an additional methyl group at the 5’ position of 
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the cytosine pyrimidine ring typically occurring in a CpG dinucleotide (Talbert and 
Henikoff 2006).  Histone modifications include acetylation, methylation, ubiquitylation 
and phosphorylation and are believed to be major contributors to epigenetic regulatory 
mechanisms(Lachner, O'Sullivan, and Jenuwein 2003).   The acetylation of histones marks 
active, transcriptionally competent regions, contrasted by hypoacetylated histones that 
are found in transcriptionally inactive euchromatic or heterochromatic regions. In 
contrast, histone methylation may be a marker for both active and inactive regions of 
chromatin (Tamaru and Selker 2001; Tariq et al. 2003). During gametogenesis, germ cells 
undergo extensive epigenetic reprograming which involves the establishment of sex 
specific patterns in the sperm and oocytes(Loukinov et al. 2002).  These reprograming 
events can be affected by environmental factors which can cause idiopathic male 
infertility and affect implantation potential, placentation, as well as fetal growth (Emery 
and Carrell 2006; Dada et al. 2012; Jenkins et al. 2016).   
 
 
10.4. Factors affecting the quality of the embryo or oocyte 
 
Heavy emphasis is placed on the metric of oocyte/embryo competence, however this 
remains an elusive factor to quantify accurately. Culturing and handling IVF embryos, of 
course, exposes them to environmental stresses to which they otherwise would not have 
been subject. An important objective in all IVF clinics is to generate a stress-free 
environment for IVF and embryo growth, as close to natural conditions as can be made 
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possible (Swain 2010; Swain et al. 2016). Factors to consider include the culture medium, 
the surrounding gaseous environment, the laboratory consumables, pH and temperature.  
 
The culture media currently in use has been continually modified over time, but is still 
based more or less on mouse embryo culture media that formed the basis of model 
species “work up” studies. Principally, it is a balanced salt solution (Chronopoulou and 
Harper 2015). Manufacturers rely on the abundant supply of mouse embryos to assess 
each batch (Quinn and Horstman 1998). This standard practice has limitations, however, 
as mouse embryos have different needs and sensitivity to human ones (Ackerman et al. 
1985; Ackerman et al. 1984). Such tests ensure that media has no obvious toxins and that 
it is able to support growth of mouse embryos to blastocyst.  
 
The precise composition of commercially available culture media are often a trade secret, 
however, they incorporate varying concentrations of glucose, pyruvate, and lactate to 
help embryo development (Gardner and Lane 1996). Contemporary formulations include 
amino acids, chelating agents (EDTA) and growth factors.  
 
In a review by Mantikou the efficacy of different culture media was compared, concluding 
that there was no evidence to demonstrate the superiority of one medium over another 
(Mantikou et al. 2013). Some studies do however demonstrate differences in clinical 
outcomes between different media. For example, an RCT performed by (Kleijkers et al. 
2016) demonstrated an increase in the incidence of low birthweight offspring using once 
Molecular Signatures of Reproductive Success 
35 
 
commercially available medium. Whether or not media constituents or culture 
environment generally affects the dynamics and rate of cell divisions and embryo 
development is still a topic of much debate (Ciray et al. 2012; Meseguer et al. 2012). 
 
As culture conditions have continued to improve, in part because of media development, 
as well as improved knowledge and more sophisticated and reliable incubators, the ability 
to culture embryos beyond day 3, to day 5 has led to blastocyst stage transfer becoming 
more the norm in most quality IVF clinics. 
 
10.5.  Estimating embryo viability by conventional means 
 
Most commonly, the “best” available embryo for transfer are chosen for their 
morphology and kinetics alone. If an embryo has successfully developed beyond day 3 
when the embryonic genome is activated (Niakan et al. 2012) and undergone blastulation, 
is seems reasonable to suggest that it has better chance of implantation compared to one 
that has not. Failure to select a viable embryo for transfer will of course limit the chance 
of a pregnancy in a given treatment cycle. Taking into account highly successful 
vitrification regimes, it is is now thought that “freeze all” strategies and transferring the 
patients’ embryos consecutively (following vitrification and warming) “one by one” can 
have the same end result as selection of the morphologically “best looking” embryo on 
the basis that, at some point, the best embryo will be transferred. However, to minimise 
both the financial and emotional burden on patients, identification and selection of the 
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most viable embryo should be prioritised. Visual observations (including time lapse) 
creates a picture of the quality, or viability of the embryo and the focus is heavily weighted 
on the embryo’s appearance and its progression from fertilisation and through 
development. Given that many of the developing embryo’s morphological features are 
more accurately assessed compared to time (morphokinetics) the assessment should be 
performed within designated, evidence-based time windows. 
 
10.6. Non-Invasive Analysis:  Viability and Developmental 
Competence in Assisted Reproduction 
 
There is a fundamental need within the clinical laboratories of Reproduction 
Endocrinology and Infertility (REI) practices to continually improve and expedite 
assessment methods for the health and overall viability of oocytes and embryos in an IVF 
cycle. Current standards and practices within a modern IVF laboratory primarily use 
extended day 5/6 culture, combined with grading systems based on morphology (Gardner 
and Schoolcraft 1999b), and though widely integrated within daily use, it is unfortunately 
imperfect in regards to questions pertaining to competence and viability. To date, studies 
specifically investigating the embryo attrition rates associated with IVF (from oocyte 
retrieval throughout embryo development to live birth) are scarce.  This may be due to 
individual clinics being reluctant to share the exact breakdown of their loss rate at each 
individual stage of daily embryo development (Zhao et al. 2020).  However, based on 
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clinical data reported to the Society for Assisted Reproductive Technology (SART), the 
likelihood of a single aspirated oocyte to successfully develop and result in a live birth is 
merely ~5% (Patrizio and Caplan 2010). A recent study by Abe et al. found that the live 
birth rate per matured ooctyte in clomiphene citrate only minimal stimulation cycle IVF 
to vary heavily based on infertility etiology, as well as maternal age.  However the loss to 
attrition from oocyte to live birth was exceptionally high in patients of advanced maternal 
age at ~2% (Table 1) (Abe et al. 2020).   
 
Table 1:  Live birth rate per matured oocyte in clomiphene citrate only minimal 
stimulation cycle IVF. 
 
This extremely low efficiency translates to higher cost per patient due to the reality that 
IVF technicians must devote extra time, materials and resources on each oocyte/embryo, 
as it is impossible to select which developing embryo is competent to successfully implant 
and develop following an embryo transfer.  
 
One of the greatest developments in the field of ART, has been the advancement and 
development of pre-genetic testing for aneuploidy (PGT-A), as many studies have 
demonstrated that embryo aneuploidy is the most important factor of IVF failure 
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(Litwicka et al. 2018; Dahdouh, Balayla, and Garcia-Velasco 2015; Sahin et al. 2014). 
Recent 2018 Data from the Society for Assisted Reproductive Technologies (SART)/U.S. 
Centers for Disease Control and Prevention (CDC) reveals that PGT-A improved live birth 
rates by approximately 19.0% from embryos chosen for transfer in women who 
underwent their first embryo transfer (D5/D6 day of transfer; frozen embryo transfer 
only) aged 35-37, and by 25.1% in women aged 38-40  relative to their peers who did not 
utilize PGT-A. This dramatic increase in live birth has revolutionized treatment strategies, 
especially in women presenting with advanced maternal age (defined as women >37 
years of age), where the live birth rate is improved approximately 36.5% (National 
Summary Report. Atlanta: U.S. Department of Health and Human Services, 2018).  
 
Though many IVF laboratories around the world have adopted PGT-A technologies, it 
remains a controversial subject.  Specifically, several studies utilizing PGT-A on cleavage 
stage embryos had somewhat ambiguous or contrarian results with several studies 
finding it to be useful (Munne et al. 1993; Gianaroli et al. 2005) while other RCTs found 
no benefit from the practice (Mastenbroek et al. 2007; Schoolcraft et al. 2009).  
Performing blastomere biopsies at this stage of embryo development (~8 cell stage) is 
very invasive for the growing embryo, and the loss of ~25% of its cells retards its 
development as it now has to regenerate the lost cells.  Although it is considered much 
less invasive, trophectoderm biopsy of blastocysts at the hatching stage is still an invasive 
procedure that injures the embryo.  Often after performing laser assisted biopsy, the 
embryo will pulse in reaction to the large influx of energy, and may take an hour or more 
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to re-expand.  Several studies have questioned whether PGT-A on trophectoderm 
biopsies is necessary at all, as by means of natural selection and attrition, blastocysts tend 
to have a higher euploidy rate than cleavage stage embryos (Kokkali et al. 2007; Fragouli 
et al. 2008).  Finally, for a large proportion of patients, PGT-A may be unnecessary, it is 
prohibitively expensive for many, and for patient populations outside of those presenting 
with advanced maternal age, especially women under 38 years of age, the benefit may 
not be worth the cost as the likelihood of having a transfer grade, euploid embryo within 
a given cycle is high (Murphy et al. 2019; Doyle et al. 2020; Goldman et al. 2018). 
 
A retrospective analysis of 15,162 trophectoderm biopsies with PGT-A, showed that 
beginning at age 26, the rate of aneuploidy begins to notably increase. From a clinical 
perspective, women aged 26-37 seeking ART treatment with PGT-A had at least one 
euploid embryo available for transfer ~96% of the time. Women classified as advanced 
maternal age had less favorable prognoses, with women aged 42 having one or more 
euploid embryos in ~77% of cases. By age 44, the number of patients that produced at 
least one euploid embryo fell to approximately 47% (Figure 1)(Franasiak and Scott 2014). 




Figure 1: A) Prevalence of aneuploidy in embryos relative to the maternal age of the 
female partner. B)  The odds of an ART cycle resulting in no-euploid blastocysts available 
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However, even with these improved rates of positive clinical pregnancy and live birth, 
there remains room for improvement. One ongoing question that researchers continue 
to examine is, what additional factors are causing implantation failure and pregnancy loss 
in the instance of a morphologically top quality, euploid blastocyst embryo transfer into 
a seemingly healthy and receptive endometrium?  Any extraneous factors affecting the 
quality of care, once known and addressed, will help further increase success rates in 
modern ART laboratories, as well as provide additional information for patients. This will 
allow them to make more informed decisions regarding their care, and give them a more 
accurate representation of their probabilities for success. The integration of additional 
accurate, non-invasive means by which to measure developmental competence would be 
a boon to the ART community, and it would potentially reduce the time to conception, 
and increase pregnancy rates and clinical success. 
 
10.6.1. Time-lapse Monitoring Systems 
 
Simple monitoring of morphological characteristics and cleavage rates are the most 
widely used criteria for embryo selection in clinical ART laboratories, used worldwide as 
a selection tool prior to blastocyst transfer (Bromer and Seli 2008). Traditionally, embryos 
are observed and removed from culture incubators every 24-48 hours to limit the 
developing embryos exposure to light and atmospheric changes, giving embryologists 
only select time points of observation. However, up to 70% of embryos created through 
IVF treatment are considered unusable for transfer based on their morphological 
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characteristics, and by some estimations, up to 84.9% of embryos considered selectable 
for transfer based on their morphological characteristics and cleavage rates fail to 
produce a live birth (Min et al. 2010; Kovalevsky and Patrizio 2005; Guerif et al. 2007; 
Racowsky et al. 2009).  
 
Technological advancements have led to the development of time-lapse monitoring 
systems (TMS) that have been integrated into conventional gassed incubator systems. 
TMS generate a developmental time-line specific to each individual embryo, capturing 
images every 10-20 minutes, and do not require periodic removal of embryos from the 
incubator. This provides a non-invasive source of embryo specific morphokinetic 
information, allowing clinicians to capture subtle differences in development between 
embryos of the same cohort, in an effort to discern the top quality blastocyst for transfer 








Figure 2: Example of images taken of a zygote in which the female (fPN) and male (mPN) 
pronuclei were successfully tracked. (a) First and second polar body become visible. (b) A 
male pronuclei (mPN) is formed has moved toward the center of the oocyte. (c–e) A 
female pronuclei fPN has formed close to the second polar body and is being drawn 
toward the mPN. (adapted from Otsuki J et al., 2019)(Otsuki et al. 2019). 
 
An initial randomized control trial investigated use of a TMS with a novel morphokinetic 
algorithm and compared it to a standard cabinet culture incubator combined with routine 
morphological assessment. The results exhibited a significant increase in implantation 
and ongoing pregnancy rates in the TMS group, with a significant decrease in early 
pregnancy loss (Meseguer et al. 2011). The algorithm utilized previously un-used 
morphokinetic time points including duration of the first cytokinesis as well as duration 
of the 3-cell stage, and was determined to be a better oocyte and embryo selection 
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method than standard culture practices. However, after additional studies into the 
technology, the usefulness of TMS remains controversial, with some researchers 
concluding that fully integrating time-lapse imaging technologies into their already 
established daily routines, would not result in a net benefit (Armstrong et al. 2015; Wong, 
Repping, and Mastenbroek 2014). Recently, a meta-analysis of time-lapse culture, 
incorporating morphokinetic embryo selection, was published. This meta-analysis 
examined five randomized control trials including 1637 ART patients. The authors 
concluded that although the studies did not weight equally within the combined dataset, 
all showed some degree of benefit from TMS, with a total increase in ongoing pregnancy 
rates from 39.9% to 51.0% (Pribenszky, Nilselid, and Montag 2017).  
 
One of the noted limitations of the initial TMS studies was the subjective nature of the 
annotations created by individual embryologists monitoring the time lapse data. Although 
embryologists within a single lab may show high levels of congruency, morphokinetic 
milestone annotation becomes much more difficult to normalize across multiple 
locations, with intrinsic inter-reader and intra-reader variability (Storr et al. 2017). In an 
effort to address some of these concerns and integrate new technologies into the existing 
platform, deep learning (a subfield of machine learning) has been utilized to remove as 
much subjectivity from the platform as possible. Combined retrospective data, including 
time lapse imaging and individual annotations from eight IVF laboratories across four 
countries, was incorporated into a deep learning model, which was then able to predict 
positive pregnancy with an average area under the curve (AUC) of 0.90-.95, despite the 
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data coming from different laboratories with different culture and laboratory practices 
(Tran et al. 2019). This model, combining TMS with robust machine learned algorithms 
can provide insight, non-invasively, into the predicted viability of individual embryos, 
giving embryologists additional selection criteria when choosing single transferable grade 
embryos out of a larger cohort of potential candidates. 
 
10.6.2. Spent Culture Media (SCM):  Secretomics, Metabolomics & 
Non-Invasive Screening 
 
Another potentially valuable resource capable of providing developmental information 
for growing embryos, is the excess and often discarded media an embryo has been grown 
in. As an embryo develops and interacts with its environment, it absorbs and releases key 
nutrients found within the media. Previous studies have shown it is possible to observe 
an individual embryos metabolism (metabolome) by measuring the uptake of amino acids 
and carbohydrates from the surrounding media, and creating a unique, individual 
metabolic profile (Lane and Gardner 1996). It has been demonstrated that for the earliest 
stages of embryo development pyruvate is the primary substrate (1-8 cell stage), which 
later shifts to an increasingly glucose driven metabolism during the post compaction 
stages (Leese and Barton 1984; Gott et al. 1990). Embryonic glucose consumption results 
in subsequent lactate production, and it is by this glucose consumption to lactate 
production  ratio that we can quantify an embryos glycolytic rate (Lane and Gardner 
1996). Other important amino acids such as serine and potentially proline, may be 
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predictive of embryo viability, and embryos above a cutoff value for serine showed a 
statistically significant increase in pregnancy rates in a double embryo transfer, 62.5% vs 
12.5% respectively (Zivi et al. 2014).  
 
An embryos secretome is defined as the protein production of an embryo which is then 
sometimes secreted into the surrounding media. Secretome analysis of protein profiles 
of individual blastocysts have shown potential, and researchers have found that increased 
levels of ubiquitin were associated with increased implantation potential (Katz-Jaffe, 
Gardner, and Schoolcraft 2006; Katz-Jaffe, Schoolcraft, and Gardner 2006). Furthermore, 
the secretome from spent media has also been studied in conjunction with aneuploidy 
screening to determine if aneuploid embryos exhibit a different secretomic profile 
compared to euploid embryos. Lipocalin-1 is a protein that is secreted by embryos under 
stress, infection or inflammation and was discovered to be significantly increased in the 
spent media of aneuploid embryos (McReynolds et al. 2011). Embryo metabolism may 
also be used to observe effects of external factors, for example maternal obesity, which 
has been shown to impact embryo metabolism and embryonic development, resulting in 
a reduction of saturated fatty-acids in obese women compared to non-obese women 
(Bellver et al. 2015).  
 
Researchers have also discovered that over the course of their development embryos also 
release genomic DNA and mitochondrial DNA into the surrounding media. In a study of 
699 day 3 SCM samples, this ratio of mitochondrial DNA to genomic DNA was significantly 
Molecular Signatures of Reproductive Success 
47 
 
higher in viable embryos associated with successful implantation (Stigliani et al. 2014). 
Other molecules, including MicroRNAs have also been observed in the spent media of 
cultured embryos, including several microRNA profiles associated with positive IVF 
outcomes including miR-191 and miR-372 (Rosenbluth et al. 2014). Non-invasive 
detection of Mendelian genetic disorders such as alpha-thalassemia, has also been 
investigated by the quantification of cell-free DNA within spent media. When the SCM 
results were compared to traditional biopsy based PGD, researchers found a high rate of 
efficiency for diagnosis of this disorder (Wu et al. 2015).  
 
One principal concern when considering spent media as a non-invasive tool is the 
requirement that embryos must be cultured individually, as it has been established that 
embryos have improved development when cultured together in groups (Holm et al. 
1999; Hoelker et al. 2009). Individual embryo culture in low volumes is important so that 
the  metabolic signature it leaves behind in the spent media is not diluted out by excess 
media and remains detectable. A low volume tool to measure glycolytic activity has been 
under development which utilizes a fused-silica capillary (Madr et al. 2015). This 
technology requires a relatively small volume of media, 2uL, to accurately measure 
pyruvate and lactate substrates, which would be advantageous for single embryo culture 
where low volume media drops allow for a more concentrated substrate for molecular 
analysis.  
 
Molecular Signatures of Reproductive Success 
48 
 
Although promising, there are limitations of metabolomics and spent media analysis, as 
the results have not always been easily reproducible. A study by the Aarhus University of 
Denmark found that NMR analysis of day 3 and day 5 spent media was unable to link the 
embryonic metabolome of good prognosis patients to embryo viability and subsequent 
embryo selection outcome (Kirkegaard et al. 2014). However, metabolomics combined 
with other analysis, such as when used in conjunction with time-lapse imaging software 
may prove to be a useful tool for research. For example, studies have found that 
morphokinetically advanced embryos demonstrated a higher metabolic rate, and 
resulted in higher fetal survival post-implantation compared to embryos with lower 
metabolic rates (Figure 3) (Lee, Thouas, and Gardner 2015). 
 
Figure 3: Correlation between morphokinetic activity and blastocyst carbohydrate 
metabolism. (A) Glucose consumption and lactate production (B) Glycolytic rate of 
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blastocysts, % of glucose converted to lactate. n ≥ 30 embryos per group, 12 biological 
replicates, *P < 0.05, ***P < 0.001. White bars represent ‘fast’ cleaving embryos and dark 
bars represent ‘slow’ cleaving embryos as observed with time lapse imaging (adapted 
from Lee et al., 2015)(Lee, Thouas, and Gardner 2015). 
 
Beyond traditional secretomics and metabolomics investigating culture media, is a newly 
developed a non-invasive PGT-A technique utilizing SCM. As an embryo grows and divides 
throughout its development, small amounts of genomic DNA and mitochondrial DNA are 
shed into the surrounding environment, allowing detection as early as day 2-3 of 
development (Hammond et al. 2017; Yang et al. 2017). It has also been shown that this is 
more than mere DNA contamination, and that the genetic information leaked into the 
culture medium increases during embryo culture (Vera-Rodriguez et al. 2018). The source 
of this genomic DNA is still a cause of debate. Apoptosis of cells is one proposed theory, 
although many healthy embryos display none of the hallmarks of apoptosis as they grow 
and develop, despite this increase of genomic DNA found within SCM (Chi et al. 2011). 
However, SCM samples with the highest concentration of genomic and mitochondrial 
DNA was found in samples associated with poor to average quality blastocysts, with top 
quality blastocysts displaying less on average (Stigliani et al. 2013). Researchers have been 
attempting to use SCM proactively in conjunction with traditional trophectoderm biopsy 
based PGT-A to look for concordance between the two techniques. There are ongoing 
clinical trials investigating SCM use as an alternative source of genomic DNA, and initial 
results from a few pilot studies have been interesting. One report used vitrified embryos 
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combined with next generation sequencing (NGS) and evaluated the results found within 
the day 3-5 SCM and compared it to the corresponding whole blastocyst and discovered 
100% chromosome copy number evaluation in 42 embryos obtained from 17 couples, 
representing the highest rate achieved by a study to date (Figure 4) (Xu et al. 2016).  
 
 
Figure 4:  Example of validation of results from the comparison of non invasive 
chromosome screening (NICS) with spent media, versus the whole-blastocyst embryos 
(adapted figure from Xu J et al., 2016)(Xu et al. 2016). 
 
Additional promising studies have concluded that although the techniques involved could 
use some additional refining, SCM is an alternative source of individual embryonic 
genomic DNA, and may be a promising alternative to more invasive, and technically 
difficult methods of blastocyst trophectoderm biopsy PGT-A screening (Fang et al. 2019; 
Rubio et al. 2019). 
 
10.6.3. Follicular Fluid for Assessing Oocytes 
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During fetal development, primordial germ cells multiply, forming approximately 400,000 
primordial follicles at birth within the ovary. These primordial follicles contain primary 
oocytes that will remain arrested within prophase stage of meiotic division I, until sexual 
maturity is reached. Upon reaching sexual maturity, two hormones, follicle stimulating 
hormone (FSH) and lutenising hormone (LH), are produced by the pituitary gland. The 
production of these hormones results in primary follicle development. In each 
subsequent ovarian cycle, approximately 20 primordial follicles are activated to begin 
maturation and development throughout the stages of folliculogenesis. 
 
Within the standard operating procedure for oocyte retrieval during an ART cycle, 
follicular fluid is aspirated at the time of oocyte retrieval and is generally discarded post 
cumulus oocyte complex isolation (Figure 5). Prior to aspiration, this fluid is contained 
within the follicular antrum which surrounds the oocyte and changes its composition 
throughout the process of folliculogenesis. The intimate proximity of follicular fluid to the 
developing cumulus oocyte complex is important for follicular development, and the 
follicular fluid contains vital nutrients, including proteins associated with lipid transport, 
complement pathways, blood coagulation as well as plasma proteins (Schweigert et al. 
2006; Jarkovska et al. 2010).  




Figure 5: Follicular fluid aspiration is performed using transvaginal ultrasound guidance 
and a 22-gauge needle in human subjects. The collected fluid contains an abundance of 
cellular messages exchanged during follicle development (adapted from Kenigsberg S et 
al., 2017)(Kenigsberg et al. 2017). 
 
This makes follicular fluid analysis an attractive prospect for the non-invasive analysis of 
oocytes because it reflects the metabolism of the developing follicle and is routinely 
discarded within an IVF lab. A recent investigation into the protein composition of 
follicular fluid identified a subset of 75 follicular fluid proteins that were linked with IVF 
outcome. Within the 75 proteins, 13 were involved in acute response signaling, 
coagulation, prothrombin activity, compliment system and growth hormone pathways 
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(Kushnir et al. 2012). Interestingly, follicular fluid protein composition appears to be 
dynamic, and studies have shown, that by using MALDI-TOF/TOF-MS technologies, 
observable differences are found in the follicular fluid proteins from women of advanced 
maternal age (38-42 years old), as compared to younger women (20-32 years old), with 
both groups of patients exhibiting normal FSH levels. The proteins serotransferrin, 
hemopexin precursor, complement C3, C4 and kininogen were uniquely down regulated 
in follicular fluid obtained from patients of advanced maternal age (Hashemitabar et al. 
2014).  
 
One theory pertaining to the cause and effect regarding changes within the ovary as it 
ages and the follicular metabolic age, states that improper levels of reactive oxygen 
species in follicular fluid may have the adverse effect of gradually distorting the levels of 
hydrogen peroxide in the follicles. By assessing the levels of ROS and H2O2 within the 
follicular fluid, it may be possible to determine the follicular metabolic state as a result of 
ovarian aging (Elizur et al. 2014). Outside of maternal age, oxidative stresses can also be 
induced by other factors such as high-fat diets, which can affect the levels of  Malon-di-
aldehyde (MDA) and total antioxidant capacity (TAC) within follicular fluid, which then has 
a negative effect on oocyte fertilization, and future developmental competence (Kazemi, 
Ramezanzadeh, Nasr-Esfahani, et al. 2013; Kazemi, Ramezanzadeh, Esfahani, et al. 2013).  
Follicular fluid also contains a number of exosomes, which are small vesicles used for 
transferring molecules in cell-to-cell signaling. A recent investigation into the function of 
exosomes within the follicular fluid discovered that exosomes contain a total of 35 
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microRNAs (small non-protein nucleotide chains of RNA) which were not present in serum 
derived from the same patient. Of the 35 microRNAs, 32 were transported by 
microvesicles containing exosomal biomarkers CD63 and CD81. These follicular fluid 
microRNAs are involved in critical pathways including follicle growth and oocyte 
maturation (Santonocito et al. 2014). Additionally, specific metabolites (arginine, 
glutamate, isoleucine and valine) found within follicular fluid are associated with oocyte 
developmental stage and maturity based upon their consumption and release (Hemmings 
et al. 2013).  
 
Clinically, specific metabolic profiles of follicular fluids have also been correlated to cycle 
outcomes in patients who utilized ART. Researchers were able to correlate the metabolic 
profiles of follicular fluid containing variable concentrations of glucose, lactose, 
choline/phosphocholine and lipoproteins, to pregnancy outcome in patients undergoing 
an ART cycle (Wallace et al. 2012). Fatty acid ratios and carbohydrate concentrations have 
been associated with specific developmental stages including embryogenesis. Follicular 
fluid also contains cytokines and additional growth factors, including BMP2, interleukins 
6, 8, 12 and 18, GDF-9, GCSF and amphiregulin (Sugiyama et al. 2010; Sarapik et al. 2012; 
Bedaiwy et al. 2007; Gode et al. 2011; Ledee et al. 2013; Liu et al. 2012). Several studies 
have used this information to develop multifactorial, individual, predictive values for 
oocytes to assess developmental potential and subsequent viability (Matoba et al. 2014; 
Wallace et al. 2012; O'Gorman et al. 2013).  
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Recently, the predictive values of follicular fluid profiles have been investigated, 
prospectively. One prospective analysis investigated the concentrations of anti-Müllerian 
hormone (AMH) and progesterone (P4) levels in follicular fluid, where it was discovered 
that elevated levels of these two molecules were correlated with increased oocyte 
viability and competence, and were able to predict which fertilized oocytes were 
developmentally competent enough to grow to the blastocyst stage (O'Brien, Wingfield, 
and O'Shea 2019). Another prospective analysis of 322 oocytes paired with follicular fluid 
samples found that increased levels of AMH and decreased levels of FSH were correlated 
with top quality blastocysts, whose transfer led to a live birth, compared with oocytes 
that failed to fertilize (91.2% sensitivity; 91.7% specificity) (Ciepiela et al. 2019). Follicular 
fluid collection and molecular biomarker analysis remains a promising, yet underutilized 
resource for the non-invasive assessment of oocyte developmental potential, which may 
be integrated into the standard operating protocols of ART laboratories in the future. 
 
10.6.4. Cumulus Cells 
 
During oocyte retrieval, follicles are aspirated from the ovary, and cumulus-oocyte-
complexes (COC) are retrieved and isolated (Figure 6). Given ample time to complete 
maturation and development, the cumulus is then mechanically separated from the 
oocyte. To remove the remaining corona cells, the innermost collection of cells 
immediately surrounding the oocyte, diluted hyaluronidase is used to denude the corona 
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cells so the oocyte may be washed and held separately for future fertilization. The cumuli, 
as well as the corona cells, are then discarded.  
 
Figure 6: Cumulus oocyte complex before denudation, with compact, non-radiating 
cumulus cells. (100× magnification) (image adapted from Rienzi L et al., Atlas of Human 
Embryology atlas@eshre.eu 2020). 
 
The molecular analysis of these follicular cells is another potential source for non-invasive 
oocyte viability assay development. Cumulus cells (CC) are nurse cells that surround the 
oocyte during development, and maintain a close bond through transzonal processes and 
gap junctions. These bonds serve to provide key nutrients and additional factors to the 
oocyte, which are crucial for oocyte development and maturation (Anderson and Albertini 
1976).  
 
This discarded material had been developing in conjunction with the oocyte, and may 
provide valuable information pertaining to the oocytes developmental potential. Gene 
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expression of CCs has been conducted, and found specific profiles able to predict oocyte 
maturation, cumulus expansion and fertilization potential (McKenzie et al. 2004; Assou et 
al. 2006; Anderson et al. 2009; Ouandaogo et al. 2011; Feuerstein et al. 2012; Yerushalmi 
et al. 2014). Gene expression within  cumulus cells is very active, and is affected by specific 
events including maternal age (Al-Edani et al. 2014) as well as specific ovarian stimulation 
gonadatropin regimens (Assou, Al-edani, et al. 2013). CC gene profiles have also been 
investigated with regard to oocyte competence, and several CC genes were identified as 
potential developmental biomarkers, including BCL2L11, PCK1 and NFIB (Assou et al. 
2008). Following this initial study, a panel of 45 CC genes associated with oocyte and 
embryo developmental potential were utilized in a prospective study by the researchers. 
The test group included patients receiving a day 3 transfer based solely on the gene 
expression of the panel of 45 genes, while the control group consisted of patients who 
received a day 3 transfer based on the standard morphological grading practices. 
Implantation rates and ongoing pregnancy rates were then observed between the two 
groups of subjects. The test group exhibited a statistically significant increase in 
pregnancy outcome as compared to control (40% vs 26.7% for implantation and 70% vs 
47.7% for ongoing pregnancy rates). The study included the analysis of 267 CC samples, 
of which 27% had a gene expression profile predicting positive pregnancy outcome, 42% 
that predicted negative pregnancy outcome and 13% that predicted early arrested 
development. It is also noteworthy that no link between the gene expression of CCs and 
the morphological grades of the subsequent embryos was observed (Assou et al. 2010).  
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There have also been several retrospective studies of CC gene expression, and the 
following genes have been correlated with positive pregnancy outcome: NRP1, UBQLN1, 
PSMD6, HIST1H4C, CALM1, PTGS2, EFNB2 and CAMK1D. Alternatively, TOM1 has been 
correlated to negative pregnancy outcome (Assidi et al. 2011; Wathlet et al. 2012). 
Researchers have also looked beyond genes purely associated with developmental 
potential, and investigated a combinatorial panel of 12 genes found in CCs involved in 
glucose metabolism, transcription, gonadotropin regulation and apoptosis. By analyzing 
the gene expression of the specific 12 genes, researchers were able to predict pregnancy 
outcome for 55 patients with 78% accuracy (Iager et al. 2013). Although these studies 
show great potential, there are many inconsistencies between gene expression data. This 
may be due to differences in experimental design, or failure to take into account 
important parameters such as maternal age, IVF laboratory practices and specific ovarian 
stimulation protocols, all of which may affect embryo development. 
 
10.6.5. Endometrial Environment 
 
Although the oocyte and subsequent embryo remains the primary contributor to a failed 
IVF cycle, it is also important to consider the environment it is being transferred into. The 
embryo-endometrium interface represents the initial stages of implantation with 
blastocyst adhesion to a receptive uterus. Specifically, the endometrium is the 
compromised of mucosa and multiple tissue types including reticular connective tissue, 
secreted proteins, epithelial cells as well as a proliferation of blood vessels which supply 
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nutrients to the cells (Beier and Beier-Hellwig 1998). The endometrial cycle is tightly 
regulated by physiological alterations caused by changes in expression of genes and 
proteins. This cycle is composed of three specific phases which are marked by 
physiological changes controlled by circulating levels of estrogen and progesterone 
secreted and synthesized by the ovary (Ruiz-Alonso, Blesa, and Simon 2012).  
 
The first phase of the endometrial cycle is the proliferative phase. During the proliferative 
phase, estradiol derived from growing follicles leads to the regeneration of the 
functionalis layer with re-epithelialization, which occurs on approximately day 5 of the 
menstrual cycle (Makieva et al. 2018). This phase is primarily characterized by the 
proliferation and hypertrophy of glands, increased stromal matrix and elongation of the 
terminal arterioles of the luminal epithelium (Gray et al. 2001; Taylor et al. 2001). 
Estrogen also upregulates the progesterone receptors, which alters the environment for 
the subsequent secretory phase (Fox et al. 2016; Gellersen and Brosens 2014). The 
cellular structure of the endometrial stromal cells during the proliferative phase, 
resemble a fibroblast-like appearance with developed rough endoplasmic reticulum and 
Golgi apparatus elongated nuclei and reduced cytoplasm (Cornillie and Lauweryns 1984). 
During decidual transformation, the nucleus of the stromal cells becomes rounded, the 
endoplasmic reticulum of the Golgi systems become dilated, and the cytoplasm begins to 
accumulate lipids and glycogens (Kajihara et al. 2014). Progesterone also induces the 
formation of pinopodes, the epithelial cells that lose their polarity and microvilli through 
down regulation of cell-to-cell adhesion molecules, producing a smooth apical surface 
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(Thie et al. 1995). This is critical for all future implantation, as the introduction of 
pinopodes also serves to decrease surface glycoprotein mucin 1 (MUC1), a mucus 
secretion responsible for forming a barrier against pathogens, which is inhibitory during 
the subsequent window of implantation (Haller-Kikkatalo et al. 2014; Redzovic et al. 
2013). 
 
The secretory phase is the second phase of the endometrial cycle. During the early and 
mid-secretory phase, cytoplasmic processes extend within the edematous connective 
tissue, releasing secretory products into the extracellular space. In the late-secretory 
phase, decidualizing cells display pseudopodia extensions engulfing the extracellular 
matrix. This phase of extreme remodeling may be attributed to the exhibition of 
phagocytotic activity during stromal cell decidualization (Cornillie, Lauweryns, and 
Brosens 1985). During this phase it is vital that the intercellular communication between 
the endometrial stromal cells is established in order to create the surface that will 
function as the site of embryo implantation along the fetomaternal interface (Figure 7). 
This communication is established by either direct cell to cell contact, or through 
intracellular junctions which mediate selective paracellular and intracellular transport of 
molecules (Garcia, Nelson, and Chavez 2018). Extensive communication networks are 
established which exert influence on the tissue, allowing physiological alterations as well 
as changes in homeostasis and tissue remodeling, making the endometrial surface one of 
great plasticity (Grund and Grummer 2018).  
 




Figure 7:  Changes within the human endometrium during the menstrual cycle, illustrating 
the growth, differentiation and shedding of the functionalis layer. The functionalis layer 
regenerates 4-10 mm during the proliferative phase (10 days) as cells proliferate in 
response to rising circulation of estrogen levels. During the secretory phase, progesterone 
induces differentiation of the luminal epithelium and stroma to generate an environment 
that is receptive to the implantation of an embryo (adapted from Gargett CE et al., 
2007)(Gargett, Chan, and Schwab 2007). 
 
The subsequent window of implantation occurs naturally between day six and day ten 
post ovulation (Figure8). Endometrial receptivity is characterized by changes in the 
endometrial layer and secretion of nutrients, including numerous vitamins and steroid-
dependent proteins (Martin et al. 2002). During this period of endometrial receptivity, 
molecular dialogue is exchanged between the implanting blastocyst and the luminal 
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epithelium of the endometrial layer (Cuman et al. 2015). As the embryo approaches the 
uterine luminal epithelium near the future sight of implantation (usually near the upper 
posterior wall in the midsaggittal plane), a pro inflammatory reaction occurs causing 
endometrial vascular permeability to increase at the implantation site, mediated by 
Cyclooxygenase (Cox)-derived prostaglandins (van der Weiden, Helmerhorst, and Keirse 
1991). Next, prostaglandin E2 is increased in both the luminal epithelium and surrounding 
stromal cells, which has the added benefit of activating a multitude of other signaling 





Figure 8: The blastocyst and uterus establish intimate physical and physiological contact 
resulting in the penetration of the basal membrane and controlled invasion of the stromal 
endometrium (adapted from Fitzgerald JS et al., 2008)(Fitzgerald et al. 2008). 
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Recently, researchers have benefited from transcriptomic studies investigating the 
endometrial window of implantation, which enabled the development of several 
commercial endometrial receptivity assays to diagnose the receptivity window including 
the Endometrial Receptivity Array (ERA) (Igenomix®), ERPeakSM Endometrial Receptivity 
Test (CooperSurgical®) and the ReceptDivaDX (CiceroDX, Inc.). The ERA is a customized 
array containing 238 genes that are known to be differentially expressed depending on 
the receptivity status of the sample, is highly reproducible and more accurate than 
histologic dating (Garrido-Gomez et al. 2013). Likewise, the CooperSurgial and CiceroDX 
offerings also examine the expression of hormone-regulated genes to help determine a 
patients individual and uniquely timed window of implantation or identifies potential 
problems based on the upregulation of inflammatory genes, such as BCL6, based on a 
previously regulated cycle (Ruiz-Alonso et al. 2013; Tan et al. 2018; Almquist et al. 2017).  
 
Researchers are also interested in alternative methods for evaluating the uterine 
environment, as these assays require an endometrial biopsy from a previously regulated 
cycle, and may not always accurately represent future endometrial receptivity profiles. 
One of the more prolific types of signaling molecules found to be biologically active during 
the window of implantation are cytokines, which are regulatory peptides or 
glycoproteins. Cytokines act as local autocrine or paracrine signals, and occasionally have 
more distant effects as endocrine mediators (McEwan et al. 2009). Cytokines critical for 
successful implantation include Leukemia-inhibitory factor (LIF), a member of the 
interleukin-6 family of cytokines responsible for mediating estrogen actions. Knockout 
Molecular Signatures of Reproductive Success 
64 
 
studies investigating the Lif gene in mice found animals lacking this gene have a defect in 
implantation and decidualization that can be rescued by adding recombinant LIF into the 
environment (Stewart et al. 1992). LIF is also important for driving stromal proliferation 
by regulating epidermal growth factor (EGF) (Hantak, Bagchi, and Bagchi 2014). Another 
active cytokine during the window of implantation within the uterine environment is 
colony-stimulating factor-1 (CSF-1), believed to be involved in molecular dialogue 
between the implanting embryo and the endometrium due to both cell types having CSF-
1 receptor mRNA (Pollard et al. 1991). Other cytokines involved in implantation and pre-
implantation cellular development include interleukin 1 (IL-1), interleukin 6 (IL-6) and 
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) (Krussel et al. 2003; 
Dominguez et al. 2015; Cha, Sun, and Dey 2012). 
 
One minimally invasive method used to study the extracellular signaling molecules found 
within the endometrial environment, in-vitro, was the development and use of an 
endometrial co-culture system. This method involves taking a small endometrial biopsy 
from a subject prior to any further ART treatment, separating endometrial and stromal 
cells for culture, and finally growing a monolayer of these cell types in order to explore 
the molecular interactions between the culture media and the cells either in the presence 
or absence of an embryo (Figure 9) (Simon et al. 1997; Dominguez et al. 2010).  




Figure 9: A) Confluent monolayer of epithelial endometrial primary cells. B) Example of a 
co-cultured fully hatched blastocyst. C) Co-cultured hatched blastocyst adhering to the 
monolayer on day 7 of embryo development (images Presented at ASRM by Parks et al., 
2014). 
 
To further study the molecular interaction between a developing embryo and a 
monolayer of endometrial epithelial cells (EECs), researchers co-cultured the cell types 
together and performed embryo transfer with the co-cultured blastocyst, and correlated 
the clinical outcome with the secreted molecules found within the co-cultured spent 
media. When compared with the spent media of embryos grown sans EECs, they 
discovered increased concentrations of IL-6, PLGF, and BCL (CXCL13) (indicating they were 
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secreted by the EECs in the presence of an embryo), and decreased levels  of FGF-4, IL-
12p40, VEGF, and uPAR (indicating EEC consumption) (Dominguez et al. 2010). These 
minimally invasive techniques offer insight into the molecular dialogue that occurs in the 
moments prior to implantation, and allows researchers to further investigate the 
beneficial, and the mandatory signalling molecules involved during this critical time.  
 
Finally, the third phase of endometrial cycle consists of menstruation.  When hormone 
levels are decreased during this final phase, the modified endometrium is unable to be 
maintained, and menses begins, and is considered to be day 0 to day 5 of the next 
menstrual cycle.  The duration of menses is variable, but the usual duration of the 
menstrual flow is 3-5 days, and the amount of blood loss can vary, with the average being 
30mL.  Menstrual blood is mostly arterial in nature, and contains prostaglandins, tissue 
debris, and relatively large amounts of fibrinolysis from endometrial tissue. The 
fibrinolysis lyses clot so that menstrual blood does not contain clots typically unless the 
flow is particularly heavy.  On average, a woman will experience 450 menses throughout 
her lifetime (Thiyagarajan, Basit, and Jeanmonod 2021). 
 
10.6.6. Uterine Environment Aspiration 
 
A common criticism of extrapolating data from endometrial co-culture data is that it 
oversimplifies the complex nature of the in-vivo environment. Furthermore, inter cycle 
reliability may be a concern, where uterine conditions may subtly vary from cycle to cycle, 
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and one brief snapshot may not perfectly represent all cycles going forward. In an attempt 
to address these concerns, a technique called uterine fluid aspiration has been developed 
to, non-invasively, study the in-vivo uterine microenvironment during the window of 
implantation. This method involves a transfer catheter and gentle suction to sample one 
isolated location of the uterine luminal endometrium, adjacent to potential implantation 
sites (Figure 10).  
 
Figure 10: Endometrial aspirations taken at the time of embryo transfer, offer a brief 
snapshot into the uterine microenvironment the embryo is likely to encounter as it 
searches for a potential implantation site (images presented at ASRM by Parks JC et al., 
2019).  
 
The superficial uterine environment is composed of a protein-rich histotroph, made up of 
specific glandular secretions. It contains cytokines, anti-proteases, transport proteins, 
nutrients and enzymes (Hannan et al. 2010; Leese et al. 2008). Studies have shown uterine 
secretion aspiration at the time of transfer is a minimally invasive technique, capable of 
safely sampling the endometrial microenvironment (van der Gaast et al. 2003; Hannan et 
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al. 2012). Endometrial aspirations taken 24 hours prior to embryo transfer are an 
effective, minimally invasive means of sampling the endometrial micro-environment of a 
patients’ current embryo transfer cycle. Studies, have demonstrated that endometrial 
aspirates collected 24 hours prior to embryo transfer contained specific prostaglandin 
levels that were correlated with successful implantation (Vilella et al. 2013). 
 
Although this technique seems promising, in practice successful integration into ART 
laboratories has been thus far unconvincing. Based on the literature and previous studies, 
researchers have unsuccessfully attempted to use pre-determined cut-off values for a 
panel of promising molecular biomarkers (including urocortin, activin A, human decidua-
associated protein (hDP) and interleukin-18), to predict endometrial receptivity and 
subsequent implantation success (Ledee-Bataille et al. 2004; Florio et al. 2008; Florio et 
al. 2010). Similarly, additional studies investigated other molecular biomarkers found 
within the uterine fluid milieu, including the mean levels of cytokines, glycodelin, isoforms 
of leucine-rich alpha2-glycoprotein, LIF and TNF, interleukin-1β, TNF-α, interferon 
gamma-induced protein 10 and monocyte chemoattractant protein. These levels were 
then categorized based on fertility treatments and outcomes to search for commonalities 
between patients who experienced successful implantation (Gillott et al. 2008; Boomsma, 
Kavelaars, Eijkemans, Amarouchi, et al. 2009; Boomsma, Kavelaars, Eijkemans, Lentjes, et 
al. 2009; Bentin-Ley et al. 2011; Rahiminejad et al. 2015; Rahiminejad et al. 2016). The 
results of these studies indicate that the individual levels of these potential molecular 
biomarkers are far too variable from one subject to the next, and that the use of uterine 
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aspirate assays are thus inadequate for determining implantation receptivity, so their use 
in a clinical setting is very limited. 
 
10.6.7. Sperm Analysis 
 
An integral component of an ART cycle is the analysis of the male gamete. However, the 
standard operating protocols focus more on simple, superficial observations. The 
methods for the evaluation of semen is described in World Health Organization (WHO) 
manuals, and includes viscosity, volume, color, pH, concentration, motility, vitality, the 
presence of leukocytes and the morphology of the sperm (Cooper et al. 2010). These 
parameters are used to standardize male subfertility in the population, and while they 
are correlated with successful oocyte fertilization and embryonic development, 
collectively, they do not produce a definitive predictive threshold of whether or not a 
patient will be able to conceive within an ART setting (van der Steeg et al. 2011; van Weert 
et al. 2004).  
 
One factor limiting the usefulness of conventional semen analysis is that it fails to account 
for the integrity of sperm genome constitution and DNA integrity. There are many causes 
of sperm DNA damage and fragmentation, including defective apoptosis, excessive 
reactive oxygen species (ROS) production, toxic effects of drugs, pollution, cigarette use 
and even high testicular temperature (Boissonneault 2002; Moustafa et al. 2004; Saalu 
2010; Sakkas et al. 2002; Colagar, Jorsaraee, and Marzony 2007). Several techniques have 
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been developed to investigate the sperm DNA integrity of patients including the sperm 
chromatin structure assay (SCSA) which utilizes specific staining techniques and a flow 
cytometer to quantitate the percentage of sperm with intact vs. fragmented chromatin. 
Another technique is the sperm chromatin dispersion (SCD) detects DNA fragmentation 
by incubating spermatozoa in a thin inert matrix with an acid solution that denatures the 
DNA, followed by an adapted lysing solution that removes the majority of nuclear 
proteins. This procedure results in DNA loops spreading out into the inert matrix, 
producing halos of chromatin, which will be largely absent in samples with DNA 
fragmentation. Alternatively, the single cell gel electrophoresis (Comet) assay embeds 
sperm cells in a thin layer of agarose on a microscope slide and subsequently lysed with 
detergent under high salt conditions. This process removes protamines and histones 
allowing the nucleus to form a nucleoid-like structure containing supercoiled loops of 
DNA.  Alkaline pH conditions result in unwinding of double-stranded DNA, and 
subsequent electrophoresis results in the migration of broken strands towards the anode, 
forming a comet tail, when observed under fluorescence microscope. The amount of DNA 
in the head and tail is reflected by its fluorescent intensity. The relative fluorescence in 
the tail compared with its head serves as a measure of the level of DNA damage (Simon 
and Carrell 2013). Finally the terminal deoxynucleotidyl transferase mediated 
deoxyuridine triphosphate nick end labelling (TUNEL) assay analyzes DNA fragmentation 
by measuring the number of breaks or nicks in the DNA of the sperm. It can be performed 
on as few as 1,000 sperm, even on sperm retrieved from a small testis biopsy (Sharma et 
al. 2010).  Of the four clinical assays developed, the COMET and TUNEL assays have been 
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the most successful at reliably predicting the DNA integrity of sub fertile men (Figure 11) 
(Cissen, Wely, et al. 2016). These assays have been integrated into many ART laboratories 
to evaluate sperm genome integrity, and have been successful at detecting damaged DNA 
within sperm. These assays are helpful for counseling patients regarding the cause of their 
infertility, however the predictive value of DNA fragmentation on evaluating the chances 
of achieving a successful pregnancy may need further research and analysis (Cissen, 
Bensdorp, et al. 2016).  
 
 
Figure 11: Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) 
immunofluorescent staining of human spermatozoa aids in detection of DNA 
fragmentation. Cells which fluoresce green are indicative of DNA fragmentation which 
takes place during late stages of apoptosis. Spermatozoa are considered TUNEL positive 
if approximately 40% or more of the head is fluorescent (adapted from Palermo GD et al., 
2017)(Palermo et al. 2017). 




Investigation into genome wide mutation rates reveal up to 80% originating in the 
paternal lineage (Acuna-Hidalgo, Veltman, and Hoischen 2016), and studies analyzing 
multi-generational sperm genomic DNA have observed an increase in de novo point 
mutations over the course of a males lifetime at a rate of 2 base pair changes per year on 
average (Kong et al. 2012; O'Roak et al. 2012)  There are several mechanisms responsible 
for these de novo base substitutions sometimes acting in combination, including errors in 
replication and damage induction.  As male germ cells undergo continuous mitotic cell 
divisions (800 rounds of division and replication by age 50), this leads to increased 
mutation rates as men age, although many remain fertile well past middle age.  Mutations 
may also occur when the template or free nucleotides are damaged prior to replication.  
Interestingly, not all mutations found within the paternal genome are correlated with 
paternal age; in fact, a recent study found that a significant proportion of human germline 
mutations were correlated with maternal age at conception.  As a woman reaches 
advanced maternal age, there is an accumulation of damage in oocytes and the 
subsequent number of postzygotic mutations in the embryo and the oocyte is no longer 
able to repair the damage introduced by the fertilizing sperm, as is seen in younger 
women (Gao et al. 2019).   The known effects of these mutations are accumulating , and 
a recent publication of a parallel two-group, randomised trial indicated that although 
poor quality sperm can successfully fertilize and produce transfer grade blastocysts, the 
subsequent pregnancies have a much higher incidence of miscarriage following clinical 
pregnancy (Miller et al. 2019).  Furthermore, evidence also points to a correlation 
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between de novo point mutations in sperm and adverse health effects in offspring, 
including increased risks of birth defects and neurodevelopmental and psychological 
disorders (Kojima et al. 2018; Kimura et al. 2018). Although not currently practical due to 
cost and techniques involved, screening for DNA mutations found within sperm may be 
incorporated into ART laboratories in the future, which would provide potential parents 
with additional information and assist with potential offspring health risk evaluation. 
 
10.6.8. Placental Epigenetics 
 
One of the earliest events which occurs during embryonic development, is the 
differentiation of the inner cell mass (ICM) and the trophectoderm cells (TE). This stage in 
development is the first period during which two distinct tissue types can be observed 
after successful fertilization has occurred. The TE cells make up the periphery of the 
blastocyst, while the ICM is located on a single side within the blastocoel cavity (Niwa et 
al. 2005). These two tissue types also give rise to two distinct types of stem cells, the 
embryonic stem cells that will eventually develop into the subsequent fetus, while the 
trophoblast stem cells will continue to develop and differentiate into the placenta, which 
is the first fetal organ to develop as well as the largest. Proper development and growth 
of the placenta is critical to the health of the fetus and the mother, and defects can lead 
to several major disease etiologies found within pregnancy including pre-eclampsia, fetal 
growth restriction, still birth and recurrent miscarriage, which can result in long term 
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health consequences for the mother and subsequent offspring (Brosens et al. 2011; 
Salam, Das, and Bhutta 2014; Amaral et al. 2015). 
 
Epigenetics is the study of inherited changes in gene expression, whose mechanisms do 
not involve changes to a specific DNA sequence. This may be accomplished by several 
distinct mechanisms, including DNA methylation, acetylation, phosphorylation, 
ubiquitylation, and sumolyation (Weinhold 2006).  
 
Recently, studies focusing on the importance of epigenetics and placental development 
by way of genome-wide methylome sequencing have revealed large partially methylated 
domains within the human placenta, interspersed with highly methylated domains 
(Schroeder and LaSalle 2013). These partially methylated domains are developmentally 
dynamic, and usually cover tissue-specific genes that are transcriptionally repressed. 
There are several factors that make placental tissue appealing as a study material for 
investigating epigenetic disturbances in methylation patterns. A 2015 study concluded 
that hypomethylation found within the placenta is likely derived from the 
hypomethylated state of an early embryo and trophectoderm. Thus, large-scale 
methylation disturbances found within the placenta may be indicative of methylation 
perturbations present in the embryo, and subsequent fetal development (Bianco-Miotto 
et al. 2016). Upon closer observation, researchers discovered that some of the genes 
statistically overrepresented by these partially methylated domains, include genes 
associated with neuronal development and synaptic transmission, making them excellent 
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candidate biomarker genes for autism spectrum disorder in at risk patient populations 
(Schroeder et al. 2016). 
 
Genomic imprinting is a form of epigenetic modification in which gene expression differs 
in an allele-specific manner depending on parent of origin. Imprinting restricts gene 
expression to only one of the parental alleles, from either the sperm or egg. While 99% 
of the genes in our genome are bi-allelically expressed from both chromosomes, 
imprinted genes are a small subset of genes that are expressed only from one 








Figure 12: Genomic imprinting is an epigenetic phenomenon resulting from differences 
in methylation depending on whether the allele originated from the maternal allele (egg), 
or paternal allele (sperm) (Presented by Parks et al., at the 2017 ASRM conference). 
 
In this diagram (Figure 12), methylated, or silenced imprinting regions are represented by 
the closed circles, whereas an unmethylated imprinting region is indicated by open 
circles. For example if a gene is paternally imprinted and silenced by DNA methylation on 
the chromosome from the sperm, it results in that gene being maternally expressed from 
the egg. Genomic imprinting offers an opportunity to study the expression of genes that 
may be transient and highly tissue specific. The placenta contains a high number of 
imprinted genes compared to many mammalian organs (Frost and Moore 2010). Within 
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the context of ART, researchers have studied placental tissue samples derived from 
murine embryos cultured in an in-vitro setting and discovered aberrant DNA methylation 
of imprinted genes after in vitro preimplantation culture of mouse embryos when 
compared to in-vivo derived controls, specifically the loss of imprinted expression of H19 
and Snrpn imprinting control regions (Mann et al. 2004). This led to questions regarding 
the safety of extended embryo culture and ART practices, however it is difficult to 
replicate such a study in humans, as many IVF patients have a number of different 
infertility etiologies which act as confounding variables in relation to any aberrant 
epigenetic imprinting (Litzky and Marsit 2019). 
 
 




Although the field of ART has come a very long way in a relatively short amount of time, 
it also has ample room for improvement. In order to continue to advance and increase 
clinical excellence, we must build upon our great, but ultimately inadequate, base of 
knowledge. Non-invasive methods for evaluating fertility constitution should be focused 
on materials that are considered excess, and are commonly discarded, for its low-risk 
high-reward potential. If we can develop additional techniques and skills to incorporate 
into our clinical practices, we will get closer to our ultimate goal of providing top quality 
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care to sub fertile and infertile couples, assisting them to achieve their goal of having a 
successful and healthy pregnancy, and build their family. 
 
As pointed out in section 10.5.4., the gene expression profiling of cumulus cells has 
revealed cumulus cell gene expression involved in glucose metabolism, transcription, 
gonadotropin regulation and apoptosis, and although promising, so far this data has had 
limited success predicting pregnancy outcome. Although cumulus cells are a potential 
window into oocyte competence and viability, inconsistency in the methodology and 
subjects studied has resulted in a need for a study investigating individual cumulus cell 
transcriptomes of chromosomally normal (euploid) embryos, to eliminate aneuploidy as 
a confounding variable, and finally, utilizing RNA sequencing to identify novel biological 
pathways associated with implantation outcome. 
 
As pointed out in section 10.5.5, the co-culture model, taking an endometrial biopsy, 
isolating and culturing the endometrial cells into a monolayer with a late-stage blastocyst, 
is a great way to study the molecular dialogue that occurs between the luminal epithelial 
cells of the endometrium and the implanting blastocyst. However, the literature has not 
explored the differences in the secretomic dialogue that occurs between the blastocysts 
and endometrium of specific infertility etiologies that may have sub-optimal implantation 
rates. Such a study would be beneficial, as it may help doctors and clinicians understand 
the effects of infertility etiologies on the window of implantation, and provide them with 
information for counselling as well as potential treatment opportunities. 




As pointed out in section 10.5.8, studies investigating the effects of ART and prolonged 
embryo culture on genomic imprinting, have found correlations with deficiencies in the 
subsequent placenta and offspring in murine studies. However, there is insufficient 
evidence as to the causal nature of these correlations, and there is limited information 
available overall on the direct effects of external influences on epigenetics and genomic 
imprinting. Specifically, due to the bi-allelic nature of genomic imprinting within the 
placenta, this offers an opportunity to investigate any potential paternal lifestyle choices 
and their impact, especially in a mouse model by controlling for any female factors that 
may be present. Furthermore, patients seeking fertility treatment are older on average, 
and especially in men, the effects of this advanced age etiology on their offspring is poorly 
understood. Therefore, an investigation into the effects of advanced paternal age on the 
epigenetics of the placenta, and viability and health of the subsequent offspring would be 
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11.0 Specific aims of this thesis 
 
With the above in mind, the purpose of this thesis was to perform basic and applied 
research with the aim, ultimately, of providing underlying data to support the 
improvement of IVF: 
 
Specific aim 1. To test the hypothesis, through corona cell RNA sequencing from individual 
oocytes, that transcripts and pathways are linked to euploid oocyte competence and live 
birth.  
 
Specific aim 2. To investigate the impact of infertility diagnosis on embryo-endometrial 
dialogue.  
 
Specific aim 3. To test the hypothesis that advanced paternal age directly impacts mouse 
embryonic placental imprinting.  
 
The specific aims are supported by a series of published works to which I contributed (see 
page 5) with a similar overall purpose.  
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11.1. Specific aim 1 
 
This chapter is based on published work from the following publication.  
 
Parks JC, Patton AL, McCallie BR, Griffin DK, Schoolcraft WB, Katz-Jaffe MG. Corona cell 
RNA sequencing from individual oocytes revealed transcripts and pathways linked to 
euploid oocyte competence and live birth. Reprod Biomed Online. 2016 May;32(5):518-
26. doi: 10.1016/j.rbmo.2016.02.002. Epub 2016 Feb 24.  
 
11.1.1. My contribution to the work 
 
I worked closely with Dr. Katz-Jaffe to develop and implement the experimental design of 
this experiment. I coordinated corona cell collection with the embryologists within the 
IVF lab at the Colorado Center for Reproductive Medicine during their routine IVF 
procedures. I performed the subsequent experiments, results analysis and interpretation, 
and wrote and edited the manuscript for publication. 
 
11.1.2. Chapter summary 
 
Capsule. RNA-sequencing of corona cells identified differentially expressed transcripts 
and observed numerous signaling pathways in association with euploid oocyte 
competence, including live birth and negative IVF outcome. 
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Purpose:  To investigate the corona cell transcriptome of euploid oocytes utilizing RNA 
sequencing technologies. 
Methods:  Corona cell samples from individual cumulus oocyte complexes that developed 
into euploid blastocysts and were transferred in a frozen embryo transfer (n=10), were 
collected during oocyte retrieval. RNA-Sequencing was performed on corona cell samples 
alongside bioinformatics and statistical analysis to compare IVF outcomes. 
Results:  RNA-Sequencing of corona cell samples, produced a mean number of sequence 
reads of 21.2 million. Statistical analysis of differentially expressed genes revealed 343 
statistically significant transcripts (P<0.05; fold change >=2). Enriched pathway analysis 
showed WNT signalling, MAPK signalling, focal adhesion and TCA cycle to be impacted by 
IVF outcome. Specifically, key genes within the WNT/beta-catenin signalling pathway, 
including AXIN, were associated with oocyte competence. 
Conclusions:  Oocyte-specific transcriptomic corona cell profiles were successfully 
generated by RNA-sequencing. Key genes and signalling pathways were identified in 
association with IVF outcome following the transfer of a euploid blastocyst in a frozen 
embryo transfer. This new information could provide novel biomarkers for the non-




Current estimates state that 1 in 6 couples in the United States will require the use of 
Assisted Reproductive Technologies (ART) to successfully conceive a child (Thoma et al. 
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2013). For many infertile couples treatment will involve in vitro fertilization (IVF) and a 
subsequent embryo transfer. The oocyte is a major contributor to the success of an IVF 
cycle with oocyte competence tightly linked to embryo viability. Numerous factors 
determine oocyte competence including mitochondrial health, metabolomic processes, 
functional spindle assembly and successful meiotic division (Prates, Nunes, and Pereira 
2014), (Keefe, Kumar, and Kalmbach 2015). Based on current IVF protocols, the likelihood 
of a single aspirated oocyte being fertilized, successfully developing, implanting and 
resulting in a healthy live birth is ~5% (Patrizio and Sakkas 2009). Consequently, additional 
non-invasive methods to measure oocyte competence could represent a valuable asset 
to improve embryo selection and IVF outcomes. 
 
Follicular fluid is a potential non-invasive source of oocyte information. The fluid is 
aspirated at the time of oocyte retrieval and discarded following oocyte isolation. 
Follicular fluid is contained within the follicular antrum surrounding the oocyte and the 
composition of this fluid changes throughout folliculogenesis. Protein analysis of follicular 
fluid revealed diverse protein compositions containing mostly plasma proteins and 
proteins associated with lipid transport, complement pathways and blood coagulation 
(Schweigert et al. 2006), (Jarkovska et al. 2010). A recent study identified a subset of 75 
follicular fluid proteins correlated with IVF outcome. Thirteen of these proteins were 
involved in acute response signaling, coagulation, prothrombin activation, complement 
system and growth hormone pathways, uniquely associated with IVF outcome (Kushnir 
et al. 2012). Metabolic analysis of follicular fluid has revealed metabolites that are 
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correlated with oocyte maturity based on the depletion/appearance of specific amino 
acids: arginine, glutamate, glutamine, isoleucine and valine (Hemmings et al. 2013). In 
addition to amino acids, carbohydrates and fatty acid ratios have been shown to correlate 
with developmental milestones including embryogenesis and form an overall predictive 
value of oocyte quality and developmental potential (Matoba et al. 2014), (Wallace et al. 
2012), (O'Gorman et al. 2013). However, it is important to understand that many of these 
predictive studies are based on retrospective data, and are not equivalent to a truly 
independent prediction/replication experiment.  Additional studies have linked oocyte 
quality with cytokines and growth factors in follicular fluid, including increased BMP2, 
interleukins (6, 8, 12 and 18), GDF-9, GCSF and amphiregulin (Sugiyama et al. 2010), 
(Sarapik et al. 2012), (Bedaiwy et al. 2007), (Gode et al. 2011), (Ledee et al. 2013), (Liu et 
al. 2012). Although follicular fluid molecular profiling appears promising, to date, there 
are no prospective studies utilizing a panel of follicular fluid biomarkers to determine 
potential clinical value in identifying oocyte competence. 
 
Another promising area of research into oocyte competence has been the molecular 
analysis of follicular cells. Corona cells (CC) surrounding the oocyte maintain a close 
relationship via transzonal processes and gap junctions, providing key nutrients and other 
factors essential for oocyte maturation and future developmental competence (Anderson 
and Albertini 1976).   CC’s remain in close proximity to the oocyte throughout 
development through gap junctions which are formed by transzonal cytoplasmic 
projections transverse the zona pelucida matrix (ERICKSON et al. 1985).  This in turn 
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results in the cumulus-oocyte-complex development(Plancha et al. 2005).  Cumulus cells 
surround the oocyte and form the cumulus oophorus and corona radiata inner cell layer.  
Gap junctions connect the corona cells to the oocyte and allow bi-directional 
communication and the exchange of nutrients and metabolites.  This results in the 
stimulation of the oocyte, triggering maturation (Saeed-Zidane et al. 2017; Mora et al. 
2012).  Transzonal projections, which penetrate the zona pelucida surrounding the oocyte 
allow the corona cells to maintain contact with the oocyte through and are believed to be 
involved in paracrine gap junctional communication and adhesion between the oocyte 
and corona cells (Simon and Goodenough 1998).  Amino acids are transported through 
these gap junctions enhancing uptake of glycine, alanine, lysine and taurine required for 
oocyte development(Pelland, Corbett, and Baltz 2009). Specific profiles of cumulus cell 
gene expression have been able to predict oocyte maturation, cumulus expansion and 
fertilization (McKenzie et al. 2004), (Assou et al. 2006), (Anderson et al. 2009), 
(Ouandaogo et al. 2011), (Feuerstein et al. 2012), (Yerushalmi et al. 2014). CC gene 
expression is dynamic and can be affected by specific events such as maternal aging (Al-
Edani et al. 2014) and ovarian gonadotropin treatments (Assou, Haouzi, et al. 2013). One 
of the first studies to investigate oocyte competence identified several CC genes as 
biomarkers for assessing developmental potential including BCL2L11, PCK1 and NFIB 
(Assou et al. 2008). Follow up investigations identified 45 CC genes of interest to be 
considered biomarkers of successful embryo development and pregnancy outcomes that 
were tested in a prospective study. The test group received a day 3 embryo transfer based 
on the 45 CC gene expression profiles, while the control group had a day 3 embryo 
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transfer based on traditional embryo grading selection. Both implantation and ongoing 
pregnancy rates were significantly higher in the test group after embryos were chosen 
based upon their CC gene expression profile (40% vs control = 26.7% and 70% vs control 
= 46.7% respectively). Of the 267 CC samples studied, 27% had a CC gene expression 
profile that predicted positive pregnancy outcome, 42% that predicted negative 
pregnancy outcome and 13% that predicted early arrested development. Remarkably, no 
relationship between traditional morphological grading and CC gene expression was 
observed (Assou et al. 2010). Other retrospective studies have shown a significant 
correlation between the cumulus transcriptome and subsequent pregnancy outcome 
where NRP1, UBQLN1, PSMD6, DPP8, HIST1H4C, CALM1, PTGS2, EFNB2 and CAMK1D 
gene expression correlated with pregnancy and TOM1 with negative outcome (Assidi et 
al. 2011), (Wathlet et al. 2012). Recently the combinatorial expression of 12 CC genes 
involved in glucose metabolism, transcription, gonadotropin regulation and apoptosis 
were utilized to estimate pregnancy outcome for 55 patients with 78% accuracy  for an 
independent sample (Iager et al. 2013). Together, these studies indicate cumulus cells are 
a potential valuable source of information relative to the oocyte competence. However, 
there exists inconsistency in the CC transcriptome data to date primarily due to 
differences in experimental design and methodology including factors such as maternal 
age, ovarian stimulation protocols and various in vitro laboratory protocols. 
 
The purpose of this study was to investigate the individual CC transcriptome of 
chromosomally normal (euploid) embryos utilizing RNA sequencing to identify novel 
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biological pathways associated with implantation outcome. Results demonstrated that 
the WNT-Canonical pathway and AXIN transcription are strong indicators of oocyte 
developmental competence and subsequent chromosomally normal live birth. 
 
11.1.4. Materials and Methods 
 
11.1.4.1. Corona Cell Collection 
 
Corona cells were donated from individual cumulus oocyte complexes (COC's) (n=10) with 
patient and consent by the Western Institutional Review Board, Inc (WIRB® Protocol 
#20142383). Female subjects presented with normal ovarian reserve (AMH>1.0, FSH<10, 
AFC>6) and advanced maternal age (36-43 years old) but no other infertility diagnosis. 
Cumulus cells were collected and stored at -80 degrees Celsius from up to 10 oocytes per 
patient (30 patients, n=300 total), only cumulus cell samples that met the following 
criteria were analysed for this study, and oocytes that failed to fertilize or develop to the 
blastocyst stage were excluded from further experimentation.  Next, patients underwent 
routine IVF with embryos individually cultured to the blastocyst stage for a 
trophectoderm (TE) biopsy prior to vitrification. Only embryos graded 3BB or better were 
chosen for TE biopsy, based on the Gardner Schoolcraft grading system (Gardner and 
Schoolcraft 1999a). Comprehensive chromosome screening (CCS) was performed on 
biopsied TE cells, and following the identification of a euploid blastocyst, patients were 
scheduled for a frozen embryo transfer (FET). Cumulus samples were chosen based upon 
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the previously described criteria and were subsequently randomized and grouped based 
on implantation outcome (live birth n=5 and negative implantation n=5).    
 
Following routine oocyte retrieval, cumulus cells were mechanically separated from each 
individual COC without disturbing the inner corona cells. Oocyte maturity was visually 
confirmed and individual oocyte corona complexes were allowed to recover for 4 hours 
in an incubator at 7% CO2, 5% O2. Corona cells were removed prior to ICSI using a media 
solution containing 0.33mg/mL hyaluronidase and rinsed through sequential 3x20uL 
drops of PBS/BSA before transfer into 10 uL of Extraction Buffer (PicoPure® RNA-isolation 
kit, Life Technologies, Carlsbad CA). All CC samples were snap-frozen in liquid nitrogen 
and stored at -80°C until later analysis. 
 
11.1.4.2. RNA Sequencing 
 
Purified cDNA libraries were constructed from 50ng of rRNA-depleted Total RNA using the 
Ion Total RNA-Seq Kit v2, Whole Transcriptome Library Prep protocol (Life Technologies, 
Carlsbad CA). rRNA-depleted Total RNA was fragmented using RNase III and purified by 
Agencourt Ampure XP micro-beads (Beckman Coulter Inc., Brea CA). The fragmented RNA 
was then hybridized and ligated prior to reverse transcription and addition of multiplexing 
barcode adaptor. The subsequent cDNA was then amplified via PCR and purified again. 
Barcoded libraries were equalized and pooled into an evenly represented final library 
consisting of 100pM cDNA, which was then coupled onto templated capture beads and 
enriched using the Ion OneTouch 2 and OneTouch ES systems (Life Technologies, Carlsbad 
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CA). Final libraries were prepped for loading on the ION PI v2 chip and then sequenced on 
the Ion Proton with a P1 200 v2 Sequencing kit (Life Technologies, Carlsbad CA). 
 
11.1.4.3. RNA-Sequencing Data and Bioinformatic analysis 
 
Raw reads in FASTQ format were trimmed and filtered with FastQC 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) such that only reads with 
Phred Q-scores > 20 and read lengths > 35 bp were retained. Duplicate reads were 
removed thus retaining unique reads with higher average base quality. Strand NGS v.2.1 
(Strand Life Sciences Inc., Aurora CO) was used for subsequent RNA-Seq data analysis. The 
trimmed/filtered reads were aligned to NCBI RefSeq human reference genome 
(GRCh37/hg19) and human transcriptome. Transcript isoform assembly, abundance 
estimation and quantification were performed with Strand NGS. Differential gene 
expression was performed with DESeq v.3.0 normalization and Fold Change > 2.0 
(bioconductor.org). Strand NGS identified significantly differentially expressed up- and 
down-regulated genes. Gene annotations were provided by NCBI Entrez Gene database.  
Biological pathway analysis was performed with Strand NGS based on WikiPathways 
Analysis, Reactome, GenMAPP and Other pathway databases and the BioCyc pathway 
database (Martens et al. 2018; Fabregat et al. 2017; Prickett and Watson 2009; Paley and 
Karp 2017).  Significantly enriched pathways were identified with a threshold Fold Change 
> 2.0.   
 
 




11.1.4.4. RNA-Sequencing Gene Expression Validation 
 
Additional individual CC samples (n = 10) were collected for RNA-sequencing validation 
using the PicoPure® RNA Isolation Kit (Life Technologies, Carlsbad CA) with modifications. 
Briefly, samples were lysed and bound to a silica-based filter, treated with RNase-free 
DNase I (Qiagen, Valencia CA) and washed several times before recovered in 20 μL elution 
solution. Reverse transcription was performed using the High Capacity Reverse 
Transcription cDNA kit (Life Technologies, Carlsbad CA) to generate cDNA template for 
real-time polymerase chain reaction (PCR). 
 
Quantitative real-time PCR (Q RT-PCR) was performed using the ABI 7300 Real Time PCR 
System with the Power SYBR Green PCR Master Mix (Life Technologies, Carlsbad CA). 
After a 10-minute incubation at 95°C, amplification was performed for 40 cycles at 95°C 
for 15 seconds and 60°C for 1 minute, then a dissociation stage for 15 seconds at 95°C, 1 
minute at 60°C, 15 seconds at 95°C, and 15 seconds at 60°C. The quantification of two 
genes, AXIN1 (GenBank NM_003502.3) and TNFRSF10A (GenBank NM_003844.3), was 
calculated relative to the constant level of transcription in every sample of the 
housekeeping gene, RPL19. The PCR reaction efficiency recorded R2 values ≥0.9, and the 
correlation coefficient was calculated to be >0.99. Statistical analysis was performed with 
REST-2008 software using bootstrap randomization techniques (Qiagen, Valencia CA). 
Gene expression fold differences with P<0.05 were considered statistically significant. 
 





Traditional oocyte and embryo morphology parameters were not predictors of 
chromosome constitution, or implantation outcome. Embryos of equivalent good 













1 Normal 9  (4-) 3BA Negative 
2 Normal 8 (4-C) 5BB Negative 
3 Normal 12(4-C) 5AA Negative 
4 Normal 8(4-) 5BA Negative 
5 Normal 9(3+) 4BB Live Birth 
6 Normal 10(4) 5AA Live Birth 
7 Normal 8(4) 4BB Live Birth 
8 Normal 8(4-) 5BB Live Birth 
9 Normal 8(3+) 3BB Negative 
10 Normal 8(4) 4AA Live Birth 
 
Table 2: Oocyte and embryo morphology with embryo transfer outcome. 
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RNA-sequencing was successfully performed for individual CC samples, with the mean 
number of sequence reads per individual CC sample, 21.2 million (range = 10.2 million to 
29.8 million reads). Following CC gene expression quantification with DESeq 
normalization, an unpaired t-test was performed comparing live birth (n=5) with negative 
outcome (n=5) that identified 343 significantly differentially expressed genes (P<0.05; 
fold change >=2). Of these 343 differentially expressed CC genes, 82 were observed to 
have increased expression and 261 CC genes decreased expression in association with a 
live birth. A volcano plot was generated to visualize RNA-sequencing transcripts between 
live birth and negative outcome CC samples. Each dot on the volcano plot represents a 
transcript, red dots indicate transcripts that showed statistically significant differential 
expression between the two groups of CC samples, with p-value on the y-axis. The x-axis 
represents increased and decreased fold change reflecting differential gene expression 
observed between live birth and negative outcome (Figure 13).  
 





Figure 13: Volcano Plot for live birth vs. negative RNA-sequencing transcripts. Each dot 
represents a gene; red dots are significantly differentially expressed genes at p< 0.05 and 
fold change >=2. Up-regulated genes are shown as positive values on the x-axis, and 
down-regulated genes are shown as negative values on the x-axis. 
 
Upon further examination of these differentially expressed genes, 87% were observed to 
be protein-coding, with the remaining 13% being either pseudo or small regulatory RNAs. 
Several genes were identified in the RNA-Sequencing data with differential expression 
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relative to live birth that have been published previously in association with oocyte 
competence including HDAC2, ANG and TNFRSF10A (data not shown) (Bessa et al. 2013), 
(Feuerstein et al. 2012), (Santonocito et al. 2013).  
 
Gene Ontology analysis revealed significantly enriched biological processes among the 
differentially expressed transcripts including response to hormone stimulus, regulation of 
cellular protein metabolic processes, as well as, transcription and transmembrane 
transport in association with a live birth (P<0.05; >=2 fold). Pathway analysis of the 
differentially expressed transcripts identified enriched downstream biochemical signaling 
pathways. Table 3A displays the enriched signaling pathways with increased differentially 
expressed transcripts in association with live birth including WNT signaling, MAPK 
signaling, focal adhesion and TCA cycle (Table 3A).  
 
Enriched Signaling Pathways with Increased Expression p-value 
Mitotic Prometaphase 0.00011 
Mitotic Metaphase and Anaphase 0.00127 
Hedgehog Signaling Pathway 0.00692 
TCA cycle 0.00789 
Glutamate removal from folates 0.00789 
Methylglyoxal degradation VI 0.00789 
Wnt Signaling Pathway and Pluripotency 0.00824 
Toll-like receptor signaling pathway 0.00882 
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Nucleosome assembly 0.01291 
Signal Transduction of S1P Receptor 0.01527 
Focal Adhesion 0.01570 
Histone Modifications 0.01607 
Activation of Genes by ATF4 0.01651 
 
Table 3A:  Enriched signaling pathways with increased differentially expressed 
transcripts in association with live birth. 
 
In contrast, Table 3B shows the enriched signaling pathways identified with decreased 
differentially expressed transcripts in association with live birth including degradation of 
beta-catenin, apoptosis, DNA damage response and the detoxification of reactive oxygen 
species (Table 3B).  
 
Enriched Signaling Pathways with Decreased Expression p-value 
 Degradation of beta-catenin by the destruction complex 0.000000367 
 Metabolism of non-coding RNA 0.000002327 
 Metabolism of amino acids and derivatives 0.000007400 
 MAPK Signaling Pathway 0.000016274 
 Mitotic Prophase 0.000024329 
 Wnt Signaling Pathway and Pluripotency 0.000046015 
 RNA Polymerase II Transcription 0.000046015 
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 Apoptosis Modulation and Signaling 0.000049197 
 Cell Cycle Checkpoints 0.000053863 
 Synthesis of DNA 0.000055260 
 Metabolism of carbohydrates 0.000074778 
 Detoxification of Reactive Oxygen Species 0.000077281 
 M-G1 Transition 0.000115366 
 
Table 3B:  Enriched signaling pathways with decreased differentially expressed 
transcripts in association with live birth. 
 
Further examination of both enriched signaling pathway lists revealed the WNT signaling 
pathway and the degradation of beta-catenin by the destruction complex pathway as two 
highly significant pathways associated with IVF outcome. These pathways are 
components of the WNT-canonical pathway, which is known to be functionally critical 
during development (Logan and Nusse 2004). It is important to note, FSH stimulates 
proliferation of granulosa cells; however, after the LH surge, granulosa cells stop dividing 
and exit the cell cycle (Baumgarten and Stocco 2018). This may account for the similarities 
in the observed cell signalling pathways and those expected within oocytes, such as a 
strong G2/M arrest, decrease of S phase and G1 genes etc. 
 
A key gene of the WNT-canonical pathway is AXIN1, which showed differential expression 
in the RNA-sequencing data, and thus was chosen for qPCR validation. Additional CC 
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samples were collected and run individually using RT-PCR for AXIN1 gene expression 
relative to the internal constant housekeeping gene RPL19. AXIN1 showed significantly 
increased expression in individual CC samples that resulted in negative implantation 
versus live birth CC outcomes, in concordance with the RNA-sequencing data (Figure 14). 
 
 
Figure 14:  qPCR validation validated the RNA sequencing data showing a significant 
increase in AXIN1 expression with negative outcome relative to the internal housekeeping 




In this study RNA-sequencing technologies were utilized to generate an individual profile 
of corona cell (CC) gene expression in association with oocyte developmental potential 
and successful live birth following the transfer of a euploid blastocyst. This is the first 
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study to investigate CC gene expression in correlation with the frozen embryo transfer of 
a euploid blastocyst, thereby controlling for embryonic chromosomes and an 
unstimulated uterine environment. This ongoing research of cumulus cell gene expression 
biomarkers for non-invasive assessment of oocyte competence could represent a 
valuable tool in IVF. 
 
Initial analysis of the CC RNA sequencing data confirmed genes previously published in 
association with oocyte competence including HDAC2, a member of the histone 
deacetylase family. This gene is responsible for the formation of large multi-protein 
complexes and the deacetylation of core histone complexes allowing for more compact 
histones wrapping around the DNA helix. HDAC2 gene expression has been shown to be 
vital for oocyte competence acquisition, and is critical for chromosomal segregation 
during maturation (Ma and Schultz 2013). 
 
Another previously reported CC gene associated with oocyte competence that had 
increased expression levels relative to live birth is ANG. ANG is an angiogenesis stimulator 
promoter, responsible for transcribing the protein angiogenin, and stimulating the 
production of novel blood vessels. ANG expression in mechanically separated cumulus 
clouds has been observed to be a good predictor of oocyte development, and therefore 
a potential biomarker of oocyte competence (Feuerstein et al. 2012).  
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TNFRSF10A is a member of the TNF-receptor superfamily. The TNFRSF10A receptor is 
activated by the tumor necrosis factor-related apoptosis inducing ligand 
(TNFSF10/TRAIL), which is responsible for inducing apoptosis and cell death. In this study, 
decreased TNFRSF10A expression levels were observed in relation to live birth. 
Overexpression of TNFRSF10A is indicative of problematic cell regulation, which leads to 
increased apoptosis, and decreased developmental competence. Apoptosis is an essential 
pathway during folliculogenesis, however a balance between cell death and division is 
crucial with increased levels of apoptosis shown to be associated with impaired oocyte 
maturation, as well as fertilization and pregnancy outcome (Lee et al. 2001), (Host et al. 
2002). 
 
The WNT-Canonical Pathway was associated with both increased and decreased 
differentially expressed transcripts, suggesting this pathway may play a key role in oocyte 
developmental competence. When WNT binds to cell surface receptors, it turns off beta-
catenin destruction, which in turn stabilizes beta-catenin, allowing translocation into the 
nucleus (Clevers 2006). Accumulation of beta catenin within the nucleus, activates genes 
by binding to transcriptional activators including transcription factors belonging to the 
TCF/LEF family (Clevers 2006), activating WNT target gene transcription (MacDonald, 








Figure 15:  Wnt’s are secreted extracellular signaling molecules that exert local control 
over diverse developmental processes including cell-fate specification, differentiation 
and regulation of cell-cell interactions. 
 
WNT’s are extracellular molecules that are secreted locally to exert control over a 
multitude of developmental processes including cell-to-cell interactions, differentiation, 
cell-fate specification and regulation. WNT signaling is vital for development, and is 
modulated by cytoplasmic, extracellular and nuclear regulations. Within the WNT 
signaling pathway WNT4 regulates a number of genes involved in late follicular 
development is required for normal antral follicular development  (Boyer et al. 2010). In 
a mouse knock-out study, it was shown that inhibition of the Wnt4 gene led to a 
phenotype of compromised ovarian folliculogenesis and severely reduced fertility and 
premature ovarian failure (Prunskaite-Hyyrylainen et al. 2014). WNT signaling during 
embryogenesis participates in multiple processes including cell differentiation, regulation 
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and migration (Logan and Nusse 2004), and loss of even a single WNT gene can produce 
embryonic lethality (Gilbert et al. 2010). In the absence of WNT stimulus, cytoplasmic 
beta-catenin is targeted for proteolysis by a large multi-protein assembly called the beta-
catenin destruction complex. Additionally the relative levels of the destruction proteins; 
Axin, adenomatosis polyposis coli (APC), protein phosphatase 2A (PP2A), glycogen 
synthase kinase 3 (GSK3) and casein kinase 1α (CK1α) are critical for both homeostasis as 
well as responsiveness to WNT (Minde et al. 2011). It has been suggested that WNT 
signaling in cumulus cells may act by recruiting beta-catenin and promoting the formation 
of adherens junctions, and may be important for folliculogenesis (Wang, Tekpetey, and 
Kidder 2009). 
 
Key genes within the WNT/beta-catenin signaling pathway were observed in CC samples 
to be associated with oocyte competence. For example, AXIN which is expressed mostly 
within the cytoplasm can function as a negative regulator of the WNT signaling pathway, 
is capable of inducing apoptosis. AXIN acts by recruiting beta-catenin into plasma 
membranes and promotes the formation of adherens junctions (Wang, Tekpetey, and 
Kidder 2009). AXIN functions also as a scaffold protein capable of shuttling between the 
nucleus and cytoplasm, allowing beta-catenin to be transported from the nucleus to the 
cytoplasm where it is degraded (Wiechens et al. 2004). The increase of AXIN observed in 
CC samples with negative outcome may be indicative of a degradation of beta-catenin, 
causing a reduction in WNT-signaling, cellular proliferation, cellular migration and an 
increase in apoptosis. 




Additional enriched CC signaling pathways in association with a live birth included the 
MAPK signaling pathway which moderates multiple cellular processes including 
differentiation, growth and proliferation (Ono and Han 2000). In oocytes the MAPK 
signaling pathway is associated with maintaining an arrested metaphase II, though 
recently it has been discovered that when it is inhibited during the transition from meiosis 
I and meiosis II, meiosis I is accelerated, leading to an increase in aneuploidy in the 
metaphase II stage of development (Nabti et al. 2014). MAPK signaling is mediated by FSH 
and EGF, essential for cumulus expansion which is critical for oocyte advancement 
(Dragovic et al. 2007). The Focal adhesion pathway similarly showed increased expression 
in CC's resulting in live birth. This pathway is responsible for the transmission of 
mechanical force and regulatory signaling between extracellular matrices and cells (Chen 
et al. 2003). The focal adhesion pathway has been linked to oocyte maturation thereby 
impacting oocyte developmental competence, and is partially involved in the 
communication between CCs and the developing oocyte (Ohtake et al. 2015). In cumulus 
cells, disruption of the MAPK/focal adhesion signaling pathways may affect critical 
processes involved in cumulus-oocyte communication, which may result in a less 
competent oocyte and embryo. 
 
Finally, the citric acid (TCA) cycle and respiratory electron transport pathway were 
observed to have increased CC gene expression in association with a live birth. These 
pathways are responsible for generating energy in eukaryotic cells in the form of 
Molecular Signatures of Reproductive Success 
103 
 
adenosine triphosphate (ATP). Energy production can be glucose derived, or extracellular 
pyruvate may be metabolized by the mitochondria, producing most of the ATP found in 
the oocyte (Dumollard et al. 2007), (Dumollard et al. 2009). In the mouse, the oocyte 
controls intercellular metabolomic cooperation for energy production through the TCA 
cycle between the CCs and the developing oocyte. Sufficient energy production during 
development is crucial for oocyte competence (Sugiura, Pendola, and Eppig 2005).  
 
In summary this study has demonstrated that RNA-Sequencing technologies can 
retrospectively generate a unique, oocyte-specific, transcriptomic corona cell profile on 
individual corona cell samples. This data looks promising, but more research, specifically 
an experiment designed around independent prediction and replication, must be 
performed to truly assess the value of the proposed developmental biomarkers 
highlighted in this study.  Another limitation of this study is that the patients’ stimulation 
protocols were not the same between the patients, nor the test groups, and the 
researchers did not perform any analysis of the stimulation protocol as a variable that 
may affect the molecular profiles discovered.  However, the transfer of known euploid 
blastocysts into an unstimulated uterine environment strengthens this corona cell 
transcriptome data, specifically in relation to true negative outcomes. Ongoing research 
to elucidate the biological and signaling pathways of corona cells associated with oocyte 
competence could assist with advancements in embryo selection. A corona cell biomarker 
assay developed for the identification of oocyte viability, utilized in conjunction with 
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advanced morphological algorithms and comprehensive chromosome screening, could 
result in the routine use of single embryo transfers and overall improved IVF outcomes. 
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11.2. Specific aim 2  
 
This chapter is based on published work from the following publication.  
 
Parks JC, McCallie BR, Patton AL, Al-Safi ZA, Polotsky AJ, Griffin DK, Schoolcraft WB, Katz-
Jaffe MG. The impact of infertility diagnosis on embryo-endometrial dialogue. 
Reproduction. 2018 Jun;155(6):543-552. doi: 10.1530/REP-17-0566. Epub 2018 Apr 10.  
 
 
11.2.1. My contribution to this work 
 
I worked closely with Dr. Katz-Jaffe to develop and implement the experimental design of 
this experiment. I coordinated endometrial biopsy collection taken at the time of oocyte 
retrieval with the physicians at the Colorado Center for Reproductive Medicine during 
their routine IVF procedures. I performed the subsequent experiments, results analysis 
and interpretation, and wrote and edited the manuscript for publication. 
 
 
11.2.2. Chapter summary 
 
Initial stages of implantation involve bi-directional molecular crosstalk between the 
blastocyst and endometrium. This study investigated an association between infertility 
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etiologies, specifically advanced maternal age (AMA) and endometriosis, on the embryo-
endometrial molecular dialogue prior to implantation. Co-culture experiments were 
performed with endometrial epithelial cells (EEC) and cryopreserved day 5 blastocysts (n 
= 41 ≥ Grade 3BB) donated from patients presenting with AMA or endometriosis, 
compared to fertile donor oocyte controls. Extracellular vesicles isolated from co-culture 
supernatant were analyzed for miRNA expression and revealed significant alterations 
correlating to AMA or endometriosis. Specifically, AMA resulted in 16 miRNAs with 
increased expression (P ≤ 0.05) and strong evidence for negative regulation toward 206 
target genes. VEGFA, a known activator of cell adhesion, displayed decreased expression 
(P ≤ 0.05), validating negative regulation by 4 of these increased miRNAs: miR-126; 150; 
29a; 29b (P ≤ 0.05). In endometriosis patients, a total of 10 significantly altered miRNAs 
displayed increased expression compared to controls (miR-7b; 9; 24; 34b; 106a; 191; 
200b; 200c; 342-3p; 484) (P ≤ 0.05), targeting 1014 strong evidence-based genes. Three 
target genes of miR-106a (CDKN1A, E2F1 and RUNX1) were independently validated. 
Functional annotation analysis of miRNA-target genes revealed enriched pathways for 
both infertility etiologies, including disrupted cell cycle regulation and proliferation (P ≤ 
0.05). These extracellular vesicle-bound secreted miRNAs are key transcriptional 
regulators in embryo-endometrial dialogue and may be prospective biomarkers of 
implantation success. One of the limitations of this study is that it was a stimulated, in 
vitro model and therefore may not accurately reflect the in-vivo environment. 
 
 




11.2.3. Chapter Introduction  
 
The World Health Organization estimates that 10% of couples worldwide will struggle 
with infertility. Although a small number of these reproductive-age couples may succeed 
using conventional methods over many months and possibly years, most will require the 
use of assisted reproductive technologies (ARTs) and often in vitro fertilization (IVF) to 
establish a pregnancy (Thoma et al. 2013). Although considered relatively successful, 70% 
of IVF cycles will not result in a live birth (Weimar et al. 2013).  
 
An intricate, bi-directional molecular dialogue between embryo and endometrium during 
the window of implantation, approximately 6–12 days post ovulation, is crucial for 
success (Wilcox, Baird, and Weinberg 1999). Without a precise interchange between the 
two, implantation will ultimately fail. Key genes involved with cell cycle regulation, as well 
as ion-binding and signal-transporting proteins, have been identified as contributors to 
the molecular dialogue between the embryo and a receptive endometrium by sampling 
the uterine microenvironment (Hannan et al. 2012; Ruiz-Alonso, Blesa, and Simon 2012). 
MicroRNAs (miRNAs) also play an important role during the window of implantation and 
are expressed by both the implanting embryo and the receptive endometrium (Blakaj and 
Lin 2008; Laurent 2008). Altered expression of miRNAs (including miR- 30b, miR-30d and 
miR-494) have been shown to regulate endometrial receptivity (Altmae et al. 2013).  
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An in vitro co-culture system can provide valuable insight into the initial bi-directional 
dialogue (Simon et al. 1998). In vitro studies utilizing an embryo/endometrial co-culture 
system have observed key components of the molecular crosstalk between the embryo 
and endometrial epithelial cells (EEC). However, limited information regarding this 
interaction is known (Barmat et al. 1999; Rubio et al. 2000; Simon et al. 1999).  
 
Our unique study utilized a human uterine luminal endometrial epithelial cell and human 
blastocyst co-culture system to investigate the molecular dialogue at the time of 
adhesion, in association with two major causes of female factor infertility (endometriosis 
and advanced maternal age). The researchers specifically chose to investigate the role 
miRNAs within extracellular vesicles play during the window of implantation because of 
miRNAs ability to perform essential post-transcriptional regulation of gene expression.  
MiRNAs accomplish this through either the degradation of a transcript or the inhibition 
of translation and their involvement in key cellular processes, such as apoptosis, 
proliferation, or differentiation, all of which are occurring on a large scale within the 
uterine microenvironment during endometrial development and blastocyst implantation 
(Revel et al. 2011). By utilizing the miRNA data discovered within this study, the 
researchers hope to examine mRNA transcriptome and protein/protein communications 
in the future to get a more complete understanding of the intricate molecular dialogue 
during the window of implantation.  Advanced maternal age (AMA) is associated with a 
substantial linear decline in reproductive potential and is the major cause of female 
infertility (Rosenwaks, Davis, and Damario 1995). There are many factors contributing to 
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the significant decrease in live births as women approach their 5th decade, including 
diminishing ovarian reserve (Zhang 2015), and the increase in oocyte chromosomal 
aneuploidy (Harton et al. 2013). Aneuploidy screening in IVF cycles has allowed for the 
transfer of euploid blastocysts, resulting in higher implantation rates, independent of 
maternal age (Schoolcraft et al. 2011). However, there are other variables beyond the 
oocyte/embryo chromosome constitution that impact the ability of a euploid blastocyst 
to successfully implant. Traditionally, AMA patients are shown to have a longer infertility 
duration and diminished ovarian reserve and require a higher dose of gonadotropins in 
controlled ovarian hyperstimulation, all resulting in poorer oocyte quality (Ocal et al. 
2012).  
 
Another pathological cause of infertility, widely diagnosed and treated within the field of 
reproductive medicine, is endometriosis. Endometriosis is a disease which causes tissue 
normally found within the uterus, to migrate and grow outside of it (Buck Louis et al. 
2011). This debilitating disease is often painful, impacting a woman’s quality of life, and 
greatly reduces the chances of conception. It is estimated that nearly half of all women 
with this diagnosis will have difficulty achieving a pregnancy (Practice Committee of the 
American Society for Reproductive Medicine 2006, (Ozkan, Murk, and Arici 2008)). The 
causes of endometriosis remain unclear; however a genetic predisposition is suspected 
as a common risk factor, including a family history of the condition (Wenzl et al. 2003). 
Several pathways have also been identified within patients diagnosed with endometriosis 
which may contribute to the poor oocyte quality associated with the disease (Shebl et al. 
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2017). Within infertile populations, it is estimated that the prevalence of patients 
diagnosed with endometriosis is approximately 26.13% in women undergoing 
laparoscopy (Garcia-Velasco and Quea 2005; Rizk et al. 2015).  
 
The aim of this study is to investigate these different primary infertility etiologies within 
a controlled co-culture system, and to elucidate differences within the secretome that 
may offer insight, non-invasively, into the competence and viability of the blastocyst and 
endometrial monolayer. We found significant differences in the miRNA content within 
the extracellular vesicles of the supernatant, as well as differences in gene expression 
within the co-cultured endometrial cells and blastocysts which may impact endometrial 
function during the window of implantation.  
 
11.2.4. Materials and Methods  
 
11.2.4.1. Study Design 
This study was conducted in two phases, each examining a distinct infertility etiology.  
This included women presenting with advanced maternal age, or endometriosis.  These 
particular infertility etiologies were chosen due to their significant impact on implantation 
potential and the high number of patients presenting with these distinct phenotypes 
available to participate in the study.  Both phases utilized surplus cryopreserved human 
blastocysts and endometrial biopsies, which were donated to research with consent by 
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current and prior IVF patients under the guidance of the Western Institutional Review 
Board, Inc (WIRB® Protocol #20140449). 
 
Phase 1 incorporated blastocysts from infertile endometriosis patients, while phase two 
examined blastocysts from patients presenting with advanced maternal age (Figure 16).  
Our control group across both phases consisted of blastocysts from fertile oocyte donor 




Figure 16: Phase 1 Experimental groups (CD = fertile control endometrium/fertile control 
blastocyst; ED = endometriosis endometrium/fertile control blastocyst; EE = 
endometriosis endometrium/endometriosis blastocyst) and the affected miRNAs for 
Molecular Signatures of Reproductive Success 
112 
 
embryos and endometrial cells derived from patients diagnosed with endometriosis 
compared with fertile control. 
 
Phase 2 examined advanced maternal age by utilizing our co-culture model with two 
groups, a control which consisted of donor oocyte blastocysts co-cultured with donor 
endometrial cells, and an advanced maternal age group which consisted of AMA 
blastocysts co-cultured with donor endometrial cells.  Following the establishment of the 
EEC monolayer, individual vitrified blastocysts that were donated to research were 
warmed and co-cultured with the EEC monolayer for 48 hours. 
 
Similarly, following the 48 hour co-culture, the EEC monolayer was collected, as well as 
the supernatant and the associated blastocyst for analysis (Figure 17). 
 
 




Figure 17: Phase 2 Experimental groups (Control = donor oocyte blastocyst co-cultured 
with donor EECs; AMA Group = AMA blastocyst co-cultured with donor EECs) and the 
affected miRNAs for embryos and endometrial cells derived from patients diagnosed with 
endometriosis compared with fertile control. 
 
 
11.2.4.2. Embryos  
 
Surplus, cryopreserved, hatching, transfer-grade blastocysts as identified by the Gardner 
& Schoolcraft grading system (Gardner & Schoolcraft 1999) as ≥Grade 3BB on day 5 of 
embryonic development (n = 41) were donated with patient consent and IRB approval. 
Blastocysts were derived from IVF cycles: young fertile oocyte donor controls (fertile 
control group) with no history of female or male factor infertility, based on WHO 
guidelines (maternal age ≤32 years old, BMI <29, non-smoker, non-drug user, with normal 
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ovarian reserve and regular menstrual cycles, n = 15), infertile women of AMA group 
without pre-implantation genetic diagnosis (≥39 years or older, with no other infertility 
diagnosis, n = 14), and younger female patients diagnosed with endometriosis as the only 
cause of infertility (mean maternal age of 34.3, with 11 of the 12 patients ≤33 years old, 
n = 12). Subjects underwent an ovarian stimulation protocol based on clinical discretion 
which included gonadotropin-releasing hormone (GnRH) agonist down-regulation, 
microdose GnRH agonist flare or GnRH antagonist with Menopur (Ferring 
Pharmaceuticals, Saint-Prex, Switzerland) or Bravelle (Ferring Pharmaceuticals) with or 
without clomiphene citrate. Final oocyte maturation trigger was induced when the lead 
follicle reached 20 mm mean diameter using an intramuscular injection of hCG, a 
subcutaneous injection of leuprolide acetate, or a combination of both, based on clinical 
judgment. Routine oocyte retrieval was performed transvaginally under ultrasound 
guidance 35 h post trigger. Patients within the endometriosis group were asymptomatic 
at the time of their oocyte retrieval and biopsy. Patients were excluded from the study if 
they had any other infertility comorbidities including polycystic ovary syndrome and 
depleted ovarian reserve. Embryos were vitrified and warmed according to routine 
laboratory procedures described previously (Kuwayama et al. 2005). Total time spent 
frozen varied, with an average time of approximately 4 years.  
 
11.2.4.3. Endometrial Biopsies  
 
Endometrial biopsies were collected from either young, fertile oocyte donors (fertile 
control group, n = 7) or from patients diagnosed with endometriosis who were currently 
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asymptomatic at the time of their oocyte retrieval (n = 2). Subjects were stimulated as 
described earlier. Endometrial biopsies measured 1.5–3.0 cm in length and approximately 
0.5 cm in diameter. For every endometrial biopsy collected, tissue was minced into <1 
mm sections and incubated at 4°C overnight in a 0.1% collagenase solution (Sigma-
Aldrich). The primary epithelial endometrial cells (EEC) were isolated by vigorously 
vortexing and rinsing the cell milieu in 10 mL of room temperature DMEM (Sigma-
Aldrich), prior to resting the cells for 5–10 min as they settled into distinct layers of EEC 
and stromal cells. The supernatant containing stromal cells was then removed and the 
process was repeated three times until no further stromal cells remained. 500 μL of the 
EEC/DMEM was then added to 6 wells of a Falcon Multiwell 24-well Tissue Culture Plate 
(Corning Incorporated) (Mercader et al. 2003). Cells were cultured in a media composed 
of 75% Dulbecco Modified Eagle Medium (Sigma) and 25% MCDB- 105 (Sigma) containing 
antibiotics, 5 μg/mL insulin (Sigma) and supplemented with 10% exosome-depleted fetal 
bovine serum (System Biosciences, Palo Alto, CA, USA) and observed daily to monitor the 
development of an EEC monolayer. The monolayer reached acceptable levels of well 
coverage at >65% after 4–6 days. The growth medium was then replaced with a serum-
free medium for embryo development and supplemented with 4% recombinant human 
serum albumin (Vitrolife, Englewood, CO, USA). For each endometrial biopsy processed, 
4–6 wells received an individual thawed blastocyst which was co-cultured for 48 h at 5% 
O2 and 6% CO2 at 37°C based on current laboratory practices for human blastocyst 
culture (Kovacic 2012).  
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11.2.4.4. Co-culture collection  
 
Blastocysts were co-cultured together for 48 h prior to collection. AMA or fertile control 
donor blastocysts were co-cultured with fertile control donor endometrial tissue. 
Additionally, the endometriosis subjects were divided into three groups: fertile control 
donor blastocysts co-cultured with fertile control donor endometrium (CD), fertile control 
donor blastocysts co-cultured with endometrial cells from patients diagnosed with 
endometriosis (ED) and blastocysts and endometrial cells that were both obtained from 
patients diagnosed with endometriosis (EE). Adhesion by the blastocyst to the 
endometrial monolayer was observed twice in the AMA group, twice in the fertile control 
group and once in both of the endometriosis groups. Adhered blastocysts were gently 
scraped off the monolayer prior to collection. Following co-culture, blastocysts were 
graded and rinsed in 10% phosphate buffered saline-bovine serum albumin (PBS-BSA) 
before lysis in 10 μL of extraction buffer (PicoPureRNA Isolation Kit, Thermo Fisher 
Scientific). Co-culture supernatant was collected (500 μL) and snap-frozen in liquid 
nitrogen. The monolayer was visually measured for 100% confluence, then rinsed with 
DPBS (Thermo Fisher) and incubated at 37°C with 1× diluted TrypLESelect (10×) (Thermo 
Fisher) until cells lifted from the bottom of the plate (5–15 min). Each well of EEC were 
collected individually. The pelleted EEC were lysed with 50 μL Extraction Buffer 
(PicoPureRNA Isolation Kit, Thermo Fisher) and snap-frozen with liquid nitrogen. All 
samples were stored at −80°C until further analysis (Figure 16). 
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11.2.4.5. Supernatant extracellular vesicle miRNA analysis  
 
Extracellular vesicles were isolated using Total Exosome Isolation Reagent (from cell 
culture media) kit (Thermo Fisher) which isolates small vesicles (30-120 nm) from water 
molecules.  The reagent forces less-soluble components such as vesicles out of solution, 
allowing them to be collected by a short, low-speed centrifugation. The reagent is added 
to the cell media sample, and the solution is incubated overnight at 2°C to 8°C. The 
precipitated extracellular vesicles are recovered by standard centrifugation at 10,000 x g 
for 60 min. The pellet is then resuspended in PBS, and the extracellular vesicles are ready 
for downstream analysis or further purification by affinity methods.  350 μL of 
supernatant was combined with 175 μL of reagent and vortex-mixed prior to an overnight 
incubation at 4°C. Samples were centrifuged under refrigerated conditions for 1 h, then 
the supernatant was aspirated and discarded. The resulting pellet was lysed in 10 μL of 
lysis solution containing DNase (Taqman MicroRNA Cells-to-CT Kit, Thermo Fisher) and 
incubated at room temperature for 8 min. Lysed miRNA was reverse-transcribed using 
the Taqman MicroRNA Reverse Transcription Kit with MegaPlex RT Human Primer Pool A 
(Thermo Fisher) in a final volume of 7.5 μL under the following thermal cycling conditions: 
40 cycles at 16°C for 2 min, 42°C for 1 min and 50°C for 1 s followed by a hold for 5 min at 
85°C. cDNA was pre-amplified using the Taqman PreAmp Mastermix with MegaPlex 
PreAmp Human Primer Pool A (Thermo Fisher). 100 μL of the diluted pre-amplified 
product was added to each well of the Taqman Human MicroRNA Array Card A and was 
then run on the 7900HT Fast Real-Time PCR System (Thermo Fisher) under the following 
thermal cycling conditions: 50°C for 2 min, 94.5°C for 10 min and 40 cycles at 97°C for 30 
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s and 59.7°C for 1 min. Data were analyzed using the RQ Manager 1.2.1 (Thermo Fisher), 
and statistical analysis was performed using REST 2009 software (Qiagen). miRNAs that 
displayed significantly altered expression profiles were further investigated for target 
gene analysis using miRTarBase (http://mirtarbase.mbc.nctu.edu.tw/index.php), a 
database of experimentally validated miRNA-target interactions that are classified as 
strong evidence based if there is sufficient published empirical evidence.  
 
11.2.4.6. Blastocyst gene expression  
 
Individual blastocysts stored in 10 μL of extraction buffer (PicoPure RNA Isolation Kit, 
Thermo Fisher) were incubated at 42°C for 30 min prior to isolating RNA. This procedure 
entailed adding 1 volume of 70% EtOH to each sample before transferring to a pre-
conditioned purification column. Samples were then DNase-treated using the RNase-Free 
DNase Set (Qiagen) and eluted in 20 μL following several washes. All 20 μL of purified 
total RNA was reverse-transcribed using the High-Capacity cDNA Reverse Transcription 
Kit (Thermo Fisher) in a final volume of 40 μL. The reaction occurred in a thermal cycler 
at 25°C for 10 min followed by 37°C for 2 h. cDNA samples were diluted 1:5 with nuclease-
free water and a 5 μL template was used for real-time PCR using the Power SYBR Green 
PCR Master Mix (Thermo Fisher) and a 5 μM primer mix (forward + reverse) in a 25 μL 
final volume. Duplicates of each sample were performed on the ABI 7300 Real-Time PCR 
System under the following thermal cycling conditions: 95°C for 10 min, 40 cycles at 95°C 
for 15 s and 60°C for 1 min, followed by a dissociation stage to determine melt 
temperatures. Standard curves were also employed for each gene using Universal Human 
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Reference RNA (Agilent) in 10-fold serial dilutions and an internal housekeeping gene 




11.2.4.7. Endometrial cell molecular analysis  
 
EEC samples were lysed in 75 μL of lysis solution and miRNAs were isolated using the 
RNaqueous-Micro Kit (Thermo Fisher) which required the addition of 1.25 volumes of 
100% EtOH prior to loading onto a micro filter cartridge assembly. Samples were DNase-
treated in the same manner as the blastocyst samples, and washed several times before 
eluting in 10 μL of elution solution previously heated to 75°C (performed twice for 
maximum recovery, 20 μL final volume). miRNA samples were then concentrated down 
to a 10 μL volume using a vacuum concentrator (Vacufuge Plus, Eppendorf).  
 
miRNA samples were pre-amplified, diluted and evaluated using the Taqman Human 
MicroRNA Array Card A (Thermo Fisher) as described in the earlier supernatant exosome 
miRNA analysis section. Data were analyzed using the RQ Manager 1.2.1 (Thermo Fisher) 
and statistical analysis was performed as described in the following.  
 
11.2.4.8. Statistical analysis  
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A Mann–Whitney U test was used to compare differences in the age of the donor women 
(fertile control, AMA and endometriosis blastocysts), with significance at P ≤ 0.05. The 
PCR reaction efficiencies recorded R2 values ≥0.9 and correlation coefficients were 
calculated to be >0.99. Statistical analysis was performed with REST-2009 software 
(Qiagen) which uses bootstrap randomization techniques to correct for exact PCR 
efficiencies with mean crossing point deviations between sample and control groups to 
determine an expression ratio that is tested for significance by a pair wise fixed 
reallocation randomization test. The standard error and the 95% confidence interval (CI) 
given by REST-2009 software are not derived from Ct values. They are the standard error 
and the CI for the 50,000 iterations the program runs to calculate the P value; thus, no 
error bars are generated for graphical presentation. Gene expression fold differences with 
P ≤ 0.05 were considered statistically significant.  
 
11.2.5. Results  
 
11.2.5.1. Co-culture of AMA blastocysts and fertile control blastocysts  
 
The age of the donors in the fertile control blastocyst group were significantly different 
than those in the AMA blastocyst group (P ≤ 0.05). Isolated cargo of extracellular vesicles 
from supernatant collected after co-culture of fertile endometrial epithelial cells with 
blastocysts from infertile AMA patients revealed altered miRNA expression profiles 
compared to fertile control blastocysts. A total of 16 miRNAs showed increased 
expression and 2 exhibited reduced expression in association with the maternal age of 
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the blastocyst relative to the internal housekeeping gene RNU48 (P ≤ 0.05, Figure 18). 
Target gene investigation of these 18 altered miRNAs using miRTarBase 
(http://mirtarbase. mbc.nctu.edu.tw/index.php) revealed 576 genes, 206 of which 
displayed strong evidence as defined by Western blot, qPCR or reporter assay as 
described previously. Of these strong evidence-based genes, VEGFA was identified as a 
target gene, specifically regulated by four of the altered miRNAs: miR-126, 150, 29a and 
29b. Examination of VEGFA transcription by qPCR observed decreased expression in both 
the corresponding endometrial epithelial cells and blastocysts from infertile AMA patients 
following co-culture, specifically a 50% fold change reduction compared to fertile controls 




Figure 18: Differential expression of extracellular vesicle-bound miRNAs in co-culture 
supernatant in association with maternal age (*P ≤ 0.05). 
 




Figure 19: Target gene VEGFA expression in endometrial cells (A) and AMA blastocysts (B) 
compared to young fertile controls (*P ≤ 0.05). 
 
11.2.5.2. Co-culture of endometriosis blastocysts or fertile control blastocysts on 
donor endometrium or endometriosis endometrium  
 
The ages of the donors in the fertile control blastocyst group were not significantly 
different from those in the endometriosis blastocyst group (P ≥ 0.05; ns). Isolated 
extracellular vesicles from supernatant collected after co-culture of endometriosis EEC 
with blastocysts from endometriosis patients revealed an altered miRNAome compared 
to fertile controls. Specifically, 10 miRNAs showed significant decreased expression 
including miR-7b miR-24, miR-34b, miR-200c, miR- 342-3p, miR-9, miR-484, miR-200b, 
miR-106a and miR-191 (P ≤ 0.05; Figures 18 and 19) compared to fertile control 
endometrium co-cultured with fertile control blastocysts. Using mirTarBase, strong 
evidence-based target genes were revealed, including, among others, 27 target genes for 
miR-106a. Of these 27 target genes CDKN1A, E2F1 and RUNX1 were chosen for further 
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investigation because of their known roles in association with implantation in murine 
(Cdkn1a) (Das 2009) and human models (E2F1 and RUNX1) (Tapia et al. 2011; Tapia-
Pizarro et al. 2014). qPCR analysis observed increased expression of CDKN1A in 
endometriosis blastocysts compared to fertile controls when co-cultured with fertile 
control derived EEC (P ≤ 0.05). This expression was further increased when endometriosis 
derived blastocysts were co-cultured with endometriosis derived EEC (P ≤ 0.05; Figure 
22A). Endometriosis EEC co-cultured with fertile control blastocysts displayed increased 
expression of E2F1 and RUNX1 (P ≤ 0.05). This significant difference in expression was 
further increased when endometriosis derived blastocysts were co-cultured using 
endometriosis derived EEC(P ≤ 0.05; Figure. 20B).  
 
11.2.5.3. Gene ontology and pathway analysis  
 
DAVID Bioinformatics Resources 6.8 (https://david. ncifcrf.gov/) was utilized for 
functional annotation clustering analyses of differentially expressed miRNAs to explore 
the GO biological processes and pathways, common to both infertility etiologies, and 
included cellular development, proliferation and cell cycle regulation.  
 
The enriched pathways and processes that were identified as being specific to only the 
AMA etiology included PI3K-Akt and vascular endothelial growth factor (VEGF) signaling, 
as well as biological processes involving cellular development and migration, adhesion 
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and cell cycle regulation (P ≤ 0.05; Table S1, see section on supplementary data given at 
the end of this article).  
 
For the endometriosis etiology group, enriched biological processes and pathways crucial 
for development and implantation were revealed within functional annotation clusters of 
the 1014 strong evidence-based target genes, including positive regulation of cell 
proliferation, G1/S transition of mitotic cell cycle and the p53 signaling pathway and 
angiogenesis (P ≤ 0.05). Additionally, cell cycle regulation and arrest, positive regulation 
of cell proliferation, negative regulation of apoptotic processes and negative regulation 
of G1/S transition of mitotic cell cycles were also identified (Table S2). 
 
Figure 20: Experimental groups (CD = fertile control endometrium/fertile control 
blastocyst (n = 6); ED = endometriosis endometrium/fertile control blastocyst (n = 7); EE 
= endometriosis endometrium/endometriosis blastocyst (n = 7)) and the affected miRNAs 
for embryos and endometrial cells derived from patients diagnosed with endometriosis 
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compared with fertile control. No significant differences in expression were found 
between groups EE and ED (p>0.05). 
 
 
Figure 21: Extracellular vesicle-bound microRNA expression of co-culture supernatant. 
Endometriosis derived blastocysts cultured on a monolayer of endometriosis derived 
endometrial tissue and fertile control derived endometrial tissue, fertile control oocyte 
derived blastocysts (*P ≤ 0.05). 
 




Figure 22: (A) miR-106a target gene validation of endometriosis derived blastocysts 
revealed significantly increased expression of CDKN1A when co-cultured with 
endometriosis derived endometrial cells compared to fertile control (CD = fertile control 
endometrium/ fertile control blastocyst (n = 6); ED = endometriosis endometrium/fertile 
control blastocyst (n = 7); EE = endometriosis endometrium/endometriosis blastocyst (n 
= 7)) (*P ≤ 0.05). (B) miR-106a target gene validation of endometriosis derived 
endometrial cells co-cultured with endometriosis derived blastocysts revealed 
significantly increased expression of E2F1 and RUNX1 compared to fertile control derived 
controls (CD = fertile control endometrium/fertile control blastocyst (n = 6); ED = 
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endometriosis endometrium/fertile control blastocyst (n = 7); EE = endometriosis 
endometrium/endometriosis blastocyst (n = 7)) (*P ≤ 0.05). 
 
11.2.6. Discussion  
 
This is a novel study investigating the bi-directional molecular communication at the time 
of implantation in association with infertility etiologies, a model which will offer a non-
invasive way to identify deficiencies found within the secretome. Blastocysts from 
patients presenting with AMA or endometriosis were co-cultured on a monolayer of 
endometrial cells to capture the molecular dialogue between a blastocyst and the 
endometrium during the initial stages of implantation. Specific extracellular vesicle-
bound miRNAs derived from co-culture supernatant were identified to have significantly 
altered expression in association with AMA or endometriosis, highlighted by the 
differences within embryo-endometrial communication depending on the source of the 
embryo or endometrium. This impacted downstream target gene expression in either 
blastocysts or endometrial cells during the window of implantation.  
 
11.2.6.1. Advanced maternal age  
 
It is well documented that infertile women presenting with advanced maternal age have 
some of the poorest prognoses with regard to oocyte and blastocyst quality. Additionally, 
there is some evidence that the endometrium is also affected by advanced age, resulting 
in embryo-endometrial asynchrony (Shapiro et al. 2016). The molecular dialogue between 
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the embryo and endometrium is crucial for successful implantation, and it is believed that 
miRNA-bound extracellular vesicles are involved in this bi-directional molecular 
communication.  
 
A total of 18 extracellular vesicle-bound miRNAs displayed altered expression with the 
presence of AMA blastocysts. One example was miR-150, a critically important miRNA for 
lineage cell differentiation, which also plays a role in mediating an appropriate 
inflammatory response within the endometrial environment. This response includes not 
only the endometrial epithelial cells and stromal cells, but also the immune-related cells 
and vasculature (Elton et al. 2013; Goossens et al. 2013; Pan and Chegini 2008). Pregnancy 
is a pro-inflammatory state and molecular miscommunication may result in an improperly 
coordinated auto-immune response, leading to inflammation at the implantation site, 
causing implantation failure and embryonic death. This is a delicate balance, and if the 
immune response is too great or insufficient, implantation potential may be impacted 
(Clark 2008). miR-150 is also a regulatory miRNA for the platelet-derived growth 
factor/VEGF family of genes, responsible for both angiogenesis and vasculogenesis, and 
is vital for successful embryo implantation. It has also been shown that supplementing 
embryo culture media with VEGF had beneficial effects with regard to post-compaction 
mouse embryo development, outgrowth, implantation and fetal development (Binder et 
al. 2014; Binder et al. 2016).  
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VEGFA is a glycosylated mitogen that specifically acts on endothelial cells with various 
effects, including mediating vascular permeability, angiogenesis, cell growth and cell 
migration and inhibiting apoptosis. Treatment of human endometrial cells with 
recombinant human VEGFA protein has been found to significantly increase endometrial 
cell adhesion (Hannan et al. 2011). In this study, VEGFA displayed a significantly lower 
expression in AMA samples (P ≤ 0.05), which may lead to dysregulated cellular function 
and increased apoptosis. This decrease in VEGFA expression may be indicative of the 
compromised communication between the AMA blastocyst and fertile control 
endometrium.  
 
An additional altered miRNA observed in extracellular vesicles following co-culture was 
miR- 135a with an 8-fold decrease in expression in AMA blastocysts (P ≤ 0.05). A previous 
study observed that increased expression of miR-135a during pre-implantation embryo 
development led to the down-regulation of E3 ubiquitin ligase seven in absentia 
homologue 1A (SIAH1A) expression (Pang et al. 2011). The SIAH1A protein is involved in 
many cellular processes including apoptosis, TNF-alpha signaling and cell cycle regulation 
(Relaix et al. 2000). Nearly a third of the zygotes injected with miR-135a inhibitor were 
observed to arrest in development. The mechanism for this disruption is believed to be 
due to dysregulated proteosomal degradation, possibly controlling the expression of 
chemokines in DNA-binding protein (Pang et al. 2011). miR-135a has also been correlated 
to increased apoptosis resistance in cancer cells by BCL2 regulation, a protein which 
determines cell survival and death through the mitochondrial apoptotic signaling 
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pathway. Dysregulation of BCL2 and disruption of the apoptotic pathway resulted in 
interference of not only the establishment of pregnancy, but also pregnancy maintenance 
if successful implantation was able to occur at all (Mathew et al. 2009; Pan et al. 2014). 
The dysregulation of miR-135a observed in our samples suggests that the cellular 
regulation of blastocysts derived from AMA patients may be compromised, thus 
decreasing their viability and implantation potential.   
 
Another miRNA found in the extracellular vesicles of the supernatant that displayed 
significantly disrupted differential expression was miR-449b. One strong, evidence-based 
target gene for miR-449b is NOTCH1 which has demonstrated its ability to act as a 
promoter of centriole multiplication multiciliogenesis by repressing the Delta/Notch 
pathway in Xenopus laevis embryonic dermis (Marcet et al. 2011). It is currently unknown 
precisely how mammalian cells are affected by this pathway; however it is hypothesized 
that, rather than the cilia found in Xenopus cells, it is the formation of the pseudopodia 
within the blastocyst trophectoderm that is being directly regulated (Goossens et al. 
2013). miR-449b showed significantly increased expression in the co-culture supernatant 
of AMA blastocysts, which may indicate compromised trophectoderm formation, leading 
to an increase in failed implantation as observed clinically in this patient population.  
 
11.2.6.2. Endometriosis  
 
Endometriosis is a disease characterized by an abnormal, and in many cases, 
compromised endometrium. The impact this diagnosis bears on the bi-directional 
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embryo-endometrial dialogue at the time of implantation is largely unexplored. In our 
study, co-culture of endometriosis endometrium with blastocysts derived from patients 
diagnosed with endometriosis displayed significantly decreased extracellular miRNA, 
from within the isolated extracellular vesicles, when compared to fertile control 
endometrium with fertile control derived blastocysts for 10 key miRNAs (P ≤ 0.05). Of 
particular interest was miR-106a, commonly associated with adherens junctions, receptor 
interactions, metabolic pathways and VEGF signaling. In one study utilizing a uterine 
cavity lavage, miR-106a was identified in the exosomes found within the mucus near the 
time implantation may occur. It is suspected that as the blastocyst transitions toward the 
implantation site and begins to adhere, exosomes trapped within the mucus on the 
luminal surface of the endometrium release miRNAs which contribute to endometrial-
embryo crosstalk by binding to the trophectoderm cells themselves (Ng et al. 2013). miR-
106a has also revealed itself to be a strong identifying biomarker for various types of 
cancer where it is often down-regulated (Wang 2016). MiRTarBase target gene analysis 
of miR-106a identified 29 strong evidence-based target genes, including CDKN1A, E2F1 
and RUNX1.  
 
CDKN1A works in conjunction with TP53 and is linked to stress response in the G1 phase. 
If this stress response continues to cascade, it causes arrested cell cycle, potentially 
compromising the viability of embryos, and also contributing to possible de-regulation of 
the endometrium itself (Sharma, Kubaczka, et al. 2016). CDKN1A expression has been 
shown to induce cellular growth, arrest, terminal differentiation or apoptosis (Ying et al. 
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2011). Altered aberrant CDKN1A expression is also believed to play a vital role in the 
pathogenesis of specific cancer types, including ovarian and uterine carcinomas 
(Elbendary et al. 1996). Our results demonstrate altered CDKN1A gene expression in 
blastocysts derived from patients diagnosed with endometriosis, which may negatively 
impact their viability, and also contribute to the reduced implantation potential of 
embryos derived from this patient population. 
 
E2F1 is a transcription factor that plays a crucial role in the control of the cell cycle and 
can mediate apoptosis. Over-expression of E2F1 in myoblasts has demonstrated 
proliferation stimulation while also inhibiting differentiation (Luo et al. 2016). E2F1 
induces the transcription of several genes involved in cell cycle entry, resulting in either 
the induction or inhibition of apoptosis. This influence leads to both negative and positive 
feedback loops, having a critical impact on the outcome of the cell’s fate. The E2F1 protein 
has also shown increased expression in patients diagnosed with endometrial cancer, 
where the cell cycle becomes accelerated and irregular (Mints et al. 2016). Decreased 
expression of miR-106a can increase p53 expression in human glioma cells by inhibiting 
E2F1, negatively effecting cell proliferation and inducing apoptosis (Feng, Cao, and Wang 
2013; Yang et al. 2011). Within the endometrium derived from patients diagnosed with 
endometriosis, irregular feedback loops may lead to inhibited differentiation, 
compromising the viability of the implantation site.  
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RUNX1 is also a transcription factor that, when over expressed, increases apoptosis. In a 
mouse embryo knockout study, embryos with homozygous mutations on Runx1 
terminated after 12.5 days of development, and suffered from a lack of fetal liver 
hematopoiesis as well as hemorrhaging of the central nervous system (Okuda et al. 1996; 
Wang et al. 1996). Similar to E2F1, over-expression of the RUNX1 protein has been linked 
to various forms of cancer, including endometrial and endometrioid carcinomas (Abal et 
al. 2006; Planaguma et al. 2004). In mice, Runx1 also plays an important role in regulating 
the gene expression of Ada in trophoblast cell lineage which is critical for embryo 
development (Schaubach, Wen, and Kellems 2006). In our study, endometriosis derived 
endometrium showed increased expression of RUNX1 that may lead to decreased 
implantation potential by compromising hematopoiesis and influencing the gene 
expression of placental ADA.  
 
DAVID functional annotation bioinformatics microarray analysis revealed further 
dysfunction within the expression of miRNAs for both infertility etiologies, in relation to 
GO biological processes and pathways. When comparing the three different design 
groups, we found that miR-24, 34b and 484 were not commonly expressed between the 
groups of ED vs CD and EE vs CD, highlighting a subset of developmental pathways that 
were affected by the presence of endometrial cells from patients diagnosed with 
endometriosis (Table S3). Interestingly, there were also no significant differences in 
miRNA expression between the groups of EE and ED (P > 0.05), which signifies that the 
endometriosis EEC are contributing the majority of the extracellular vesicles to the 
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supernatant and may affect the developmental potential of the implanting blastocyst.  
Target gene validation within the EE and ED endometrial cell samples did show significant 
differences in expression of CDKN1A, E2F1 and RUNX1, which may be indicative that the 
blastocysts from endometriosis phenotype may have an increased sensitivity to miRNA 
dysregulation found within the supernatant. One commonality between the 
endometriosis and AMA groups was the focus on cell cycle regulation. This may be 
indicative of compromised dialogue within the extracellular matrix. As the window of 
implantation approaches, specific auto-induction loops must occur to mediate the critical 
crosstalk between a competent blastocyst and the uterine epithelium at the implantation 
site (Hamatani et al. 2004). If these critical processes and pathways are disrupted, the 
resulting cell cycle dysregulation may contribute to a harsh environment, unsuitable for 
implantation and further development necessary for a viable pregnancy by preventing 
firm adhesion between the blastocyst and the uterine epithelium (Wang et al. 2008).  
 
A few limitations of this study include the source of the endometrial biopsy. These 
biopsies were taken at the time of oocyte retrieval from women undergoing controlled 
ovarian stimulation. It has been shown that this leads to estrogen-dependent changes in 
the protein profiles of the endometrial compartments which may affect endometrial 
receptivity (Ullah et al. 2017).  Most importantly, these biopsies were not taken during 
the window of implantation, and as such are not truly representative of endometrial 
micro environment found in vivo.  Furthermore, due to the scarcity of research materials, 
these protein profile alterations were unable to be validated further by ELISA analysis.  
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In conclusion, our study displayed a theme of compromised cellular communication in 
blastocysts and endometrium derived from patients diagnosed with AMA or 
endometriosis. These alterations may account for the lower implantation potential and 
clinical outcomes observed for these infertile patient populations, and future studies 
utilizing a model that includes independent prediction and replication will be the best way 
to proactively test these molecular data for their usefulness as developmental biomarkers 
to be used clinically in the future. Any compromise in the delicate embryo-endometrial 
molecular dialogue, either autocrine or paracrine, may impact transcription levels of key 
miRNAs and their target signaling molecules, resulting in significantly lower potential for 
reproductive success. Further investigation of the bi-directional molecular dialogue may 
help elucidate important implantation biomarkers during this critical time point, and 
advance our understanding of reproductive success.  
 
Supplementary data  
 
This is linked to the online version of the paper at https://doi.org/10.1530/REP-17-0566.  
 
Table S1:  Enriched pathways of statistically significant miRNA target genes (p<0.05) 
increased or decreased in the Endometriosis group compared to donor controls 
hsa-miR-106a 
   
GO Term Term # of genes P-Value 
GO:0008284 positive regulation of cell proliferation 4 3.40E-02 
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GO:2000134 negative regulation of G1/S transition of mitotic cell cycle 3 6.80E-04 
GO:0043066 negative regulation of apoptotic process 7 5.60E-05 
GO:0051726 regulation of cell cycle 5 3.70E-05 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04110 Cell cycle 5 3.10E-04 
 
 
   
hsa-miR-let-7b 
   
GO Term Term # of genes P-Value 
GO:2000766 negative regulation of cytoplasmic translation 3 8.30E-05 
GO:0071230 cellular response to amino acid stimulus 4 1.16E-04 
GO:0000082 G1/S transition of mitotic cell cycle 5 5.17E-05 
GO:0051301 cell division 7 6.45E-05 
GO:0001934 positive regulation of protein phosphorylation 3 0.027192 
GO:0030335 positive regulation of cell migration 6 3.22E-05 
GO:0008284 positive regulation of cell proliferation 5 0.014057 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04914 Progesterone-mediated oocyte maturation 7 3.76E-07 
hsa04152 AMPK signaling pathway 6 5.13E-05 
hsa04914 Progesterone-mediated oocyte maturation 7 3.76E-07 
hsa04114 Oocyte meiosis 4 0.006072 
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hsa04110 Cell cycle 5 7.95E-04 
hsa04115 p53 signaling pathway 3 0.022282 
hsa04151 PI3K-Akt signaling pathway 10 1.17E-06 
hsa04068 FoxO signaling pathway 7 4.80E-06 




   
hsa-miR-200c 
   
GO Term Term # of genes P-Value 
GO:0001525 angiogenesis 7 6.36E-04 
GO:0048010 
vascular endothelial growth factor receptor signaling 
pathway 6 2.22E-05 
GO:0010595 positive regulation of endothelial cell migration 4 0.001315 
GO:0001701 in utero embryonic development 7 2.49E-04 
GO:0035924 
cellular response to vascular endothelial growth factor 
stimulus 4 1.66E-04 
GO:0045766 positive regulation of angiogenesis 5 0.002113 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04510 Focal adhesion 9 6.30E-05 
 
Table S2:  Enriched pathways of statistically significant miRNA target genes (p<0.05) 
increased or decreased in the AMA group 





   
GO Term Term # of genes P-Value 
GO:0001938 positive regulation of endothelial cell proliferation 5 3.13E-05 
GO:0045766 positive regulation of angiogenesis 5 2.29E-04 
GO:0001525 angiogenesis 5 2.70E-03 
GO:0048010 vascular endothelial growth factor receptor signaling pathway 3 1.53E-02 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04151 PI3K-Akt signaling pathway 10 1.32E-05 
hsa04012 ErbB signaling pathway 6 3.70E-05 
hsa04015 Rap1 signaling pathway 7 2.86E-04 
hsa04370 VEGF signaling pathway 4 2.46E-03 
hsa04210 Apoptosis 4 2.59E-03 
hsa04668 TNF signaling pathway 4 1.15E-02 
hsa04010 MAPK signaling pathway 5 2.60E-02 
hsa04664 Fc epsilon RI signaling pathway 3 3.69E-02 
hsa05213 Endometrial cancer 5 7.72E-05 
hsa04152 AMPK signaling pathway 5 2.01E-03 
    
miR-150 
   
GO Term Term # of genes P-Value 
GO:0043066 negative regulation of apoptotic process 5 3.68E-03 
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GO:0008284 positive regulation of cell proliferation 5 4.00E-03 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04110 Cell cycle 3 4.90E-02 
    
miR-29a 
   
GO Term Term # of genes P-Value 
GO:2000352 negative regulation of endothelial cell apoptotic process 4 2.80E-04 
GO:0007160 cell-matrix adhesion 5 7.75E-04 
GO:0030335 positive regulation of cell migration 9 1.97E-06 
GO:0048010 vascular endothelial growth factor receptor signaling pathway 3 4.32E-02 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04510 Focal adhesion 16 1.81E-11 
hsa04151 PI3K-Akt signaling pathway 18 3.14E-10 
hsa04068 FoxO signaling pathway 7 5.17E-04 
hsa04115 p53 signaling pathway 5 1.65E-03 
hsa05213 Endometrial cancer 4 7.22E-03 
hsa04370 VEGF signaling pathway 4 1.12E-02 
    
miR-29b 
   
GO Term Term # of genes P-Value 
GO:0030335 positive regulation of cell migration 11 8.74E-09 
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GO:0051781 positive regulation of cell division 7 6.01E-08 
GO:0043406 positive regulation of MAP kinase activity 7 2.42E-07 
GO:0016477 cell migration 6 1.03E-03 
GO:0050680 negative regulation of epithelial cell proliferation 4 2.00E-02 
GO:0016049 cell growth 4 2.00E-02 
GO:0043065 positive regulation of apoptotic process 7 2.22E-02 
GO:0007050 cell cycle arrest 4 2.52E-02 
GO:0007160 cell-matrix adhesion 8 1.48E-07 
GO:0050714 positive regulation of protein secretion 6 5.25E-07 
GO:2000352 negative regulation of endothelial cell apoptotic process 5 6.93E-06 
GO:0048010 vascular endothelial growth factor receptor signaling pathway 3 4.11E-02 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04510 Focal adhesion 22 2.71E-19 
hsa04151 PI3K-Akt signaling pathway 24 4.96E-17 
hsa04014 Ras signaling pathway 9 2.51E-04 
hsa04068 FoxO signaling pathway 7 4.65E-04 
hsa05213 Endometrial cancer 4 6.85E-03 
hsa04110 Cell cycle 6 2.27E-03 
hsa04350 TGF-beta signaling pathway 5 3.53E-03 
hsa04370 VEGF signaling pathway 4 1.06E-02 
hsa04390 Hippo signaling pathway 5 2.64E-02 
hsa05213 Endometrial cancer 4 6.85E-03 
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hsa04370 VEGF signaling pathway 4 1.06E-02 
hsa04668 TNF signaling pathway 4 4.51E-02 
 
Table S3:  Enriched pathways of statistically significant miRNA target genes (p<0.05) 
increased or decreased in Combined Differentially expressed miRNA in Association with 
Endometriosis Diagnosis Endometrial Cells 
 
GO Term Term # of genes P-Value 
GO:0000082 G1/S transition of mitotic cell cycle 12 4.01E-12 
GO:0051301 cell division 8 0.002112036 
GO:0001701 in utero embryonic development 7 3.96E-04 
GO:0060070 canonical Wnt signaling pathway 4 0.00887545 
GO:0016055 Wnt signaling pathway 4 0.071185563 
GO:0048599 oocyte development 3 0.001949408 
GO:2001234 negative regulation of apoptotic signaling pathway 3 0.002969315 
GO:0045766 positive regulation of angiogenesis 6 3.09E-04 
GO:0001525 angiogenesis 6 0.005756441 
 
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04151 PI3K-Akt signaling pathway 16 3.01E-07 
hsa04110 Cell cycle 13 8.02E-10 
hsa04115 p53 signaling pathway 7 2.92E-05 
hsa04390 Hippo signaling pathway 8 4.11E-04 
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hsa05213 Endometrial cancer 5 0.001224143 
hsa04310 Wnt signaling pathway 6 0.008213403 
hsa04510 Focal adhesion 9 5.15E-04 
hsa04370 VEGF signaling pathway 4 0.017862483 
hsa04350 TGF-beta signaling pathway 5 0.007023653 
hsa04068 FoxO signaling pathway 5 0.033410186 
hsa04010 MAPK signaling pathway 6 0.081996404 
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11.3. Specific aim 3 
 
This chapter is based on published work from the following publication.  
 
Denomme MM*, Parks JC*, McCallie BR, McCubbin NI, Schoolcraft WB, Katz-Jaffe MG. 
Advanced paternal age directly impacts mouse embryonic placental imprinting. PLoS One. 
2020 Mar 6;15(3):e0229904. doi: 10.1371/journal.pone.0229904. eCollection 2020.  
 
11.3.1. My personal contribution to the work 
 
I worked closely with Dr. Katz-Jaffe and Dr. Denomme to develop and implement the 
design of this experiment. I worked in tandem with Dr. Denomme to perform the 
subsequent experiments, results analysis and interpretation, and co-wrote and edited the 
manuscript for publication as a co-first author. 
 
11.3.2. Chapter summary 
 
The placental epigenome plays a critical role in regulating mammalian growth and 
development. Alterations to placental methylation, often observed at imprinted genes, 
can lead to adverse pregnancy complications such as intrauterine growth restriction and 
preterm birth. Similar associations have been observed in offspring derived from 
advanced paternal age fathers. As parental age at time of conception continues to rise, 
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the impact of advanced paternal age on these reproductive outcomes is a growing 
concern, but limited information is available on the molecular mechanisms affected in 
utero. This longitudinal murine research study thus investigated the impact of paternal 
aging on genomic imprinting in viable F1 embryonic portions of the placentas derived 
from the same paternal males when they were young (4-6 months) and when they aged 
(11-15 months). The use of a controlled outbred mouse model (male and female) enabled 
analysis of offspring throughout the natural lifetime of the same paternal males and 
excluded confounding factors like female age or infertility.  It was also the researcher’s 
opinion that the use of an outbred model more accurately mimics the genetic diversity 
found within an analogous homo sapien population (please note that this is a limitation 
that will be discussed in section 11.3.6). Firstly, paternal age significantly impacted 
embryonic placental weight, fetal weight and length. Targeted bisulfite sequencing was 
utilized to examine imprinted methylation at the Kcnq1ot1 imprinting control region, with 
significant hypermethylation observed upon natural paternal aging. Quantitative real-
time PCR assessed imprinted gene expression levels at various imprinting clusters, 
resulting in transcript level alterations attributable to advanced paternal age. In summary, 
our results demonstrate a paternal age effect with dysregulation at numerous imprinted 
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As couples delay childbearing to later stages in life, the impact of increasing parental age 
on reproductive outcomes has become a significant concern (Kimura, Yoshizaki, and 
Osumi 2018). Advanced paternal age (APA) is associated with various pregnancy 
complications including increased risks for placental abruption, miscarriage, premature 
birth and low birth weight (Alio et al. 2012; Brandt et al. 2019; Khandwala et al. 2018). 
Long-term effects from delayed fatherhood have also been reported in mice, including 
reproductive fitness and longevity (Garcia-Palomares, Navarro, et al. 2009) as well as 
postnatal development and behavioural traits in offspring (Garcia-Palomares, Pertusa, et 
al. 2009). However, limited information is available on the direct influence of APA on the 
molecular mechanisms driving embryonic development in utero. 
 
Our preceding murine study showed an adverse effect of APA on in vivo and in vitro 
reproductive outcomes commencing at paternal midlife (Katz-Jaffe et al. 2013). The use 
of a murine model comes with some inherent limitations, as they are such a short-lived 
species when compared to homo sapiens.  Because of this, the underlying mechanisms 
that cause epigenetic perturbations caused by aging may be different.  It has been well 
established that in human beings, epigenetic alterations in sperm can be caused by 
environmental stressors individuals are exposed to throughout their lifetime including 
metals, air pollution, benzene, organic pollutants, and electromagnetic radiation 
(Baccarelli and Bollati 2009; Berthaut et al. 2013; Miao et al. 2014) in addition to any 
change in epigenetics associated with natural aging.  To date, most human studies have 
studied the epigenetics of aging sperm as populations of young individuals vs those of 
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aged individuals, rather than across the same males natural lifetime, (Jenkins, Aston, and 
Carrell 2018).  However, quantifying exposure risks of environmental stressors within an 
aged individual is extremely difficult to assess, especially over the course of a man’s 
natural lifetime.  This makes the prospect of using a short-lived species more attractive, 
as it is much easier to control their environment.  This allows researchers to choose to 
eliminate environmental confounding variables to focus instead on epigenetic 
permutations that occur naturally sans environmental exposures.  One potential 
underlying mechanism involves perturbations in epigenetic modifications, such as DNA 
methylation, which regulate gene expression without alterations to the DNA sequence. 
Gametogenesis and embryogenesis are important stages for the establishment and 
maintenance of epigenetic marks. It is thus hypothesized that epigenetic errors during 
spermatogenesis can occur over time as males age. In fact, age-related methylation errors 
have already been identified in human sperm (Atsem et al. 2016; Jenkins et al. 2014) as 
well as mouse sperm (Kobayashi et al. 2016; Milekic et al. 2015). Evidence has shown a 
critical role for the paternal epigenome in embryo development, and so temporal 
alterations to the sperm epigenetic landscape as fathers age may be inherited by progeny 
and subsequently affect offspring development.   
 
The placental epigenome plays a key role in regulating embryonic growth and 
development. Alterations in embryonic placental DNA methylation, frequently occurring 
at imprinted genes, have been associated with adverse pregnancy complications 
including preterm birth, intrauterine growth restriction and preeclampsia (Tilley et al. 
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2018; Toure et al. 2016). Genomic imprinting is a phenomenon that leads to monoallelic 
gene expression based on parental-origin (Bartolomei and Ferguson-Smith 2011). 
Imprinted domains often comprise of multiple genes under coordinated epigenetic 
control. The Kcnq1ot1 imprinting cluster consists of a maternally-methylated imprinting 
control region (ICR) with paternally-expressed Kcnq1ot1 non-coding RNA and numerous 
maternally-expressed protein-coding genes (Mancini-DiNardo et al. 2003). Importantly, a 
large proportion of imprinted genes are involved in growth, development and 
metabolism, and play critical roles in both the placenta and the brain. 
 
The aim of this longitudinal research study was to investigate the impact of paternal aging 
in a controlled outbred murine model on the imprinted methylation of the Kcnq1ot1 ICR 
and gene expression at various imprinting clusters in viable embryonic placentas. An 
outbred mouse model was utilized as previous research has found that it more accurately 
mimics the genetic diversity found within an analogous aging homo sapien population 
(Kõks et al. 2016). The use of a mouse model enabled analysis throughout the natural 
lifetime of the paternal males and excluded confounding factors like female age or 
infertility. The placenta tissue used to conduct these experiments represents another 
tissue commonly discarded at birth that can be used to non-invasively assess the health 
of the accompanying new life.  Our results demonstrate a paternal age effect on 
embryonic placental and fetal weight, likely due to widespread dysregulation of imprinted 
genes restricted to the paternal allele, providing a mechanism for future adverse offspring 
health conditions. 




11.3.4. Materials and methods 
 
11.3.4.1. Ethics Statement 
 
This study conducted in a privately-owned corporate setting followed national ethical 
guidelines for humane animal treatment and complied with relevant legislation. All 
experimental designs including studies involving animals were approved by an Internal 
Research Committee (IRC Protocol #990205, 5/11/2010) , adhering to a high standard of 
animal care in strict accordance with the recommendations in the Guide for the Care and 
Use of Laboratory Animals (8th Edition). Euthanasia was performed by cervical 
dislocation, and all efforts were made to minimize suffering. 
 
11.3.4.2. Animals and male aging  
 
Eight 6-8 week old outbred CF1 male mice (Charles River) with proven fertility were 
randomly selected for this study. Throughout the study, only young fertile 6-8 week old 
outbred CF1 female mice were selected for mating. 
 
 
11.3.4.3. Placenta collection 
 
Young male CF1 mice with proven fertility (“paternal males”) were mated routinely from 
4-15 months of age with superovulated young CF1 females (6-8 week old). Before mating, 
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females underwent an ovarian superovulation protocol as described previously (Larman 
et al. 2011), by an injection of 5 IU PMSG (Sigma) followed 48 hours later by 5 IU hCG 
(Sigma). The females were superovulated in both young and aged groups to ensure that 
the authors were able to collect an appropriate number of pregnancies.  This is common 
practice for many murine studies. The pregnant females were sacrificed each month at 
E16 of fetal development  and the F1 embryonic portions of the placentas (“embryonic 
placentas”; n=8 males, 96 placentas total) were carefully dissected by excising the 
superficial portion of the chorion/chorionic plate and stored at -80oC; this tissue has been 
shown to contain no maternal cells (Sood et al. 2006). Embryonic placental weight (g), 
fetal weight (g) and crown-rump length (mm) were also measured and recorded. 
Student’s t-test was performed, with differences considered to be significant at p<0.05. 
DNA and RNA were concurrently isolated from embryonic placentas derived from the 
same males in their youth (4-6 months) and aged (11-15 months) (All-in-One Purification 
Kit, Norgen) and stored at -80oC for further processing. 
 
11.3.4.4. Targeted bisulfite sequencing 
 
F1 embryonic placenta samples derived from the same males (n=8) in their youth (6/male; 
48 total placentas) and aged (6/male; 48 total placentas). The overall number of fetuses 
varied by mating and male. Exactly 6 were randomly chosen from each young and aged 
mating per male.  Collected samples were analyzed for targeted DNA methylation analysis 
as previously described (Denomme et al. 2016). Briefly, DNA isolation of individual 
embryonic placenta samples using the QiaAmp DNA Mini kit (Qiagen) was followed by 
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bisulfite mutagenesis using the EZ DNA Methylation-Direct kit (Zymo Research). PCR 
amplification involved the addition of 4 ng converted DNA directly to Hot Start Ready-To-
Go (RTG) (GE Healthcare) PCR beads that each contained 0.4 μM Kcnq1ot1 primers, 1 μL 
of 240 ng/mL transfer RNA and water up to 25 μL, with 25 μL mineral oil overlay. 
Methylation primers and PCR parameters are outlined in the supplementary data (Table 
S4A). PCR products were gel extracted, ligated into the pGEM-T EASY vector system 
(Promega), and transformed into Z-competent DHα Escherichia coli cells (Zymo Research). 
Following colony PCR amplification, 30 μL of individual clone samples were sent for 
sequencing at Bio Basic Inc. (Markham, ON, Canada). Approximately 26-28 clones were 
sequenced for each of the 96 samples. Methylation patterns were determined using two 
online software programs (BISMA and QUMA). Identical clones with the same CpG 
methylation and unconverted cytosines were considered to be representative of one 
individual DNA strand, and thus were included only once. Total DNA methylation for each 
gene was calculated as a percentage of the total number of methylated CpGs divided by 
the total number of CpG dinucleotides. Two-way ANOVA statistical assessments were 
used to examine significance for methylation between paternal age groups and individual 
paternal males for 4-6 vs. 11-15 months (n=8) and aged subgroups 4-6 vs. 11-12 months 
(n=5), and 4-6 vs. 14-15 months (n=3), while a one-way ANOVA test was used to evaluate 
significance between the young group and the two aged subgroups (4-6 vs. 11-12 vs. 14-
15 months). A reanalysis was also performed by calculating total DNA methylation for 
each gene as a percentage of the total number of methylated clones divided by total 
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clones in each placenta. Percent methylation differences with p<0.05 were considered to 
be statistically significant. 
 
11.3.4.5. Quantitative real-time PCR 
 
Analysis of transcript abundance on isolated RNA from the same individual embryonic 
placenta samples (96 placentas from 8 males) was performed as previously described 
(Denomme et al. 2018). Briefly, RNase-free DNase I (Qiagen) treated samples were 
reverse transcribed using the High Capacity Reverse Transcription cDNA kit (Thermo 
Fisher Scientific). Quantitative real-time PCR was performed with Power SYBR Green PCR 
Master Mix (ThermoFisher Scientific) on the ABI 7300 Real Time PCR System. 
Quantification of nineteen imprinted genes within five imprinting clusters were calculated 
relative to a constant internal housekeeping gene, Ppia, and the embryonic placenta 
samples derived from aged males (11-15 months, and subdivided into 11-12 months and 
14-15 months) were analyzed relative to those derived from when the same males were 
in their youth (4-6 months). Expression primers and PCR parameters are outlined in the 
supplementary data (Table S4B). The Relative Expression Software Tool (REST 2009; 
Qiagen) was used for mRNA gene expression analysis. REST uses a mathematical model 
for gene expression which is based on the PCR efficiencies and the mean crossing point 
deviation between sample and control group and tested for significance relative to a 
housekeeping gene by a pairwise fixed reallocation randomization test (Pfaffl, Horgan, 
and Dempfle 2002). Gene expression fold differences with p<0.05 were considered to be 
statistically significant. Furthermore, two-way ANOVA statistical analysis was performed 
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on deltaCt values to evaluate the effects of both paternal age as well as the paternal male 




11.3.5.1. Reproduction and Fetal Development 
 
Outbred males (n=8) with proven fertility were mated every consecutive month with 
superovulated young outbred females throughout their natural lifetime. For purposes of 
this study, paired litters of offspring from the same individual males were assessed from 
young paternal males (4-6 months) and the same paternal males when aged (11-15 
months). A secondary subdivision of the aged samples (11-12 months vs. 14-15 months) 
was executed to further characterize the timing of paternal age effects. The greatest age 
interval for a single male was 10 months, with the smallest age interval being 6 months 
















Same paternal males when 
aged (months) 
Interval (months) 
Male1 5 15 10 
Male2 4 14 10 
Male3 6 14 8 
Male4 4 11 7 
Male5 4 11 7 
Male6 6 12 6 
Male7 5 11 6 
Male8 5 11 6 
Table 4: Paternal age at time of offspring embryonic placenta collection 
 
Pregnancies conceived by the males when aged resulted in significantly smaller 
embryonic placentas (aged: 0.111g vs. young: 0.149g; p<0.0001), as well as significantly 
smaller fetuses in both weight (aged: 0.379g vs. young: 0.432g; p<0.05) and length (aged: 
13.0mm vs. young: 13.7mm; p<0.05) compared to when the same males were in their 
youth (Table 5). The fetus:placenta weight ratio was significantly higher for offspring 
conceived by the males when aged (aged: 3.45 vs. young: 3.05; p<0.05) compared to 
when the same males were in their youth, indicating placental efficiency is increasingly 
compromised in the offspring following paternal aging. No statistical differences were 
observed for the three tissues upon aged subdivision of paternal males at 11-12 months 
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0.149 ± 0.04 0.111 ± 0.02 <0.0001 0.111 ± 0.02 0.111 ± 0.03 n.s. 
Fetal weight (g) 0.432 ± 0.08 0.379 ± 0.11 0.0095 0.394 ± 0.11 0.355 ± 0.11 n.s. 
Crown-rump length (mm) 13.7 ± 1.3 13.0 ± 1.6 0.0178 13.2 ± 1.6 12.6 ± 1.5 n.s. 
Fetus:Placenta weight 
ratio (#) 
3.05 3.45 0.0147 3.28 3.56 n.s. 
Successful mating 
frequency (%) 
54.2% 28.1% 0.0494 37.5% 18.8% n.s. 
Fetuses per paternal 
male (#) 
14.8 ± 7.2 18.9 ± 10.3 n.s. 19.8 ± 10.2 17.0 ± 12.5 n.s. 
Table 5: Average offspring development results from the same males in their youth and 
aged 
 
While all eight males successfully mated in their youth, the frequency of mating activity 
significantly declined for the paternal males when aged (28% successful matings in 
months 11-15; p<0.05). This decline was exacerbated by increasing paternal age, with 
only 2/8 males resulting in a successful pregnancy at 14 months of age and only 1/8 
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resulting in a successful pregnancy at 15 months of age. Nevertheless, upon successful 
mating the litter size was unchanged between the paternal males in their youth (14.8 ± 
7.2 fetuses) and when they aged (18.9 ± 10.3 fetuses; p=n.s.).  Importantly, these averages 
include all matings from 4-6 months and all matings from 11-15 months, not just the 8 
young and 8 aged matings that lead to the placentas we used for epigenetic profiling. 
Analysis of placental and fetal weight for litters of comparable sizes demonstrated an 
equivalent reduction for offspring conceived by the males when aged compared to their 
youth (p<0.05). 
  
11.3.5.2. DNA methylation at the Kcnq1ot1 imprinting control region  
 
Several imprinted genes required for normal placentation are regulated by the Kcnq1ot1 
ICR and the non-coding RNA Kcnq1ot1 specifically expressed on the paternal allele during 
development (Oh-McGinnis et al. 2010). Results from targeted bisulfite sequencing 
analyses at the Kcnq1ot1 ICR revealed a significant DNA methylation difference in 
embryonic placentas based on the paternal age of individual males. A small but 
statistically significant increase in imprinted methylation was observed in the paternal 
aged group (59.3% average) compared to when the same males were in their youth 
(54.3% average; p<0.05; Figure 23A) due to paternal aging, with no statistical effect based 
on the individual paternal males (p=n.s.).  Significance was calculated based on all young 
vs. all aged placenta methylation, with no separation based on male (P=0.0348, n=48 
placentas). Average percent methylation increase after aging ranged from 0% to 11.5% 
for the 6 placentas per paternal male young vs. aged (P=0.0357, n=8 males) (Figure 23B, 
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Figure S1). This range correlated appropriately with age, such that the greatest 
methylation differences were observed in the embryonic placentas derived from the 
males with largest age intervals and oldest males (14-15 months). Of the twenty CpG sites 
analyzed within the Kcnq1ot1 ICR, sixteen were found to be statistically significant 
between the two groups (p<0.05; Figure 23C).   A reanalysis was performed based upon 
the methylated clones divided by total clones in each placenta, which resulted in a very 
similar outcome, though slightly higher methylated averages (56.2% Young vs. 61.4% 
Aged, p=0.0375). A clone was considered methylated when 50% or more of the CpGs were 
methylated (10 or more).  The CpGs did not all change by the exact same methylation 
percentage.  Therefore, the small but varying amounts of increased methylation argues 
for sporadic aberrant methylation on the paternal allele, rather than extra copies of the 
maternal allele which would appear as 100% methylation (all 20 CpGs would increase by 
the same amount). 
 
To further characterize the timing of the methylation aberrations, the embryonic 
placentas from the paternal males when aged were subdivided into 11-12 months (n=5 
males, 30 placentas) and 14-15 months (n=3 males, 18 placentas). Methylation at the 
Kcnq1ot1 ICR was significantly increased only in the placentas derived from the 14-15 
month aged males (63.9% average) compared to the 11-12 month aged males (56.6% 
average) and to the same males in their youth (4-6 months; 54.3% average; p<0.05), again 
with no statistical effect based on the individual paternal males (p=n.s.), demonstrating 
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the targeted increase in imprinted DNA methylation over time, specifically as the males 
aged past 12 months. 
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Figure 23: A) Percent methylation at the Kcnq1ot1 ICR in all individual embryonic 
placentas derived from all young paternal males at 4-6 months (black dots; n=48) 
compared to the same paternal males when aged (n=48); subdivided into 11-12 months 
(grey dots; n=30) and 14-15 months (red dots; n=18). Bolded middle line denotes the 
mean; error bars represent standard deviation. B) Average percent methylation at the 
Kcnq1ot1 ICR for embryonic placentas from each of the eight young paternal males 
(n=6/male) and the same paternal males when aged (n=6/male), subdivided into 11-12 
months (grey lines; n=5 males) and 14-15 months (red lines; n=3 males). C) Average 
percent methylation for all placenta samples at each of the 20 CpG sites within the 
amplified Kcnq1ot1 ICR from embryonic placentas derived from young paternal males 
(black dots; n=48) compared to the same paternal males when aged (dark grey dots; 
n=48), subdivided into 11-12 months (light grey dots; n=30) and 14-15 months (red dots; 
n=18). Error bars represent standard error of the mean. Statistical significance of p<0.05 
is denoted by a star. 
 
No individual male resulted in statistical significance between young and aged placenta 
methylation.  Importantly, taking all 8 males together, the 3 males that reach +14 months 
all experience a greater methylation change than the ~5% expected random variation (avg 
9.3% increase, p=0.008 by 2-way ANOVA), while those at 11-12 months are all within the 
~5% shift (avg 2.4% increase, p=0.609), supporting the concept that the methylation 
alterations occur after 12 months of aging and have biological relevance. Notably, we do 
not observe a decrease in average methylation for any of the 8 males after aging, an 
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added argument against random variation that would expect some males to show 
decrease. 
 
11.3.5.3. Gene expression for the Kcnq1ot1 imprinting cluster  
 
Results from imprinted gene expression analyses revealed corresponding differences 
between embryonic placentas based on paternal age. Five genes analyzed within the 
maternally-methylated Kcnq1ot1 imprinting cluster were all observed to be differentially 
expressed in the paternal aged group compared to when the same males were in their 
youth. A significant decrease in transcript abundance was observed due to paternal age 
for the paternally-expressed Kcnq1ot1 non-coding RNA and a significant increase in 
expression for the paternally-silenced protein-coding genes Nap1l4, Slc22a18, Cdkn1c, 
and Kcnq1 (p<0.05; Figure 24), with the individual paternal males resulting in a statistical 
effect at Kcnq1ot1 and Slc22a18 (p<0.05). Upon subdivision of the aged group, the 
paternally-expressed Kcnq1ot1 non-coding RNA was found to be further significantly 
downregulated in the embryonic placentas derived from the paternal males when aged 
to 14-15 months (p<0.05). This pattern of expression combined with the observed 
hypermethylation is indicative of imprinting dysregulation restricted to the paternal allele 
based on paternal aging. 
 




Figure 24: A) Expression results for imprinted genes within the Kcnq1ot1 imprinting 
cluster for embryonic placentas derived from the same males in their youth (4-6 months, 
black bars; n=48) and aged (11-15 months, dark grey bars; n=48), subdivided into 11-12 
months (light grey bars; n=30) and 14-15 months (red bars; n=18). Alphabetic letters 
indicate statistical significance of p<0.05 between groups. 
 
11.3.5.4. Gene expression for additional imprinting clusters  
 
Four additional imprinting clusters were analyzed for gene expression alterations in the 
same embryonic placentas. For the maternally-methylated Mest imprinted domain, Mest 
transcript abundance was significantly decreased, while Copg2 and Klf14 were 
significantly increased with paternal age (p<0.05; Figure 25A). Similarly, in the maternally-
methylated Airn/Igf2r imprinted domain, the non-coding RNA Airn was significantly 
decreased, with significantly increased expression of Igf2r and Slc22a3 (p<0.05; Figure 
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25B). In the paternally-methylated H19 imprinted domain, the non-coding RNA H19 
transcript abundance was significantly increased, and Ins2 was significantly decreased 
with paternal aging (p<0.05; Figure 25C). Finally, in the paternally-methylated Dlk1/Dio3 
imprinted domain, Dlk1 expression was significantly decreased (p<0.05; Figure 25D). A 
statistical effect was also observed based on the individual paternal males at Mest, Copg2 
and Slc22a3 (p<0.05). Upon subdivision of the aged group, Mest, Klf14 and Dio3 were 
significantly dysregulated in the embryonic placentas derived from the paternal males 
when aged to 14-15 months compared to those aged 11-12 months. Airn, Ins2 and Dlk1 
reached statistical significance only in those aged 11-12 months, while Meg3 was found 
to be significantly increased only in those aged 14-15 months; which did not reach 
significance when combined with the 11-12 months cohort. The subtle and varying effect 
of APA, combined with the reduced sample sizes when subdivided, may contribute to the 
variable statistical differences observed at certain imprinted genes. Significant decreases 
in gene expression for paternally-expressed imprinted genes, and corresponding 
significant increases in gene expression for paternally-silenced imprinted genes are 
indicative of imprinting dysregulation restricted to the paternal allele due to paternal 
aging. 
 




Figure 25: Expression results for imprinted genes within the A) Mest B) Airn/Igf2r C) H19 
D) Dlk1/Dio3 imprinting clusters for embryonic placentas derived from the same males in 
their youth (4-6 months, black bars; n=48) and aged (11-15 months, dark grey bars; n=48), 
subdivided into 11-12 months (light grey bars; n=30) and 14-15 months (red bars; n=18). 




While the genome is largely reprogrammed during gametogenesis and early 
embryogenesis, the epigenetic status at imprinted domains must be actively maintained, 
Molecular Signatures of Reproductive Success 
164 
 
and thus are highly susceptible to epigenetic perturbations. In our longitudinal research 
study, paternal aging during the natural lifetime of male mice was associated with 
significant dysregulation to both ICR DNA methylation and imprinted gene expression in 
embryonic placentas of their offspring, offering non-invasive insight into the health of the 
associated fetus.  
 
The Kcnq1ot1 ICR and the paternally-expressed non-coding RNA Kcnq1ot1 regulate 
several imprinted genes required for normal placentation during development (Oh-
McGinnis et al. 2010). Kcnq1ot1 ICR methylation in eight sets of paired embryonic 
placenta samples showed overall hypermethylation upon advanced paternal age (APA) 
compared to when the same males were in their youth. While the average methylation 
was situated near expected for imprinting loci, the range of methylation between 
placenta samples was considerable even when the sperm contribution was from the 
males in their youth, highlighting variability between individuals (both F0 and F1). A larger 
placental methylation range was, nevertheless, observed when the same males aged 
during their natural lifetimes. Most embryonic placentas had increased methylation, but 
markedly decreased methylation was also observed in a few select samples, indicative of 
overall epigenetic perturbations in either direction by advanced paternal age. 
Hypermethylation of the Kcnq1ot1 ICR was exacerbated in the embryonic placentas 
derived from the paternal males when they reached 14-15 months of age, demonstrating 
the targeted increase in imprinted DNA methylation over time, specifically as the males 
aged past 12 months. The gain of methylation in the majority of samples is presumed to 
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come from the unmethylated paternal allele, as the maternal allele is hypermethylated. 
This aberrant gain of methylation at a gametic imprinting control region may have 
originated in the APA sperm and been directly inherited by the offspring, or it may be 
attributable to a paternal factor(s) compromised in the aging sperm environment leading 
to inappropriate imprinting methylation maintenance in the trophectoderm of the 
embryo. The biological significance of the small methylation shift is unknown, though 
subtle epigenetic changes have been associated with complex disease phenotypes 
(Leenen, Muller, and Turner 2016), and may result in a cumulative effect on placentation 
and embryonic developmental capacity. As paternal aging is a subtle and varying effect, 
not every pregnancy from an APA father will be impacted. Indeed, a threshold of 
methylation alterations may be required to predispose placental dysfunction. As allelic 
identity was not feasible, overrepresentation of the maternal allele is also a possibility; a 
substantial number of samples were analyzed for both young and aged groups in order to 
overcome this technical limitation. 
 
The subtle, yet statistically significant shift in DNA methylation at the Kcnq1ot1 ICR based 
on advanced paternal age lead to subsequent transcription changes for five imprinted 
genes within the cluster, observed in both subdivisions of the paternally aged group. In 
particular, the embryonic placentas derived from males that aged to 14-15 months had 
the largest methylation increase, and this correlated with the largest Kcnq1ot1 expression 
decrease, statistically. These alterations may be due to disrupted transcription factor 
binding. Within the amplified Kcnq1ot1 ICR region, various binding sites exist 
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(MatInspector by Genomatix), many with direct binding motifs overlapping at least one 
CpG site. These transcription factors have potential to be impacted by compacted 
chromatin from increased methylation, including those that have been shown to be 
critical in genomic imprinting regulation. For example, the Kruppel-like zinc finger protein 
ZFP57 binds methylated DNA and is necessary for maintaining the methylation memory 
at imprinting control regions during replication in early mouse embryos (Quenneville et 
al. 2011). Binding of ZFP57 to the aberrantly methylated Kcnq1ot1 ICR paternal allele 
would result in a more maternal-like phenotype by means of recruiting additional 
repressive factors. Evidence of this is the aberrant decrease in Kcnq1ot1 gene expression, 
and the resulting aberrant increase in the surrounding imprinted genes, analogous to 
what is observed on the maternal allele. The loss of Kcnq1ot1 transcript expression is 
presumed to occur on the paternal allele, as the maternal allele is innately silenced, 
supporting a paternally-inherited effect at the Kcnq1ot1 imprinted domain from 
advanced paternal age. 
 
A large proportion of imprinted genes are involved in growth, development and 
metabolism, and play important roles in both the placenta and the brain. Paternally-
expressed genes often promote growth enhancement while maternally-expressed genes 
are involved in growth suppression. Loss of mouse paternally-expressed Mest causes 
placental growth restriction, while loss of maternally-expressed Igf2r or Cdkn1c results in 
placental enlargement (Coan, Burton, and Ferguson-Smith 2005). In the embryonic 
placentas derived from males in their old age, significantly decreased expression was 
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observed in paternally-expressed genes (Kcnq1ot1, Mest, Airn, Ins2, Dlk1) and aberrant 
expression in paternally-silenced genes (Kcnq1, Cdkn1c, Slc22a18, Nap1l4, Copg2, Klf14, 
Igf2r, Slc22a3, H19) compared to when the same males were in their youth. These results 
in combination with significantly reduced embryonic placental weight is indication of 
imprinting dysregulation restricted to the paternally-inherited allele due to paternal 
aging, despite the origin (sperm or oocyte) of methylation for the gametic imprinting 
control region. The main role of the placenta is the nutrition of the fetus, thus influencing 
the significant reduction in fetal weight and crown-rump length also observed in the 
offspring derived from the paternal males when they aged. 
 
The majority of imprinted genes have been described as belonging to imprinted gene 
networks (IGN) involved in the control of embryonic growth, that are co-regulated during 
development (Al Adhami et al. 2015; Varrault et al. 2006). For example, H19, with 
dysregulated gene expression in our study, is a master regulator of an IGN impacting 
expression of other imprinted genes including several that were also dysregulated in our 
study (Cdkn1c, Dlk1, Igf2r (Gabory et al. 2009; Monnier et al. 2013), and Mest, Meg3 
(Monnier et al. 2013)). Interestingly, various reports of multi-locus imprinting 
disturbances (MLID) exist in individuals with human imprinting disorders, having 
epigenetic errors in auxiliary imprinted regions in addition to the disease-associated locus 
(Azzi et al. 2014; Mackay et al. 2015; Sanchez-Delgado et al. 2016). The statistically 
significant alterations to fourteen imprinted gene transcripts at five imprinting clusters in 
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our study support both IGN and MLID models and provide a translational consequence to 
the subtle epigenetic dysregulation observed. 
 
It is hypothesized that epimutations in the male gamete may subsequently be 
generationally transmitted. Age-related imprinting errors have been identified in mouse 
spermatozoa (Kobayashi et al. 2016), as well as genome-wide sperm methylation 
alterations, transferring some methylation abnormalities to offspring and impacting 
offspring behavior (Milekic et al. 2015). Furthermore, placental imprinting perturbations 
have been shown to arise from other external insults to the paternal germline, including 
paternal folic acid exposure (Ly et al. 2017) and paternal obesity (Mitchell et al. 2017), 
presumably impacting imprinting on the paternal allele. In terms of aging, DNA 
methylation alterations were also observed at the Kcnq1ot1 promoter in the brain of 
offspring of older fathers compared with the offspring of younger fathers (Smith et al. 
2013). Our study further argues this generational epigenetic consequence to paternal 
aging. 
 
There are several critical limitations to this study, and it is important to note that the 
researchers used superovulated female mice in the study which may have affected the 
results of the study. Specifically, the number of embryos that were generated and 
implanted per female, and how a higher number of implantations would affect the health 
of the placenta or fetal growth.  The females were superovulated in both young and aged 
groups to ensure that the authors were able to collect an appropriate number of 
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pregnancies.  This is common practice for many murine studies.  As all females were 
superovulated, it is unlikely that superovulation contributed to the effects on placenta or 
fetal growth observed between young and aged paternal male groups.  The current study 
performed in vivo matings and development only, thus we did not compute number of 
embryos generated. However, our previously published work that was the basis of this 
study (Katz-Jaffe et al. 2013) showed a significant decline in in vitro blastocyst 
development at +12 months of paternal age. Our earlier publication also noted that 
pregnancies from natural conceptions with paternal age >12 months resulted in 
significantly smaller fetuses in length and weight. In addition, placental weight was 
observed to be significantly smaller with paternal age >12 months, similar to this studies 
results.  Another limitation of the study is the use of clone and sequence technology, 
rather than next-gen amplicon sequencing which would be more precise.  The authors 
used clone and sequence as it is a traditional low-cost targeted bisulfite sequencing 
approach for imprinted methylation analysis, and has be published recently in other peer-
reviewed articles using placenta samples (Vasconcelos et al. 2019; Monteagudo-Sánchez 
et al. 2019; Yamaguchi et al. 2019; Huo et al. 2020).  The initial analysis of this study 
calculated the total DNA methylation as a percentage of the total number of methylated 
CpGs divided by the total number of CpG dinucleotides which we then reanalysed as 
methylated clones divided by total clones in each placenta which, resulted in a very similar 
outcome and importantly, still statistically significant. The researchers note that the 
statistical significance occurs only in the 14-15 month males, and did not see a decrease 
in average methylation for any of the 8 males after aging, which the authors believe is an 
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added argument against random chance of getting more or less maternal alleles in the 
aged samples.  Finally, the use of outbred females in this study is also a very significant 
limitation, and makes it exceedingly difficult to assess the number of maternal vs paternal 
alleles cloned in this study, as the authors are unable to utilize SNPs to help determine 
parental origin, as the samples used in this study are no longer accessible.  Future 
directions for this study include the introduction of a separate, inbred strain of female 
mice to strengthen this research, and eliminate this confounding variable. 
 
In conclusion, the present study examined the contribution of male aging throughout 
their natural lifetime to genomic imprinting regulation in offspring embryonic placentas, 
with results demonstrating ICR epigenetic dysregulation, a widespread effect on 
imprinted expression, and a combined reduction in placental weight, fetal weight, crown-
rump length and successful mating frequency. A key strength to the study is the 
longitudinal feature, enabling age comparisons during the natural lifetime of the same 
males without confounding factors including female aging or infertility. Imprinted genes 
play critical roles in growth, development and metabolism, and are highly essential to 
placental function. Understanding the causal relationship between sperm aging and 
placental genomic imprinting regulation is critical as developed countries continue to 
delay childbearing. If these epigenetic changes related to paternal aging are translational, 
they could be responsible for placental dysfunction as well as adverse pregnancy 
outcomes and childhood health conditions observed in the human population. 
  






Table S4: A) Primer and PCR parameters for targeted bisulfite sequencing. B) Primer and 
PCR parameters for targeted qRT-PCR. 
 
 
SUPPLEMENTARY S1a TABLE: Primer and PCR parameters for targeted bisulfite sequencing
GENE CHROMOSOME FORWARD PRIMER REVERSE PRIMER LENGTH (BP) # of CpGs
Kcnq1or1 Chr7 GGTTAGAAGTAGAGGTGATT CAAAACCACCCCTACTTCTAT 206 20
PCR Parameters:
94°C for 10 min, 55 cycles of (94°C for 15 sec, 56°C for 20 sec, 72°C for 20 sec), 72°C for 10 min.
SUPPLEMENTARY S1b TABLE: Primer and PCR parameters for targeted qRT-PCR
GENE CHROMOSOME FORWARD PRIMER REVERSE PRIMER LENGTH (BP)
Kcnq1ot1 Chr7 CACCCCAACCTGCTATTGCTA CTGGGGAGAATGTACCAGCC 239
Kcnq1 Chr7 GCTGAGAAAGATGCGGTGAAC CATCTGCGTAGCTGCCAAAC 58
Cdkn1c Chr7 CCACGGTTTTGTGGAAATCTG CGTACTCCTTGCACATGGTACAG 71
Slc22a18 Chr7 CCTCTGCTTTGGCATTGGAA ATCCCGTATGCGGTGTTAAGG 69
Nap1l4 Chr7 TTCACTGTCCTCCCACTTACGA CTCCCTCCACTTGGTGTCACA 71
M est Chr6 CGGAAGCCCTGAGATAGTTGTG CCTAAGAAATCAAGGGCGATCAC 120
Copg2 Chr6 AAGAGGTGGGAGATGCCTTTG ACCTCTCACATGGCTGCATACC 117
Klf14 Chr6 ACCGAAGGAGGCAGATTACG ACGACTTGTAGTAGGCCTTGTTG 81
Airn Chr17 GGGAAGTGGACCTGTTTAGAAG CTGCCGATTTCCTGATAACAC 68
Igf2r Chr17 GGCACCACTCCTTCATGATC TTGGCCGATTCAAGCAA 61
Slc22a2 Chr17 CACACAACCCAACCTCACTTACC TGGACACATCAGTGCAACAAAC 89
Slc22a3 Chr17 AACTGCCTCTGATCATCTTTGG CGTTTCAGGCAAAAGCATCAC 71
H19 Chr7 ATGGTGCTACCCAGCTCATGTC GTGGTTCTGATTGCAGCATCTTC 95
Igf2 Chr7 CCTACATAACGGGAGCAGTGATC CATTGTGGTAGCCGGTGTTG 85
Ins2 Chr7 AGAAGCGTGGCATTGTAGATCAG TGGTGGGTCTAGTTGCAGTAGTTC 82
Dlk1 Chr12 CTAACCCATGCGAGAACGA AGCGGCAACGGAAGTCA 60
M eg3 Chr12 GAGTGGACTAAGCACGAAGCA CACTTGTACGAGCATCCATCTC 173
Rtl1 Chr12 GCAAGTCGCCCGTTCTCTA TGACCCAGTGATGTCTGTTTCC 71
Dio3 Chr12 ATCCAGAGTGGCACCATCATG CGCAACTCAGACACCTGGTAAC 68
PCR Parameters:
95°c for 10 min, 40 cycles of (95°C for 15 sec, 60°C for 1 min), 
followed by 95°C for 15 sec, 60°C for 1 min, 95°C for 15 sec, 60°C for 15 sec




















Figure S1: DNA methylation results for each embryonic placenta for the eight paternal 
males when young (n=6/male) and aged (n=6/male). A) Male1 (ID 61), B) Male2 (ID 18), 
C) Male3 (ID 116), D) Male4 (ID 83), E) Male5 (ID 90), F) Male6 (ID 112), G) Male7 (ID 53), 
H) Male8 (ID 81). Each group of circles represents one embryonic placenta sample, with 
the sample name indicated in the top left (Y=young, A=aged), and percent methylation 
indicated in the top right. Each row represents one DNA strand. Filled circles represent 
methylated CpG dinucleotides and unfilled circles represent unmethylated CpGs.  
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12.0 General Discussion 
 
This thesis was largely successful in the fulfilment of its specific aims, first it investigated 
the individual CC transcriptome of chromosomally normal (euploid) embryos, and by 
utilizing RNA sequencing, was able to identify novel biological pathways associated which 
were associated with implantation outcome. The results of the corona cell transcriptome 
study demonstrated that the WNT-Canonical pathway and AXIN transcription are strong 
indicators of oocyte developmental competence and viability when correlated with a 
subsequent chromosomally normal live birth. 
 
Next, this thesis utilized a comprehensive endometrial co-culture study to investigate the 
window of implantation in women presenting with advanced maternal age, and 
endometriosis.  This second study displayed a theme of compromised cellular 
communication between blastocysts and endometrium derived from patients with 
compromised fertility. These variations may account for the lower implantation potential 
and clinical outcomes observed for these infertile patient populations. There must be a 
balance in the delicate embryo-endometrial molecular dialogue, and any alterations, 
either autocrine or paracrine, may affect transcription levels of key miRNAs and their 
target signalling molecules. This may then result in significantly lowered implantation 
potential and fertility. 
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Finally, the third study included in this thesis investigated the contribution of male aging 
throughout their natural lifetime to genomic imprinting regulation in their subsequent 
offspring’s embryonic placentas. The results demonstrated ICR epigenetic dysregulation, 
as well as a widespread effect on placental imprinted expression, and a combined 
reduction in successful mating frequency, and fetal offspring parameters including 
placental weight, fetal weight and crown-rump length. A key strength to the study was its 
longitudinal nature, which allowed for age comparisons during the same subjects natural 
lifetime sans external confounding variables including female aging or infertility. The 
study concluded that imprinted genes play critical roles in growth, development and 
metabolism, and are highly essential to placental function. The investigation broadened 
our understanding the causal relationship between sperm aging and placental genomic 
imprinting regulation, which is critical, as developed countries continue to delay 
parenthood.  
 
12.1.   Common themes and insights 
 
This thesis sought to utilize commonly discarded materials and incorporate them into 
non-invasive assays to monitor the health and development of a developing life through 
multiple stages of its development.  As an oocyte, excess cumulus and corona cells that 
are commonly disregarded were collected and their molecular profile was examined in 
conjunction with their developmental potential.   
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Next, this thesis examined the maternal microenvironment a resulting developmentally 
competent embryo was likely to encounter after it was transferred to the luminal 
epithelial tissues of the endometrium within the uterine cavity.  This investigation utilized 
a minimally invasive endometrial biopsy, which was performed at a time when it would 
not affect the health of the mother or the embryo.  However, this provided us a window 
into this critical juncture, and the role of microvesicles were investigated in correlation to 
specific infertility diagnoses. Notably, aberrant expression was examined in relation to 
both the advanced maternal age and endometriosis phenotypes, which may lead to 
compromised implantation potential.   
 
Finally, the health of the subsequent pregnancy was observed by studying the epigenetics 
and genomic imprinting of placenta tissue, a tissue that is intimately connected to both 
the mother and child and due to the bi-allelic nature of its imprinted status the father as 
well.  Here it was discovered that over the natural lifetime of an aging male subject, their 
contribution to genomic imprinting regulation in the subsequent offspring’s’ embryonic 
placentas, demonstrated epigenetic dysregulation, which may have significant long term 
consequences on over the course of the progeny’s life, and are potentially passed on to 
future generations. 
 
When taken together, these studies provide a blueprint for a model underutilized in 
current ART practices, using specific discarded materials to assess the new life’s vitality 
and viability throughout multiple stages of development.  If this model is expanded upon, 
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and these practices and collected materials are used serially in conjunction with a single 
couple’s infertility journey, it is this researchers belief we will see improvements in clinical 
ART success rates and enhanced patient counselling. 
 
12.2.  Future Work 
 
Ongoing research to illuminate the biological and signalling pathways of corona cells 
associated with oocyte viability continues to be an appealing target for researchers as 
well as clinicians.  Corona cells are intimately linked with their associated oocyte 
throughout development, and provide one of the earliest windows into the health and 
competence of a mature oocyte.  However, the true value of these discovered molecular 
biomarkers will be realized when they are used in conjunction with conventional means 
of embryo selection in a prospective, randomized control trial.  This will be the best way 
to assess the usefulness of a corona cell biomarker assay, combined with the routine use 
of single embryo transfers, which may lead to overall improved IVF outcomes.  There are 
multiple ways of measuring molecular biomarkers of the maternal microenvironment 
secretome during the window if implantation including endometrial biopsy and uterine 
aspiration.  When used together in a prospective trial, these studies will provide 
researchers further insight into the bi-directional molecular dialogue during this critical 
time point.  Finally, a deeper understanding of the paternal contribution to the health and 
development of a viable pregnancy by examining the imprinting profile of the placenta 
will provide an early insight into the developmental future of the child, and may assist 
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parents by detecting risk factors, and preparing for any discovered health challenges.  To 
expand our current understanding, investigations into the placenta profile of other 
paternal risk factors should be studied, including harmful environmental exposure as well 
as any familial history of disease. 
 
12.3.  Personal Perspectives and Final Conclusions  
 
As of the writing of this thesis, despite a plethora of ongoing efforts to discover molecular 
biomarkers from non-invasive assays and incorporate them into a clinical IVF lab setting, 
relatively few have found any commercial success outside of those highlighted in the 
introduction.  This may be due to multiple factors including the additional time associated 
with collecting and assessing biological materials, the necessity of culturing the embryos 
as singletons despite their survival being higher when cultured in a group setting, the 
technical expertise that such methods require and the high costs associated with the 
purchasing required equipment.  Nonetheless, these efforts must continue if we are to 
achieve our collective goal within the field of ART for every infertile couple seeking 
treatment to attain successful conception.   
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Jason C. Parks, Alyssa L. Patton, Blair R. McCallie, Darren K. Griffin, William B. Schoolcraft, 
Mandy G. Katz-Jaffe. Secreted Endometrial Microrna Gene Regulators Are Critical For 
Successful Embryo Implantation. Presented at 2015 ASRM Conference in Baltimore, 
Maryland. 
Objective:  Successful implantation is dependent on the intricate dialogue between a 
viable embryo and a receptive endometrium. On the maternal side, specific adhesion 
changes need to occur for blastocyst attachment, in addition to tight regulation of key 
signaling molecules in the microenvironment of the implanting embryo. This study 
investigated the mammalian uterine fluid secretome prior to embryo transfer, utilizing 
two sampling techniques, to examine the microRNAome in association with implantation 
outcome. 
Design:  Research study 
Materials and Methods:  In vivo fertilized zygotes collected from super ovulated female 
BDF-1 mice were cultured to the blastocyst stage.  Hatching blastocysts were either 
collected for gene expression analysis using qRT-PCR (n=12) or selected for transfer into 
each uterine horn (n= 4/horn) of a pseudopregnant BDF-1 recipient mouse (n=16).   
Immediately prior to embryo transfer, a uterine lavage or aspirate was collected (n=32).   
On Day 16 of embryo development, implantation outcome was noted.  Endometrial tissue 
was also biopsied from pseudopregnant mice not receiving an embryo transfer (n=12).  
Uterine lavage, aspiration and endometrial tissue samples were analyzed for expression 
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of 306 miRNAs using the TaqMan® Rodent MicroRNA Array (Thermo Fisher) and analyzed 
for significance in association with implantation outcome using REST© statistical software 
(Qiagen). 
Results:  Analysis of the two uterine fluid sampling techniques revealed no similarities in 
miRNA expression profiles in relation to implantation.  Uterine aspirates that resulted in 
positive implantation, displayed 18 increased, and 7 decreased miRNAs (P<0.05). Notably, 
mir-101a, a conserved miRNA between human and mouse, showed increased expression 
in uterine aspirates with positive pregnancy.  Expression of miR-101a was observed in 
receptive endometrial tissue.  There are seven known validated target genes for miR-101a 
including, Akt1, a gene responsible for the mitigation of trophoblast migration.  Increased 
miR-101a expression, as observed in positive outcome uterine aspirates, has been shown 
to mediate Akt1 activation.  Akt1 expression was identified specifically in hatching 
blastocysts. 
Conclusions: The embryo-endometrial interaction is crucial to implantation success. 
Secreted uterine miRNAs characterize the maternal molecular dialogue, and are 
internalized by the trophectoderm to function as transcriptomic regulators, either 
promoting or inhibiting blastocyst development and adhesion.  For miR-101a, increased 
expression mediates blastocyst Akt1 expression thereby improving the likelihood of 
implantation success.  In conclusion, the uterine aspirate miRNAome represents a 
minimally invasive method to assess the embryo-endometrial interaction.  
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Jason C Parks, Blair McCallie, Julie A Reisz, Matthew Wither, William B Schoolcraft, Mandy 
G Katz-Jaffe. Maternal endometrial secretions 24 hours prior to frozen embryo transfer is 
predictive of implantation outcome. Presented at 2016 ASRM Conference in Salt Lake City, 
Utah. 
 
Objective: It is well known that successful implantation is dependent on the intricate 
dialogue between a competent embryo and a receptive endometrium. On the maternal 
side, specific biological changes in adhesion need to occur for blastocyst attachment, 
while tight regulation of signaling pathways are crucial for the invading embryo. The 
objective of this study was to examine the uterine fluid milieu in association with 
implantation outcome 24 hours prior to, and at the time of euploid embryo transfer. 
Design: Research study 
Materials and methods: Infertile patients (n=48) were recruited with IRB consent prior to 
an estradiol/progesterone replacement frozen embryo transfer (FET) with euploid 
blastocysts. Uterine secretions were collected by gentle aspiration (~2-5ul), either 24h 
prior to, or at the time of FET. Uterine secretome analysis was performed blinded of 
implantation outcome using qPCR for miRNA analysis (n=12) and mass spectrometry 
(n=36) for metabolite (UHPLS-MS, Thermo) and protein analysis (LC-MS/MS, Thermo). 
MiRNA profiles were analyzed by REST© statistical software. MS data was converted with 
MassMatrix and processed with Maven (Princeton Univ). MS/MS data was examined 
using Mascot™ (v 2.2) and Scaffold (v 2.06). Validation of target genes was performed 
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using qPCR on endometrial biopsies (n=14) and surplus cryopreserved blastocysts (n=14) 
donated with patient consent. 
Results: A notable uterine secretome profile of miRNA, metabolites and proteins was 
significantly associated with a negative, toxic environment both 24hrs prior to, and at the 
time of embryo transfer (P<0.05, >2 fold change). Specifically, 6 maternal miRNAs showed 
increased expression with negative implantation, including miR-17 (P<0.05). A known 
target gene of miR-17 through negative regulation is VEGFA, a signal protein essential for 
implantation and secreted by the receiving endometrium as well as the implanting 
embryo. Validation of VEGFA expression was confirmed in epithelial endometrial cells and 
individual blastocysts. A total of 12 amino acids displayed significant decreased quantities 
in the uterine secretome associated with negative implantation (P<0.05, >2 fold change) 
including arginine, essential for blastocyst activation and trophectoderm motility. 
Additionally, the MUC protein family were observed at increased protein levels with 
implantation failure (P<0.05). MUCIN proteins are epithelial cell surface proteins that 
have considerable effect on endometrial function, creating a barrier to implantation. 
Conclusion: Aberrant maternal uterine miRNA and molecular secretions allow for the 
characterization of implantation failure both 24 hours prior to, and at the time of FET. 
This compromised embryo-endometrial dialogue further impacts the transcription levels 
of key signaling molecules, resulting in significantly lower implantation success. Predicting 
the maternal molecular microenvironment ahead of embryo transfer may allow for fine 
tuning of procedures for IVF patients thereby improving implantation outcomes.  
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Jason C Parks, Michelle Denomme Tignanelli, Nathan McCubbin, Blair McCallie, William 
Schoolcraft, Mandy Katz-Jaffe. Advanced paternal age directly impacts placental 
epigenetic mechanisms. Presented at 2017 ASRM Conference in San Antonio, Texas. 
 
Objective: The placental epigenome plays a key role in regulating fetal growth and 
development. Alterations in placental DNA methylation have been associated with 
adverse pregnancy complications including preterm birth, intrauterine growth restriction 
and preeclampsia. The KCNQ1OT1 imprinting cluster consists of an imprinting control 
region (ICR) with paternally expressed KCNQ1OT1 non-coding RNA and numerous 
maternally expressed protein-coding genes. KCNQ1OT1 ICR methylation loss is directly 
linked to imprinting disorders in humans. The aim of this study was to investigate the 
impact of paternal aging on the methylation and expression of the Kcnq1ot1 imprinting 
cluster in viable embryonic placentas. 
Design: Longitudinal research study. 
Materials and Methods:  Male outbred CF1 mice (n=8) with proven fertility were mated 
routinely during each animals lifespan (4-15 months) with superovulated young outbred 
virgin CF1 females (6-9 weeks). Pregnant females were sacrificed on day 16 of fetal 
development and embryonic placentas were collected for DNA and RNA isolation. 
Relative expression analysis was performed by qPCR for 10 imprinted genes from the 
Kcnq1ot1 imprinting cluster (n=24 embryonic placenta, paternal age 4-6 months; n=24 
embryonic placenta, paternal age 11-15 months). Imprinted DNA methylation was 
assessed by targeted bisulfite sequencing at the Kcnq1ot1 ICR (n=24 embryonic placenta, 
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paternal age 4-6 months; n=24 embryonic placenta, paternal age 11-15 months). 
Statistical analysis was performed using REST© (Qiagen) and Student’s t-test where 
appropriate, with significance at p<0.05.  
Results: Decreased expression for Kcnq1ot1 non-coding RNA was observed in embryonic 
placentas at paternal age 11-15 months, along with increased expression for Nap1l4, 
Slc22a19, Cdkn1c, and Kcnq1 (p<0.05). Dysregulation of imprinted gene expression 
corresponded with an increase in imprinted DNA methylation at the Kcnq1ot1 ICR in 
embryonic placentas at paternal age 11-15 months (65.6%) compared to the same males 
during their youth (4-6 months, 59.0%; p=0.016).  These results are highly indicative of an 
aberrant gain of methylation on the typically unmethylated paternal allele at the 
Kcnq1ot1 ICR, resulting in the loss of paternal Kcnq1ot1 non-coding RNA expression, and 
a gain of paternal expression for otherwise only maternally expressed protein-coding 
genes: Nap1l4, Slc22a19, Cdkn1c, and Kcnq1. 
Conclusions: While the genome is largely reprogrammed during gametogenesis and early 
embryogenesis, imprinting domains escape this epigenetic reprogramming. In our study 
paternal aging was associated with significant epigenetic dysregulation to both ICR DNA 
methylation and imprinted gene expression at the Kcnq1ot1 domain in embryonic 
placenta. If these epigenetic changes related to paternal aging are translational, they 
could be responsible for placental dysfunction and adverse pregnancy outcomes.  
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Jason C. Parks, Blair R. McCallie, Alyssa L. Patton, Nathan I. McCubbin, William B. 
Schoolcraft, Mandy G. Katz-Jaffe. Antioxidant intervention promotes cell survival and 
redox balance within the ovary and subsequent oocyte resulting in improved IVF 
outcomes. Presented at 2018 ASRM Conference in Denver, Colorado. 
 
Objective:  The damaging effect of oxidative stress and reactive oxygen species in ovarian 
aging has been associated with a decrease in follicular quantity and quality. Previously we 
have reported that antioxidant intervention prior to infertility treatment benefits patient 
outcomes. The objective of this study was to utilize a murine model to explore the 
molecular mechanisms underlying this observed clinical benefit.  
Design: Research study.  
Materials & Methods:  Female CF-1 mice were naturally aged for 9 months prior to a daily 
diet intervention of 4 grams/animal of Euterpe oleracea (açaí; sourced from Brazil and 
biochemically tested for high antioxidant activity). Control mice received the same 
balanced nutritional feed but without the intervention. All aged mice were subjected to 
ovarian stimulation prior to collection of MII oocytes and ovarian tissue.  Ovaries (n=12) 
were processed for CodeLink™ Mouse Whole Genome (Applied Microarrays) with 
Ingenuity Pathway Analysis (Qiagen).  QPCR was utilized for microarray validation (n=12) 
and oocyte gene expression (n=19) with REST 2009 statistical software (Qiagen). Infertility 
patients (n=209; mean 38.0 ±4.0 years) presenting with ≥1 prior failed IVF cycle, ingested 
600mg of natural açaí three times a day for 8-12 weeks prior to routine ovarian 
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stimulation. Live birth outcomes were analyzed for each patient, with and without açaí, 
using Fisher’s exact test, with significance at P<0.05.   
Results:  Microarray gene expression analysis of murine ovarian tissue revealed significant 
transcription changes in the açaí intervention group, with the most enriched pathways 
belonging to apoptotic signaling and oxidation redox (P<0.05). QPCR validation confirmed 
a decrease of pro-apoptotic genes (Fas, Casp9, Bik and Tnf) and increases of pro-survival 
cell death regulators (Bcl2 and Bcl2l1), as well as increases of antioxidant enzymes (Gclm 
and Sod2, among others) with açaí intervention (P<0.05). Murine MII oocytes in the açaí 
intervention group were also found to have increased antioxidant gene expression (Gss, 
Gpx1, Gsr, Gsto1, Gclm, Sod1 and Sod2). Ongoing clinical results continue to show 
significant improvements in oocyte yield (17.4 ±10.1 vs. 13.7±8.2; P<0.0001) and 
proportion of euploid blastocysts (43.6% vs. 30.3%; P<0.0001) for female patients with ≥1 
prior failed IVF cycle. Euploid FET (n=138) outcomes for these intervention patients have 
resulted in a 76.1% live birth rate.   
Conclusions:  In conclusion, following antioxidant intervention with natural aging, the 
murine ovarian transcriptome revealed an environment promoting cell survival alongside 
a decrease in apoptotic signaling, and an increase in antioxidant activity that could be 
resulting in restoration of ovarian function and oocyte quality. Taken together this offers 
a molecular explanation for the clinical improvements observed for women with a history 
of IVF failures, following antioxidant intervention prior to infertility treatment.  
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JC Parks, BR McCallie, NI McCubbin, DK Griffin, WB Schoolcraft, MG Katz-Jaffe. Uterine 
miRNAs reflect the unique microenvironment in an individual murine horn during the 
window of implantation. Presented at 2018 SSR Conference in New Orleans, Louisiana. 
 
Successful implantation is dependent on the complex interchange between a viable 
embryo and a receptive endometrium.  On the maternal side, specific adhesion molecules 
are required for blastocyst attachment, in addition to tight regulation of signaling 
molecules surrounding the implanting embryo. This study utilized a minimally invasive 
technique of sampling the mammalian uterine environment, immediately prior to embryo 
transfer, to examine microRNA expression in association with implantation outcome.  In 
vivo fertilized zygotes collected from super ovulated virgin female BDF-1 mice were 
cultured to the blastocyst stage.  Two hatching, day 5 blastocysts were selected for 
individual embryo transfer into each uterine horn (n= 1 embryo/horn) of a pseudo 
pregnant BDF-1 recipient mouse (n=7).   Immediately prior to the embryo transfer 
procedure, a gentle aspiration from the lumen of the uterine horn was performed (n=14).   
On Day 16 of fetal development, recipient females were sacrificed, and implantation 
outcome was documented.  Uterine aspirates were evaluated for microRNA expression 
by qPCR (TaqMan®, Thermo Fisher) and analyzed for significance in association with 
implantation outcome, significance at P < 0.05.  Six specific microRNAs were chosen based 
on their known roles as mediators of transcription in association with embryo 
implantation: miR-22, miR-145, miR-200a, miR-223, miR-3074 and miR-let7b.  Analysis of 
the uterine aspirate revealed significant expression differences in relation to implantation 
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for miR-22, miR-200a, miR-3074 and miR-let-7b (P < 0.05).  Specifically, miR-let-7b 
displayed increased expression (P < 0.05) with successful single embryo implantation 
compared to a negative outcome in the opposite horn of the same female mouse.  
Increased expression of miR-let7b has been shown to play a regulatory role on the 
expression of Muc1 during the window of implantation, resulting in the establishment of 
viable pregnancy (Inyawilert et. al., 2015).  In contrast, miR-22, miR-200a and miR-3074 
displayed a significant decrease in expression with single embryo implantation (P < 0.05) 
compared to a negative outcome in the opposite horn of the same female mouse.  Studies 
have shown that dysregulation of miR-22 in conjunction with Tiam1/Rac1 signal 
expression inhibit embryo implantation (Ma HL et. al., 2015).  In conclusion, this study has 
revealed that each uterine horn has a unique microenvironment containing a complex 
milieu of microRNAs during the window of implantation.  Uterine microRNAs represent a 
minimally invasive means of sampling the embryo-endometrial molecular dialogue, 
allowing for the prediction of implantation potential which if translatable to the human, 
could improve IVF success for infertility patients.  
Molecular Signatures of Reproductive Success 
216 
 
Jason C Parks, Blair McCallie, Mary Sweet, Taylor Pini, William B Schoolcraft, Mandy G 
Katz-Jaffe. Minimally invasive uterine aspiration 24 hours ahead of embryo transfer 
characterizes the compromised RIF uterine microenvironment and is predictive of 
reproductive outcome. Presented at 2019 ASRM Conference in Philadelphia, 
Pennsylvania. 
 
Objective: Repeat implantation failure (RIF) is particularly challenging to treat in ART, 
resulting in limited success even when adequate preparation of the endometrium is 
established and a transfer is performed with a high grade euploid blastocyst. The 
objective of this study was to utilize a multidisciplinary approach to decipher the 
complexity of RIF through investigations of the maternal molecular components ahead of 
an embryo transfer.  
Design: Research study  
Materials and methods: Patients were recruited with IRB consent 24 hours prior to a 
programmed frozen embryo transfer (FET) with a euploid blastocyst. Uterine secretions 
were collected by gentle aspiration (~2-5ul) under ultrasound guidance and grouped 
according to reproductive outcomes: Failed euploid FET (RIF patients, ≥3 prior IVF failures) 
and Positive live birth FET (maternally age-matched patients; mean 36.6 ±3.8 years). Total 
and small RNA (n = 22) was isolated for sequencing on the NovaSEQ 6000 (Illumina).  
Reads were aligned to hg38 using GSNAP and analyzed with edgeR (FDR cutoff of 5%; 
P<0.01).  Metabolite analysis (n = 20) was performed by UHPLS-MS (Thermo) using 
MassMatrix and Maven (Princeton Univ). Proteomic analysis (n = 6) involved FASP 
Molecular Signatures of Reproductive Success 
217 
 
digestion and LC-MS/MS, with protein identifications generated by Mascot (v 2.6) and 
Scaffold (v 4.8.9) (α of 0.05; fold change >1.5 or <0.5).  
Results: A unique uterine microenvironment was observed for RIF patients and negative 
implantation outcomes 24 hours prior to an embryo transfer (P<0.05). An interplay of 
several biological processes were evident in RIF failed aspirates with a focused interest 
on 13 significantly reduced transcripts, 7 significantly increased maternal miRNAs, 12 
significantly decreased amino acids and 16 proteins of significantly altered abundance 
(P<0.05). Specific examples included decreased expression of PLA2G4D (P<0.0001) which 
regulates the eicosanoid pathway, thereby impacting downstream synthesis of 
prostaglandins like PGE2. Decreased expression of TET1 (P<0.0001), an epigenetic 
regulator required for DNA methylation. Increased expression of miR-17, a known 
negative regulator of VEGFA, required for successful implantation (P<0.01). Decreased 
quantities of arginine, essential for blastocyst activation and trophectoderm motility 
(P<0.05). Lastly, an increased abundance of SERPING1, a protein associated with 
inflammation, which regulates complement activation (P<0.05). 
Conclusion: Analysis of uterine secretions 24 hours prior to FET, allowed for an in-depth 
molecular characterization of the compromised RIF uterine microenvironment and was 
predictive of reproductive outcome. The negative influence on key miRNAs and gene 
transcription levels, in addition to altered amino acid and protein concentrations, were 
all identified as critical contributors to poor RIF outcomes. Ongoing investigations into the 
relationships of these molecular networks will lead to the possibility of more effective 
clinical interventions for this difficult patient population.  
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Jason C Parks, Mary E Haywood, Blair McCallie, Sue McCormick, William B Schoolcraft, 
Mandy Katz-Jaffe. Disruption of NFR2-mediated stress response and DNA repair 
pathways are associated with limited developmental potential of trisomy embryos. 
Presented at 2020 ASRM Virtual Conference. 
 
Objective: Embryonic chromosomal trisomy is recognized as a leading cause of 
reproductive failure and pregnancy loss in human reproduction.  Interestingly, specific 
trisomy’s have differing implantation potential and only a handful of trisomies 
(chromosome 13, 18, 21, X and Y) will even develop past the first trimester.  The aim of 
this study was to investigate the association between the embryonic transcriptome and 
a range of embryonic trisomy with differing implantation potentials. 
Design: Research study  
Materials and methods: Surplus, frozen blastocysts (n = 55) were donated to research 
with IRB and patient consent. Blastocysts underwent micromanipulation to isolate 
trophectoderm (TE) cells for transcriptome analysis. In addition to euploid blastocysts 
(n=17), the following trisomies were identified based on differing implantation potential: 
trisomy 7 (n=11) and trisomy 11 (n=5) that are most likely to result in implantation failure, 
as well as trisomy 15 (n=11) and trisomy 22 (n=11) which are able to implant but will 
always result in miscarriage. Individual TE total RNA (n = 25) was isolated for sequencing 
on the NovaSEQ 6000 (Illumina).  Reads were aligned to hg38 using GSNAP and only reads 
mapping to non-trisomy chromosomes were included in downstream analysis (genes on 
chromosomes 7, 11, 15, and 22 were excluded in all samples). Differential gene 
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expression was analyzed with edgeR and limma (FDR<5%), and interpreted using 
Ingenuity Pathway Analysis (Qiagen).  Validation was performed on additional individual 
TE samples (n = 30; 6 per group) with gene expression confirmed using Real-Time PCR 
(ViiA 7 Real-Time PCR System; P<0.05). 
Results: An interplay of several biological processes were evident in all trisomy embryo 
groups compared to euploid, regardless of the specific chromosome involved in the 
meiotic error, with a total of 389 differentially expressed genes (P<0.05). There was no 
enrichment for chromosome type or cytoband. Pathway analysis identified a globally 
inhibited NRF2-mediated stress response including validation of the two central players 
in the pathway, NRF2 and KEAP1 (P<0.001) and 8 significantly decreased NRF2 targets 
(regulating key antioxidant and metabolic genes; P<0.05). CLPTM1L, also a target of NRF2, 
was validated showing increased expression that may result in activation of apoptosis 
(P<0.05).  DNA damage response was also significantly associated with embryonic trisomy 
(P<0.05). Specific validated genes included confirmation of significant increased 
expression of BRCA2, PALB2 and ATR, all genes that are essential for DNA damage repair 
pathways (P<0.0001).  
Conclusion: This in-depth molecular characterization of embryonic trisomy concluded 
that regardless of the individual triploid chromosome, a globally compromised 
transcriptome was apparent.  Significant disruption to the NRF2- mediated stress 
response and DNA repair pathways were specifically evident in all trisomy embryos, which 
explains why the vast majority of trisomy conceptions will have limited potential and 
perish during the early stages of development.  
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15.0 Appendix 2. Additional publication 
 
McCallie BR, Parks JC, Griffin DK, Schoolcraft WB, Katz-Jaffe MG. Infertility diagnosis has 
a significant impact on the transcriptome of developing blastocysts. Mol Hum Reprod. 
2017 Aug 1;23(8):549-556. doi: 10.1093/molehr/gax034.  
 
My personal contribution to this manuscript  
 
I worked closely with Dr. Katz-Jaffe and McCallie on this research study by providing input 
with regard to the study design and results interpretation.  I was also responsible for 
coordinating the collection of study materials between the research department and the 
IVF laboratory.  I also warmed each of the vitrified embryos, confirmed their viability and 
finally prepared the samples for storage at -80°C and downstream transcriptome 
experiments.  This manuscript was co-authored by Blair McCallie and myself, with each 
of us sharing first-authorship. 
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16.0 Appendix 3. Additional publication 
 
Katz-Jaffe MG, Lane SL, Parks JC, McCallie BR, Makloski R, Schoolcraft WB. Antioxidant 
Intervention Attenuates Aging-Related Changes in the Murine Ovary and Oocyte. Life 
(Basel). 2020 Oct 22;10(11):E250. doi: 10.3390/life10110250. 
 
My personal contribution to this manuscript  
 
I worked closely with Dr. Katz-Jaffe on this research study and provided input with regard 
to the study design and results interpretation.  I was responsible for maintaining and 
monitoring the health of the mouse colony, and worked with Dr. Katz-Jaffe to coordinate 
ordering animals and reagents as needed.  I sacrificed the animals used in this study in 
accordance with the experimental timeline, and the study materials were collected by me 
including oocytes and ovaries for -80°C storage.  Finally, I contributed to the writing of the 
materials and methods section of the manuscript. 
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17.0 Appendix 4. Additional publication 
 
Denomme MM, McCallie BR, Parks JC, Schoolcraft WB, Katz-Jaffe MG. Epigenetic 
Dysregulation Observed in Monosomy Blastocysts Further Compromises Developmental 
Potential. PLoS One. 2016 Jun 7;11(6):e0156980. doi: 10.1371/journal.pone.0156980. 
eCollection 2016. 
 
My personal contribution to this manuscript  
 
I worked closely with Dr. Katz-Jaffe and Dr. Denomme to coordinate the collection of 
study materials between the research department and the IVF laboratory.  I also warmed 
the vitrified embryos used in this study, and confirmed their viability prior to preparing 
them for storage at -80°C and downstream molecular experiments.  Finally, I co-wrote 
and edited sections of the materials and methods section of the manuscript for 
publication as a co-author. 
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